[
    {
        "pmid": "40813191",
        "title": "Compounding effects of heat and high humidity on cardiovascular morbidity in Dhaka, Bangladesh: An implication of climate crisis.",
        "abstract": "Global temperature extreme heat event worsening due climate change associated adverse health outcomes However study low middleincome country LMICs rare limited research combined effect heat relative humidity despite strong physiological evidence examined 340758 cardiovascular disease CVD emergency department ED visit Dhaka summer month 2014 2019 Meteorological data temperature relative humidity RH precipitation collected Bangladesh Meteorological Department fitted timeseries regression model CVD ED data assess effect heat RH individually interaction model adjusted potential timevarying confounders Exposure heat associated 79  95  CI 46 113  excess risk CVD ED association observed RH CVD ED However effect size heat increased linearly increasing RH culminated 6fold increase excess risk humid day RH range 82 97  compared day normal humidity RH range 34 69  excess risk 267  202 337  v 44  04 86  Results held across several sensitivity analyses significant risk effect difference observed age sex group stratified analyses study provides novel alarming evidence high RH compound effect heat cardiovascular health underscore importance considering factor together clinical advice assessment development policy addressing climate change local regional global levels",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813191/"
    },
    {
        "pmid": "40776165",
        "title": "Expert System for Assistance in Diagnosing High Blood Pressure.",
        "abstract": "High Blood Pressure HBP disorder characterized elevated level pressure blood vessel constituted one risk factor cardiovascular disease mortality work proposed development Expert System Diagnosis Secondary HBP innovative tool capable providing accurate personalized diagnosis considering multiple factors system evaluated blood pressure level classify degree HBP analyzed various clinical parameter identify possible ground secondary hypertension",
        "mesh_terms": [
            "Hypertension",
            "Humans",
            "Expert Systems",
            "Blood Pressure Determination",
            "Diagnosis, Computer-Assisted"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776165/"
    },
    {
        "pmid": "40760789",
        "title": "Current Advancement and Patient Outcomes in Reperfusion Brain Injuries After Stroke: A Comparative Analysis of Thrombolysis and Thrombectomy.",
        "abstract": "Stroke remains leading cause death disability worldwide ischemic stroke accounting majority cases Advances reperfusion therapies including intravenous thrombolysis IVT mechanical thrombectomy MT significantly improved outcome acute ischemic stroke patients However reperfusion brain injury RBI paradoxical consequence recanalization pose major challenge driven oxidative stress inflammation bloodbrain barrier disruption review critically examines emerging therapeutic strategy mitigate RBI focusing pharmacological agent edaravone NXY059 tenecteplase well procedural innovation thrombectomy review employed systematic search database PubMed Cochrane Library Embase Scopus using certain keywords comparative analysis thrombolysis thrombectomy done emerging technique drug mitigating reperfusion brain injury RBI discussed Thrombolysis thrombectomy highlight key difference efficacy safety patient selection criteria thrombectomy demonstrates superior outcome large vessel occlusion LVOs thrombolysis remains cornerstone early intervention thrombectomy inaccessible Essential drug like NXY059 edaravone uric acid Nacetylcysteine others changing care RBI stroke Newer thrombectomy technique technology also promising However evident efficacy method still inconsistent various patients thrombectomy thrombolysis potential cause poststroke cognitive decline thrombectomy lead better outcomes patientspecific factor age previous medical history infarct volume others must considered Neurorehabilitation essential patient recovery poststroke cognitive decline Strategies use gasmediated therapies pharmacological agents stem cell therapies antioxidant nanomedicines modulation specific protein like sirtuins emerging treatment technique promising change narration RBI management impact patient outcomes review underscore need precision medicine approaches improved imaging patient selection comprehensive longitudinal study optimize reperfusion strategies Targeted intervention addressing oxidative damage inflammation hold promise reducing RBI improving longterm patient outcomes",
        "mesh_terms": [
            "Humans",
            "Thrombectomy",
            "Thrombolytic Therapy",
            "Reperfusion Injury",
            "Stroke",
            "Ischemic Stroke",
            "Treatment Outcome",
            "Fibrinolytic Agents"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760789/"
    },
    {
        "pmid": "40760566",
        "title": "Safety of esaxerenone (CS-3150) and its impacts on blood pressure and renal function: A systematic review and meta-analysis.",
        "abstract": "safety efficacy esaxerenone ESAX novel nonsteroidal mineralocorticoid receptor antagonist remain insufficiently explored systematic review metaanalyses SRMA SRMA aimed investigate safety effect ESAX blood pressure BP renal function Multiple database register systematically searched identify randomized controlled trial realworld study evaluating safety efficacy ESAX various conditions primary outcome risk adverse event AEs secondary outcome included effect BP renal parameters SRMA included 22 study N  4699 6 study 5 randomized controlled trial one retrospective study n  3211 comparator group metaanalyzed subject ESAX especially higher doses experienced drugrelated AEs risk ratio RR 177 discontinued due AEs RR 675 compared placebo number subject serious AEs drugrelated serious AEs similar 2 groups Higher dos ESAX associated increased risk rising serum potassium level RR 330 drug discontinuation related increase RR 571 compared placebo ESAX active comparators exhibited comparable AEs except higher risk RR 287 increasing serum potassium level ESAX ESAX led larger decrease estimated glomerular filtration rate urine albumincreatinine ratio placebo ESAX effective placebo active comparators lowering office systolic diastolic BP ESAX 5 mg showed greater 24hour average ambulatory BP reduction compared active comparators ESAX appears reasonably safe modest risk hyperkalemia worsening renal function modest efficacy treatment hypertension albuminuria",
        "mesh_terms": [
            "Humans",
            "Blood Pressure",
            "Mineralocorticoid Receptor Antagonists",
            "Kidney",
            "Pyrroles",
            "Sulfones",
            "Randomized Controlled Trials as Topic",
            "Hypertension",
            "Glomerular Filtration Rate"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760566/"
    },
    {
        "pmid": "40758217",
        "title": "Ultra-Processed Grains and Risk of Inflammatory Bowel Disease: Results from the Prospective Urban Rural Epidemiology (PURE) Study.",
        "abstract": "Ultraprocessed grains commonly consumed Western diets undergo refining process often remove beneficial component include additive enhance taste texture durability potentially influencing gastrointestinal health study examines association ultraprocessed grain consumption risk developing IBD using data Prospective Urban Rural Epidemiology PURE study analysis included 124590 participant 21 country dietary data available PURE study Dietary intake assessed validated food frequency questionnaires ultraprocessed grain intake categorized three levels primary outcome development IBD including Crohns disease CD ulcerative colitis UC Multivariate Cox proportional hazard model used calculate hazard ratio HRs adjusting confounders including age sex smoking status eating habits physical activity Among 124590 participants higher ultraprocessed grain intake associated increased IBD risk Participants consuming ≥19gday ultraprocessed grain higher risk developing IBD compared consuming 9gday HR 186 95 confidence interval CI 126261 ptrend00003 multivariate adjustment Fresh bread rice consumption associated lower IBD risk Participants greater ultraprocessed food intake ≥ 5 servingsday linked higher risk developing IBD compared consuming 1 servingday HR 395 95 CI 274571 ptrend00001 Higher intake ultraprocessed grain associated significantly increased risk developing IBD healthy eating pattern minimize consumption ultraprocessed grains study performed understand component ultraprocessed grain may detrimental health",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40758217/"
    },
    {
        "pmid": "40757253",
        "title": "Long COVID Syndrome, Mortality and Morbidity in Patients Hospitalized with COVID-19 From 16 Countries: The World Heart Federation Global COVID-19 Study.",
        "abstract": "Longterm adverse consequence COVID19 infection affect many organ systems requires comprehensive understanding disease burden determinant persistent long COVID19 symptom diverse population However data long COVID complication sparse particularly low middleincome country LMICs World Heart Federation WHF global study assessed incidence vascular complications persistent long COVID symptom factor associated mortality major adverse cardiovascular event MACE among patient COVID19 one year hospitalization recruited total 2535 patient hospitalized COVID19 followed oneyear posthospital discharge collected data long COVID symptoms quality life clinical outcomes including new onset diseases MACE mortality 1 3 6 912 month postdischarge Descriptive generalized estimating equation GEE regression analysis performed assess factor associated mortality MACE majority participant recruited LMICs 64 male 56 mean SD age 595 200 years Among tested COVID19 strain 52 Omicron strain prevalent 98 followup rate one year 90 half participant 56 reported experiencing least one major long COVID symptom fatigue breathlessness anxiety chest pain palpitations 1month onequarter participant reported persistent long COVID symptom 912 months EQ5D scale 49 reported difficulty usual activities 33 reported anxietydepression 23 reported problem mobility within first 6 months frequent newonset illness pulmonary embolism 8 kidney disease 4 hypertension 3 cumulative allcause mortality rate 15 n  382 oneyear postdischarge Long COVID symptom common among females individual preexisting comorbidities severe acute illness Age obesity ICU admission underlying cardiovascular pulmonary disease associated increased risk mortality MACE study showed substantial burden mortality morbidity quarter patient reported least one persistent long COVID symptom one year finding underscore need early identification management long COVID symptom LMICs",
        "mesh_terms": [
            "Aged",
            "Female",
            "Humans",
            "Male",
            "Middle Aged",
            "Cardiovascular Diseases",
            "COVID-19",
            "Global Health",
            "Hospitalization",
            "Incidence",
            "Morbidity",
            "Post-Acute COVID-19 Syndrome",
            "Quality of Life",
            "SARS-CoV-2"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757253/"
    },
    {
        "pmid": "40727248",
        "title": "Exploring the Epigenetic and Metabolic Pathways for Antioxidant and Anti-Inflammatory Potentials of Tart Cherry Juice Concentrate.",
        "abstract": "Tart cherry TC iPrunus cerasusi high antioxidant antiinflammatory potential due rich bioactive component like anthocyanins polyphenols vitamins betacarotene ellagic acid chlorogenic acid Oxidative damage inflammation underlying reason chronic disease pathogenesis Oxidative stress usually caused imbalance antioxidant prooxidants Additionally chronic inflammatory state typically modulated oxidative stress Inflammation play critical role chronic health conditions cardiovascular diseases hypertension insulin resistance arthritis cancer Numerous study indicate strong relationship TC inhibition inflammation oxidative damage regulating different epigenetic metabolic pathways review recent development TC component metabolite inflammatory oxidative damage discussed challenge limitation better support future research including clinical trial confirm findings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40727248/"
    },
    {
        "pmid": "40725544",
        "title": "The Angiography Pattern of Buerger's Disease: Challenges and Recommendations.",
        "abstract": "2023 VAS international working group Buergers Disease BD recommended two diagnostic criterion based prior Delphi study definitive suspected definitive criterion history smoking typical angiography typical histopathological features three feature mandatory confirm definitive diagnosis BD conundrum iswhat feature considered typical BD angiography According review segmental occlusion infrapopliteal arteries corkscrew collateral appear continue occluded arterial segment Martorells sign bypass segmental occlusion absence atherosclerotic plaque aneurysm could differentiate BD ASO Hence typical BD angiography manifestation certainly considered However data differentiating angiography pattern BD small mediumsized vasculitis including Behcets disease scleroderma hepatitis associated vasculitis antiphospholipid syndrome limited study investigating angiography pattern BD patient early late presentation BD particularly patient longterm follow up highly recommended",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40725544/"
    },
    {
        "pmid": "40712612",
        "title": "The burden of cardiovascular events according to cardiovascular risk profile in adults from high-income, middle-income, and low-income countries (PURE): a cohort study.",
        "abstract": "Current strategy prevent adverse cardiovascular outcome focus primary prevention highrisk group secondary prevention people known cardiovascular disease aimed determine proportion event occurring lowerrisk group globally included people aged 40 year younger 75 year enrolled Prospective Urban Rural Epidemiology PURE study ongoing international prospective populationbased cohort study started recruiting adult household selected broadly representative sociodemographic composition communities prospectively documented fatal nonfatal myocardial infarction stroke heart failure fatal cardiovascular event stratified history cardiovascular disease 10year predicted disease risk score based 2019 laboratory risk table 10 low 10 20 intermediate ≥20 high people without previous cardiovascular disease 26 highincome middleincome lowincome countries Outcome event rate standardised cohorts age sex distribution July 11 2000 May 6 2019 128 973 participant included 26 country mean age 53·6 year SD 8·2 75 858 58·8 female 53 115 41·2 male observed 11 483 outcome event affecting 8·9 cohort median followup 12·3 year IQR 9·814·6 Among participants 89 508 69·4 low cardiovascular disease risk 22 363 17·3 intermediate cardiovascular disease risk 5529 4·3 high cardiovascular disease risk 11 573 9·0 known cardiovascular disease agestandardised sexstandardised cardiovascular disease incidence rate per 1000 personyears 4·1 95 CI 4·04·2 lowrisk group 17·7 15·220·2 intermediaterisk group 40·8 25·156·4 highrisk group Overall 41 outcome event occurred cardiovascular diseasenaive participant low risk proportion adverse cardiovascular outcome occurring lowrisk group inversely related country income level 32 highincome 38 middleincome 54 lowincome countries higher woman 51 men 32 achieve substantial populationlevel reduction cardiovascular disease fundamental change needed preventive strategy cardiovascular disease extend beyond high even intermediate predicted risk include considered low risk funding body listed appendix p 29",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Cardiovascular Diseases",
            "Middle Aged",
            "Adult",
            "Prospective Studies",
            "Developed Countries",
            "Developing Countries",
            "Aged",
            "Global Health",
            "Heart Disease Risk Factors",
            "Cohort Studies",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40712612/"
    },
    {
        "pmid": "40703220",
        "title": "CardioTabNet: a novel hybrid transformer model for heart disease prediction using tabular medical data.",
        "abstract": "early detection accurate prediction cardiovascular disease CVDs critical reduce global severe morbidity mortality Machine learning ML methods operated Transformers proved efficiency interpreting complex data interactions One prime example would notable success Natural Language Processing NLP multiheaded selfattention mechanism disentangle complex interaction within highdimensional spaces However relationship various feature within biological system remain ambiguous spaces making difficult apply transformer clinical datasets introduce CardioTabNet transformerdriven framework designed precisely clinical cardiovascular data leverage strength tab transformer architecture effectively extract meaningful insight clinical data result downstream classical models performance significantly showed outstanding results utilized opensource cardiovascular dataset 1190 instance 11 features feature categorized numerical age resting blood pressure cholesterol maximum heart rate old peak weight fasting blood sugar categorical resting Electrocardiograms exercise angina ST slope variables Tab transformer used extract significant feature rank using Random Forest RF feature ranking algorithm highlighted important clinical predictors used ten classical machinelearning model trained transformer extractedfeatures optimized ExtraTree classifier achieved average accuracy 941 area curve AUC 95 Furthermore performed nomogram analysis draw cardiovascular risk assessment demonstrate clinical interpretability Benchmarking stateoftheart methodology affirmed superior predictive capability CardioTabNet framework demonstrating potential robust tool clinical decision support cardiovascular disease prediction early detection addition SHAP SHapley Additive exPlanations analysis carried provide insight feature contribution enhance model interpretability online version contains supplementary material available 101007s13755025003617",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40703220/"
    },
    {
        "pmid": "40688614",
        "title": "<i>TCF7L2</i> rs12255372 Gene Polymorphism and Susceptibility to Obesity: Experience from a Tertiary Level Hospital in Bangladesh.",
        "abstract": "transcription factor 7like 2 iTCF7L2i gene emerged promising gene causing type 2 diabetes mellitus associated obesity However genetic factor underlying obesity South Asian population remain largely unexplored study aimed evaluate relationship iTCF7L2i gene polymorphism rs12255372 G  T obesity along weightrelated traits Bangladeshi participants crosssectional study conducted Department Endocrinology medical university Eighty adult enrolled nonrandom sampling met inclusion exclusion criterion categorized obese nonobese based Expert Consultation 2004 rs12255372 G  T polymorphism genotyped using polymerase chain reactionrestriction fragment length polymorphism technique statistical analysis carried using SPSS version 260 Windows 80 participants 28 obese 52 nonobese allelic odds ratio OR 386 95 confidence interval CI 156954 iPi  0002 found minor allele iTCF7L2i rs12255372 obesity significant difference GT genotype observed participant obesity without obesity OR 353 95 CI 1131107 iPi  002 minor allele frequency rs12255372 G  T among participant obesity without obesity 27 9 respectively indicating rs12255372 G  T polymorphism iTCF7L2i gene may associated risk obesity studied Bangladeshi population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40688614/"
    },
    {
        "pmid": "40687743",
        "title": "Temporal dynamics in the association between depression and dementia: an umbrella review and meta-analysis.",
        "abstract": "Identifying modifiable risk factor crucial dementia prevention global health concern Depression considered risk factor dementia temporal dynamic across life course remain inconclusive Therefore aimed systematically assess relationship timing depression assessment risk allcause latelife dementia conducted umbrella review metaanalysis assess incident dementia individual noncurrent history depression PubMed Ovid Embase MEDLINE PsycInfo searched inception February 17 2025 Systematic review metaanalyses investigating association depression incident latelife dementia included eligible reviews also extracted data study reporting dementia risk hazard ratio HRs analysing timing depression measurement using randomeffects model metaanalysis study registered PROSPERO CRD42021249706 7763 record identified nine review eligible inclusion umbrella review One review judged moderate quality others either low ini  3 critically low ini  5 metaanalyses 18 study reporting depression onset later life ini  901762 participants ini  7595 incident dementia cases seven study depression assessed midlife ini ≥ 2501269 participants ini ≥ 276929 incident dementia cases included study metaanalyses deemed good quality strong evidence publication bias Pooled HRs indicated depression present latelife HR 195 95 CI 168226 iIi supi2isup  775 midlife HR 156 95 CI 112218 iIi supi2isup  975 significantly increased risk allcause dementia finding suggest depression across life course may increase dementia risk however substantial heterogeneity review quality considered interpreting strength evidence life course approach treatment prevention depression may help reduce burden dementia require scaling access effective mental health care vulnerable populations research needed clarify stronger latelife association reflects depression immediate risk factor early manifestation neurodegenerative processes National Institute Health Care Research UK Research Innovation Saudi Arabian Cultural Mission",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40687743/"
    },
    {
        "pmid": "40686567",
        "title": "Urinary Sodium and Potassium Excretion in Bangladeshi Adults: Results from a Population-Based Survey with 24-Hour Urine Collections.",
        "abstract": "high burden blood pressurerelated cardiovascular disease Bangladesh potentially caused excessive dietary sodium insufficient potassium intake objective estimate dietary salt potassium intake among Bangladesh rural urban adult urinary excretion sodium potassium conducted crosssectional study December 2017 June 2018 including participant aged 3059 year three urban three rural site Bangladesh Data included urinary excretion sodium potassium estimated one 24hr urine collection blood pressure measurements Among 840 enrolled participants complete data available 509 individuals Mean age 430 SD ±79 years 209 hypertension 509 women 509 resided urban areas Mean systolic diastolic blood pressure 1186 SD ± 166 mmHg 763 SD ± 113 mmHg respectively Overall mean urinary sodium excretion 39 gday 95 CI  38 40 corresponding mean salt intake 97 gday 95 CI  94101 Mean urinary potassium excretion 14 gday 95 CI  1314 corresponding estimated mean dietary potassium intake 20 gday Men urban resident slightly nonsignificantly higher sodium potassium excretion woman rural residents Bangladesh salt intake exceeded WHOs recommended 5gday limit potassium intake substantially lower recommended intake ≥ 35gday adults Promoting lowsodium potassiumrich diet nationwide campaign policies including advocating accessible lowsodium potassiumenriched salt substitutes recommended mitigate cardiovascular disease risks",
        "mesh_terms": [
            "Humans",
            "Adult",
            "Female",
            "Bangladesh",
            "Male",
            "Middle Aged",
            "Cross-Sectional Studies",
            "Sodium",
            "Potassium",
            "Rural Population",
            "Blood Pressure",
            "Hypertension",
            "Urban Population",
            "Sodium, Dietary"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40686567/"
    },
    {
        "pmid": "40678696",
        "title": "World health Organization's guidance for tracking non-communicable diseases towards sustainable development goals 3.4: an initiative for facility-based monitoring.",
        "abstract": "Noncommunicable disease NCDs account 60 annual global deaths disproportionately affecting low middleincome countries trend undermines progress toward Sustainable Development Goal SDG 34 seek reduce premature mortality NCDs onethird 2030 Despite availability effective relatively affordable interventions addressing NCDs requires sustained coordinated effort robust monitoring systems Facilitybased monitoring offer dynamic alternative static surveys enabling continuous assessment healthcare quality utilization study followed systematic approach develop standardized global national NCD monitoring indicators using Donabedian model conceptual framework focused four major NCD categories hypertension cardiovascular disease CVDs diabetes chronic respiratory diseases cancers methodology included systematic scoping review inception November 2021 multiround Delphi process involving global expert assess validity feasibility proposed indicators study funded internally WHO payment participants final output consisted 81 validated indicators22 core 59 optional indicator demonstrated high feasibility relevance facilitybased monitoring NCD service delivery provide actionable metric assessing improving quality care across diverse health system settings study highlight urgent need comprehensive contextsensitive NCD monitoring frameworks proposed set indicator offer validated foundation improving NCD care delivery aligns effort achieve SDG target 34 Ongoing update local adaptation essential ensure continued relevance effectiveness study funded internally WHO",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40678696/"
    },
    {
        "pmid": "40674701",
        "title": "Association of health knowledge with adoption of heart healthy behaviours: a cross-cohort analysis using data from the PURE Study.",
        "abstract": "study aim assess aspect health knowledge i awareness health effect tobacco smoking ii awareness preventive action heart disease stroke relationship adoption heart healthy behaviour smoking cessation utilisation antihypertensive treatment multicohort study recruited adult aged 35 70 year 21 countries Data health effect tobacco smoking 10 questions health action prevent heart disease stroke 11 questions collected baseline Logistic regression analysis used examine relationship outcome smoking cessation use antihypertensive treatment adjusting adjusting possible confounders 12962 included descriptive analysis 500 female 429 primary education 533  residing low lower middleincome country Among current former smokers knowledge health effect tobacco smoking heart disease Adjusted Odds Ratio aOR 170 95 CI 119 243 stroke 141 108186 heart disease nonsmokers exposed others smoking 140 106186 significantly positively associated smoking cessation compared aware health effects Knowledge importance reducing dietary salt aOR 162 123213 dietary fat aOR 156 117208 exercising aOR 148 122180 prevent heart disease stroke positively associated taking antihypertensive medication compared aware preventative actions study reinforces better health knowledge shape adoption heart healthy behaviour smoking cessation taking antihypertensive treatment even accounting baseline education wealth",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40674701/"
    },
    {
        "pmid": "40637918",
        "title": "Multi-class subarachnoid hemorrhage severity prediction: addressing challenges in predicting rare outcomes.",
        "abstract": "Accurately predicting severity subarachnoid hemorrhage SAH critical informing clinical decision improving patient outcomes study address challenge imbalanced data SAH severity classification employing Modified Rankin Scale MRS within threestage classification framework utilize threestage approach effectively categorize SAH severity first stage performed binary classification grouping SAH severity Good Outcome class 0 includes MRS level 0 1 2 3 Poor Outcome class 1 encompassing level 4 5 6 Feature selection done using Random Forest algorithm identify top 20 feature SAH severity prediction evaluated thirteen machine learning model stage selecting topperforming classifier optimize results dataset comprised 535 sample across seven MRS severity level validated using 5fold crossvalidation diverse subgroup ensure robust model performance across various scenarios Binary classification first stage achieved approximately 90 accuracy Extra Trees second stage targeting Good Outcome group Random Forest model reached 88 accuracy third stage achieved 86 accuracy Poor Outcome group increasing accuracy across unbalanced class emphasizing potential practical use multistage technique present promising solution predicting severity SAH Future research concentrate additional tuning improve models efficacy actual healthcare environments",
        "mesh_terms": [
            "Humans",
            "Subarachnoid Hemorrhage",
            "Severity of Illness Index",
            "Machine Learning",
            "Male",
            "Female",
            "Middle Aged",
            "Algorithms",
            "Prognosis",
            "Aged",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40637918/"
    },
    {
        "pmid": "40612465",
        "title": "DiaBD: A diabetes dataset for enhanced risk analysis and research in Bangladesh.",
        "abstract": "Diabetes chronic condition affecting million worldwide severely impact health quality life According International Diabetes Federation IDF 463 million adults 93 global population live diabetes Diabetes rank among prevalent chronic disease ninthleading cause mortality 2019 42 million death reported article introduces DiaBD novel dataset 5288 patient record Bangladesh designed address critical gap diabetes research aid healthcare planning risk analysis predictive modelling dataset comprises 14 attribute including age gender clinical vitals pulse rate systolic diastolic blood pressure glucose levels anthropometrics height weight body mass index BMI family history diabetes hypertension cardiovascular disease CVD stroke dependent attribute Diabetic indicates whether individual diabetes not dataset ensures demographic diversity precise measurements supporting study diabetes related health issues Features like CVD stroke enable broader research comorbidities dataset facilitates machine learning applications risk assessment personalized healthcare strategies Researchers explore link diabetes hypertension CVD stroke healthcare provider policymakers leverage DiaBD identify trends allocate resource efficiently enhance public health strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40612465/"
    },
    {
        "pmid": "40601770",
        "title": "Identifying predictors and assessing causal effect on hypertension risk among adults using Double Machine Learning models: Insights from Bangladesh Demographic and Health Survey.",
        "abstract": "Hypertension pose significant public health challenge low middleincome countries Bangladesh Health Population Nutrition Sector Development Program shown effectiveness resourcelimited settings Estimating causal relationship hypertension adjusting nonlinear observed confounders adult population complex study aim identify predictor hypertension explore observational causal inference hypertension hypertension data analyzed using Bangladesh Demographic Health survey data 2011 2022 used 11815 individual aged 34 year above Hypertension defined systolic blood pressure  140 mm Hg andor diastolic blood pressure  90 mm Hg andor history hypertension used logistic regression Random forest model Double Machine Learning DML Shapley Additive exPlanations SHAP based predefined causal structure dataset included 11815 individuals prevalence hypertension 3840 average age individual 5276 year SD 1297 6826 5877 male Random forest model achieved 93 accuracy evaluation f1scores 95 nonhypertension 91 hypertension identified older age female gender urban residency workers wealthier selfawareness excessive body weight key predictor hypertension individual conditional expectation SHAP plot reveal age body mass index BMI nonlinear relation hypertension crude excessive body weight hypertension 224 95CI 207  242 Adjusted age sex socioeconomic status SES selfawareness 197 95CI 179  217 using debiased method 130 95CI 117  143 study highlight important predictor hypertension including age sex residency socioeconomic status SES selfawareness body weight machine learning model achieved accuracy 93 predicting hypertension debiased method provided refined risk estimate Age excessive body weight found significantly contributed hypertension demonstrating complex interaction varying marginal effect across different level factors Awareness program targeted intervention vital effectively reduce excessive body weight prevent hypertension",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Hypertension",
            "Machine Learning",
            "Female",
            "Male",
            "Middle Aged",
            "Adult",
            "Risk Factors",
            "Health Surveys",
            "Prevalence",
            "Aged",
            "Computational Biology"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40601770/"
    },
    {
        "pmid": "40596364",
        "title": "Camellia sinensis powder rich in epicatechin and polyphenols attenuates isoprenaline induced cardiac injury by activating the Nrf2 HO1 antioxidant pathway in rats.",
        "abstract": "Myocardial infarction leading cause death morbidity individual cardiovascular diseases Natural antioxidants found green tea leaves beneficial preventing diseases study evaluated protective effect green tea leaf powder isoprenaline ISOinduced myocardial infarction rats Four group male Long Evans rat used Control Control  green tea leaf powder ISO ISO  green tea leaf powder Organ blood plasma sample collected measure oxidative stress biomarkers biochemical parameters gene expressions Furthermore tissue section prepared stained histologically ISOinduced rat showed decreased cellular antioxidant catalase activity glutathione concentration elevated oxidative stress markers Notable inflammatory cell infiltration fibrosis observed heart kidney ISOinduced rats Supplementation green tea leaf powder significantly restored catalase activity glutathione concentration p  005 plasma tissues also considerably reduced lipid peroxidation nitric oxide advanced oxidation protein product p  005 ISOadministered rats Furthermore green tea leaf powder supplementation halted inflammatory gene expression p  005 restored antioxidant gene p  005 Nrf2HO1 prevented cardiac fibrosis ISOadministered rats Green tea leaf powder supplementation may reduce oxidative stress inflammation fibrosis ISOadministered rats potentially Nrf2HO1mediated restoration antioxidant enzyme prevention heart inflammation",
        "mesh_terms": [
            "Animals",
            "Isoproterenol",
            "Catechin",
            "Male",
            "NF-E2-Related Factor 2",
            "Rats",
            "Antioxidants",
            "Oxidative Stress",
            "Camellia sinensis",
            "Polyphenols",
            "Powders",
            "Myocardial Infarction",
            "Plant Extracts",
            "Rats, Long-Evans",
            "Signal Transduction",
            "Heart Injuries",
            "Myocardium",
            "Heme Oxygenase (Decyclizing)"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40596364/"
    },
    {
        "pmid": "40583668",
        "title": "Cross Sectional Study on Clinical Profile and Risk Factors among Ischemic and Hemorrhagic Stroke.",
        "abstract": "common cause disability disorder stroke worldwide Prevention main focus stroke addressing risk factors stroke could prevented crosssectional observational study conducted September 2014 February 2017 department Neurology Bangabandhu Sheikh Mujib Medical University BSMMU Bangladesh patient ischemic hemorrhagic stroke confirmed neuroimaging CT scan brain MRI brain screening inclusion exclusion criteria seventyeight stroke patient included study Among 60760 ischemic Group A 18230 hemorrhagic Group B stroke patients Mean age study population 6083±1336 year 5858±1477 year Group Group B respectively group male predominant Mostly female housewife 330 higher percentage male businessman 300 study population literate Group maximum Group B illiterate Hypertension common risk factor smoking dyslipidemia diabetes mellitus ischemic heart disease respectively group ischemic hemorrhagic stroke patients Previous vascular events family history alcohol consumption higher Group Group B",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Cross-Sectional Studies",
            "Middle Aged",
            "Risk Factors",
            "Ischemic Stroke",
            "Aged",
            "Bangladesh",
            "Hemorrhagic Stroke",
            "Adult",
            "Hypertension"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583668/"
    },
    {
        "pmid": "40583666",
        "title": "Relationship of Intima-Media Thickness of Common Carotid Artery in Acute Ischemic Stroke.",
        "abstract": "Stroke second leading cause death third leading cause disability associated many risk factors progression Carotid Intima Media Thickness CIMT established strong predictor future vascular event recently purpose study assess association CIMT acute ischemic stroke cross sectional comparative study conducted Department Neurology Medicine Mymensingh Medical College Hospital Bangladesh January 2019 September 2020 Total 120 patient 60 case acute ischemic stroke 60 age sex matched apparently healthy controls included study Participants studied presence atherosclerotic risk factor CIMT high resolution ultrasonography Mean age patient acute ischemic stroke 6285±930 year 700 male significant difference noted case control term age sex occupation education socioeconomic class mean right CIMT patient group 094±024mm 066±019mm control group p0001 mean left CIMT patient group 097±030mm 063±018mm control group p0001 average CIMT patient group 096±023mm 065±017mm control group p0001 CIMT found higher among acute ischemic stroke patient smoker hypertensive nonsmoker normotensive stroke patients multivariate analysis CIMT remained associated ischemic stroke compared variable OR 453 95 CI 1571305 p001 CIMT measurement independent marker acute ischemic stroke",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Carotid Intima-Media Thickness",
            "Middle Aged",
            "Cross-Sectional Studies",
            "Ischemic Stroke",
            "Aged",
            "Bangladesh",
            "Risk Factors",
            "Case-Control Studies",
            "Carotid Artery, Common",
            "Stroke"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583666/"
    },
    {
        "pmid": "40580615",
        "title": "SER inspired deep learning approach to detect cardiac arrhythmias in electrocardiogram signals using Temporal Convolutional Network and graph neural network.",
        "abstract": "Electrocardiogram ECG signal play critical role diagnosing cardiovascular disease CVDs yet automated ECG classification remains challenging due interpatient variability signal noise heart rhythm complexity address challenges propose novel deep learning approach combine Temporal Convolutional Networks TCN Graph Convolutional Networks GCN robust cardiac arrhythmia detection Unlike conventional methods approach construct cycle graph ECG signals leveraging graph signal processing enhance data representation improve classification accuracy proposed model process raw ECG signal using TCNbased feature extractor followed spectral graph convolution via GCN evaluate model using Chapman Shaoxing 12lead ECG database consolidating 11 rhythm class four superclass improved classification reliability model achieves high classification accuracy 955 surpassing standard GCNs deep learning architecture significantly reducing graph construction complexity result demonstrate potential graphbased deep learning efficient accurate ECG analysis resourceconstrained medical settings",
        "mesh_terms": [
            "Electrocardiography",
            "Humans",
            "Deep Learning",
            "Arrhythmias, Cardiac",
            "Neural Networks, Computer",
            "Signal Processing, Computer-Assisted",
            "Databases, Factual",
            "Graph Neural Networks"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40580615/"
    },
    {
        "pmid": "40580612",
        "title": "Blockchain-aided comparative study of heart disease detection using machine learning-based approaches with an expanded dataset.",
        "abstract": "Heart disease also known cardiovascular disease CVD diverse set condition disrupt normal functioning cardiovascular system narrowing coronary arteries artery used blood circulation delivery essential nutrient oxygen various bodily parts Heart disease account approximately 31 global deaths amounting 179 million life lost annually staggering global death toll due cardiovascular disease underscore critical imperative comprehensive research innovative solutions response urgent need study employ multifaceted approach address detection cardiovascular disease leveraging combination advanced techniques Specifically integrates machine learning model disease prediction robust encryption algorithm data security private blockchain framework ensuring tamperproof storage transparency data integrity Together component form comprehensive system designed accurately detect cardiovascular condition safeguard sensitive medical information Here voting ensemble technique array machine learning models including decision trees random forests Naïve Bayes knearest neighbor KNN neural networks used achieved accuracy 892 consequence study present enhanced approach aimed mitigating profound impact cardiovascular disease implementation promise improved individual health outcome effective management societal economic challenge inherent cardiovascular disease",
        "mesh_terms": [
            "Humans",
            "Machine Learning",
            "Heart Diseases",
            "Databases, Factual",
            "Algorithms",
            "Bayes Theorem",
            "Computer Security",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40580612/"
    },
    {
        "pmid": "40568029",
        "title": "Heat impacts on health and productivity: the case of two ready-made garment factories in tropical Bangladesh.",
        "abstract": "readymade garment RMG sector pivotal Bangladeshs economy providing export opportunity employment ensure sustained productivity thriving workforce workplace hazard like heat must acknowledged assessed managed paper explores heat impact health productivity productionline worker two RMG factory Bangladesh Focus group discussion indepth interview conducted worker two RMG factory Dhaka 2022 identify perceived heatrelated health productivity impact explore barrier worker accessing heatrelated medical care Key informant interview conducted factory officials onsite health professionals government officials RMG peak body nongovernment organisation professional expertise industry workplace issues Workers health professional attributed symptom like headaches dizziness fatigue nausea heat Factory health professional observed change cardiovascular strain eg altered blood pressure responses worker summer key informant identified higher absenteeism across summer Heat identified impediment overall productivity worker others working across sector qualitative study identified heat exposure indoor work environment RMG Bangladesh influence health worker productivity influenced directly heat also indirectly via necessary cooling measure reduce heat strain take worker away production line Despite knowledge access hydration important heat health risk mitigation strategy quota pressure inherent factory restrict use vital measure",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40568029/"
    },
    {
        "pmid": "40540082",
        "title": "Molecular Interplay of Gene Network Dynamics, Epigenetic Regulation, and Therapeutic Mapping in Cardiovascular Disease.",
        "abstract": "Cardiovascular disease CVDs continue leading cause death globally driven complex interplay genetic epigenetic environmental factors Traditional risk factor alone fail explain individual variability disease susceptibility progression Recent advance genomics epigenomics revealed key molecular mechanism regulate cardiovascular function highlighting importance gene network dynamic epigenetic regulation review systematically analyzes peerreviewed literature past decade sourced electronic database including PubMed Google Scholar compiles multifaceted role DNA methylation histone modifications chromatin remodeling noncoding RNAs regulating cardiovascular gene expression cellular phenotypes disease pathogenesis DNA methylation influence transcriptional activity gene expression associated atherosclerosis myocardial infarction hypertension histone modification ATPdependent chromatin remodeling regulate cardiac hypertrophy fibrosis regeneration Noncoding RNAs act critical regulator angiogenesis inflammation myocardial remodeling Therapeutically finding facilitated development epigenetic drug geneediting technology targeting specific molecular pathway involved CVD progression Emerging technology CRISPRCas9 RNAbased therapies smallmolecule inhibitor epigenetic enzyme hold potential correct abnormal gene expression patterns Moreover integrative multiomics system biology approach advancing personalized treatment strategies improving accuracy effectiveness cardiovascular interventions Collectively unraveling complex molecular interaction among gene networks epigenetic alterations targeted therapeutic mapping aim combat CVD better precision efficacy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40540082/"
    },
    {
        "pmid": "40539522",
        "title": "Hypertension in Bangladesh: women surpass men at younger ages than worldwide.",
        "abstract": "Worldwide hypertension prevalent among men aged 30 older national survey Bangladesh show different trend paper explores difference hypertension sex age among Bangladeshi adult population throughout life span conducted secondary analysis using data Bangladesh Demographic Health Survey BDHS 20172018 nationally representative survey involved twostage stratified sample 675 household urban 250 rural 425 enumeration area EAs analytical sample comprised 12 476 individual aged 18 older 6955 woman 5521 men performed univariate bivariate test investigate variation hypertension across sex age factors applied multivariable logistic regression model logitbased marginal probability explore age sex difference well interaction hypertension estimating marginal effect sex age group assess significance sex differential hypertension throughout life course study revealed noteworthy trend Women hypertension prevalence five percentage point lower men early twenties However trend revers early thirties woman exhibiting fivepercentage point higher prevalence men adjusting confounders agesex interaction women odds hypertension significantly higher adjusted odds ratio AOR  36 95 confidence interval CI  1966 3539yearold age group may contribute combined burden chronic reproductive morbidity rising hypertension stagnant maternal health Bangladesh woman reproductive age face higher risk chronic reproductive complications complex health system Bangladesh start community level primarily focus maternal child health however recent initiative show shift focus address significant noncommunicable disease NCDs public health facilities Considering woman seek health care public facilities recognising common factor contributing early hypertension Bangladeshi woman enables targeted interventions model testing strategic adjustment primary health carefocused national noncommunicable disease management pathway",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Female",
            "Adult",
            "Hypertension",
            "Male",
            "Middle Aged",
            "Adolescent",
            "Young Adult",
            "Prevalence",
            "Aged",
            "Health Surveys",
            "Age Factors",
            "Sex Distribution",
            "Age Distribution",
            "Sex Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40539522/"
    },
    {
        "pmid": "40529206",
        "title": "Affordable Cardiac Rehabilitation An Outreach Inter-Disciplinary Strategic Study (ACROSS) - Research Programme Protocol.",
        "abstract": "evidence infrastructure needed access deliver cardiac rehabilitation CR service absent lacking low middleincome country LMICs resulting substantial loss potential health socioeconomic benefits Homebased programme provide affordable model delivery leverage scalable increase CR access LMICs ACROSS Affordable Cardiac Rehabilitation Outreach Interdisciplinary Strategic Study seek codevelop with patients caregivers clinicians service commissioners culturally contextually applicable affordable homebased programme people multimorbidity coronary heart disease andor heart failure coexisting depression andor anxiety evaluate acceptability clinical effectiveness costeffectiveness implementation Bangladesh India Pakistan determine scalability sustainability Four linked work package WPs WP1 cultural adaptationrefinement homebased rehabilitation examine rehabilitation implementation barriersenablers multiple stakeholder perspective codevelop feasible acceptable culturally  contextually adapted homebased programme extended take account coexisting depression andor anxiety WP2 external pilot assess feasibilityacceptability codeveloped rehabilitation intervention study design process necessary fullscale trial WP3 multicentremulticountry hybrid effectiveness implementation randomised trial determine clinical costeffectiveness culturally adapted homebased rehabilitation intervention people coronary heart disease andor heart failure depression andor anxiety WP4 capacity building build research rehabilitation delivery capacity ACROSS programme overarching goal develop clinically costeffective CR model lowresource setting people Bangladesh India Pakistan multimorbidity heart disease depression andor anxiety potential substantial health socioeconomic benefits",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40529206/"
    },
    {
        "pmid": "40516140",
        "title": "High-altitude physiology: Understanding molecular, pharmacological and clinical insights.",
        "abstract": "Acute mountain sickness AMS highaltitude pulmonary edema HAPE highaltitude cerebral edema HACE three common form altitude sickness condition lifethreatening symptom like fatigue dizziness headaches Ascending high elevation increase likelihood developing conditions individual adapting quickly others need descend Early acclimatization beneficial avoiding AMS HACE take week month improve job performance performance high altitudes HAPE leading cause mortality altitude sickness characterized foamy mucus coughing difficulty breathing Treatment effective administered quickly mild case resolving additional time spent altitude Oxygen therapy chemical acetazolamide spironolactone dexamethasone used restore fluid balance prevent complications Genes environmental factor influence genetic reaction low oxygen level high altitudes review explores pharmacological intervention currently used investigation acetazolamide dexamethasone novel HIF stabilizers integrating molecular insight pharmacological data aim provide comprehensive understanding altituderelated illnesses Studying altitude sickness highly relevant climber highaltitude worker also broader medical context like hypoxiarelated diseases manuscript aim bridge gap basic science clinical practice facilitating improved strategy management prevention highaltitude disorders",
        "mesh_terms": [
            "Humans",
            "Altitude Sickness",
            "Altitude",
            "Acetazolamide",
            "Brain Edema",
            "Acclimatization",
            "Pulmonary Edema",
            "Hypertension, Pulmonary"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40516140/"
    },
    {
        "pmid": "40486959",
        "title": "Wearable Technology in the Management of Chronic Diseases: A Growing Concern.",
        "abstract": "Wearable technology management chronic disease emerged significant growing concern healthcare technologies including smartwatches fitness trackers sensorbased devices offer continuous monitoring realtime data collection individual chronic conditions data collected include vital signs activity levels sleep patterns more providing valuable insight patients health trend particularly relevant context chronic diseases diabetes cardiovascular conditions respiratory disorders continuous monitoring crucial effective management Wearable device empower patient actively participate healthcare facilitating selfmonitoring promoting healthy behaviors Healthcare provider also leverage data generated device make informed decisions personalize treatment plans intervene proactively However challenge exist data security privacy concerns accuracy collected information need effective integration existing healthcare systems Despite challenges increasing adoption wearable technology chronic disease management reflects promising avenue improving patient outcome reducing healthcare cost preventive personalized care",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40486959/"
    },
    {
        "pmid": "40480226",
        "title": "SPaSE: Spatially resolved pathology scores using optimal transport on spatial transcriptomics data.",
        "abstract": "Pathological event often impact tissue region spatially variable manner making challenging identify therapeutic targets Spatial transcriptomics ST powerful technology map spatially variable molecular mechanisms yet suitable analytical method lacking introduce spatially resolved pathology score SPaSE optimal transportbased algorithm compare ST data diseased control tissues SPaSE computes pathology score spot diseased sample quantifying pathological impact spot postmyocardial infarction postMI mouse hearts score delineated zone matched independent expert annotations Modeling pathology score gene expression revealed signature predictive varying pathological severity scoring model learned mouse data showed accurate prediction human postMI data also demonstrated SPaSEs efficacy additional simulated real ST data traumatic brain injury Duchenne muscular dystrophy mouse models SPaSE useful addition existing ST algorithms record papers transparent peer review process included supplemental information",
        "mesh_terms": [
            "Animals",
            "Mice",
            "Transcriptome",
            "Humans",
            "Gene Expression Profiling",
            "Algorithms",
            "Myocardial Infarction",
            "Disease Models, Animal",
            "Muscular Dystrophy, Duchenne",
            "Brain Injuries, Traumatic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40480226/"
    },
    {
        "pmid": "40476636",
        "title": "Stenting strategy and imaging use in left main percutaneous coronary intervention: insights from a 15-year registry.",
        "abstract": "Left main LM percutaneous coronary intervention PCI remains major interventional challenge outcome influenced various patient procedurerelated factors analyze procedural characteristic outcome patient underwent LM PCI 15year period single center retrospectively analyzed data consecutive patient underwent LM PCI 2006 2022 Procedural details focus stenting technique collected Primary outcome allcause mortality 1 year total 3494 patient included majority 67 presented chronic coronary syndrome Seventyseven percent patient n  2690 underwent PCI single stent SS strategy 23 n  804 double stent DS strategy Oneyear mortality significantly lower SS case compared DS 35 vs 51 HR 064 95 CI 043096 Intravascular imaging used 17 case showed significant difference oneyear mortality compared angioguided PCI 48 vs 37 HR 111 95 CI 071173 realworld LM PCI practice patient provisional singlestent strategy feasible better outcome requiring doublestent approach",
        "mesh_terms": [
            "Humans",
            "Percutaneous Coronary Intervention",
            "Male",
            "Female",
            "Registries",
            "Retrospective Studies",
            "Aged",
            "Stents",
            "Middle Aged",
            "Coronary Artery Disease",
            "Coronary Angiography",
            "Treatment Outcome",
            "Coronary Vessels",
            "Follow-Up Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40476636/"
    },
    {
        "pmid": "40471110",
        "title": "Variations in management strategies for stable coronary artery disease in the Asia-Pacific region: Insights from a multinational survey.",
        "abstract": "Randomised controlled trial RCTs informed guideline recommendation management stable coronary artery disease CAD However realworld impact contemporary guideline trial practising physician AsiaPacific region remains uncertain aimed evaluate knowledge attitude practice among cardiovascular physician region regarding stable CAD management anonymised crosssectional electronic survey administered cardiovascular practitioner Asia Pacific assessing 3 domains 1 baseline knowledge recent trial society guideline 2 attitude towards stable CAD 3 case scenario reflecting management preferences Correlations among knowledge attitude practice score assessed physician developed developing country using Pearson correlation Overall 713 respondent 21 country completed survey mean knowledge score 290±118 out 4 373 respondent answering question correctly 746 noted guideline significant impact practice Despite guideline recommending optimal medical therapy majority chose revascularisation range 534 906 preferred strategy case scenarios Practitioners developed region higher knowledge score lower attitude score compared developing regions practice score similar groups Weakly positive correlation noted knowledge attitude practice scores Variations exist knowledge attitude towards guideline recommendation correspondingly actual clinical practice Asia Pacific practitioner choosing upfront invasive strategy treatment stable CAD difference reflect realworld disparity guideline interpretation clinical adoption",
        "mesh_terms": [
            "Humans",
            "Coronary Artery Disease",
            "Cross-Sectional Studies",
            "Practice Patterns, Physicians'",
            "Asia",
            "Health Knowledge, Attitudes, Practice",
            "Surveys and Questionnaires",
            "Male",
            "Practice Guidelines as Topic",
            "Female",
            "Attitude of Health Personnel",
            "Middle Aged",
            "Developing Countries"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40471110/"
    },
    {
        "pmid": "40465584",
        "title": "Intermittent pneumatic compression therapy as a preventive measure for venous thromboembolism after total hip arthroplasty: A systematic review.",
        "abstract": "Venous thromboembolism VTE significant avoidable complication may occur total hip arthroplasty THA Various mechanical chemical prophylactic measure may mitigate elevated risk death functional impairment Consequently early prevention VTE essential via identification related risk factors search performed using database PubMed ScienceDirect PEDro Cochrane Library get paper 2004 2024 accordance PRISMA guidelines randomized controlled trial RCTs published English included least one group undergoing intermittent pneumatic compression IPC treatment prophylactic intervention total hip arthroplasty THA included systematic review registered PROSPERO quality evaluation included study conducted using PEDro scale Cochrane risk bias instrument selected 12 study total 733 based predetermined criteria total 2352 patient gender underwent total hip arthroplasty comprising 1294 patient experimental group 1058 patient control group across included studies result indicate combination IPC pharmaceutical agent effective treatment reducing VTE risk patient underwent THA IPC therapy effective avoiding VTE particularly used combination pharmacological therapy THA surgery best way lower risk VTE use IPC anticoagulant together However IPC alone may lower risk VTE compared using prevention all general IPC crucial component comprehensive VTE prevention strategy THA",
        "mesh_terms": [
            "Humans",
            "Venous Thromboembolism",
            "Arthroplasty, Replacement, Hip",
            "Intermittent Pneumatic Compression Devices",
            "Risk Factors",
            "Postoperative Complications",
            "Randomized Controlled Trials as Topic",
            "Female",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40465584/"
    },
    {
        "pmid": "40452061",
        "title": "The functional landscape of the appendix microbiome under conditions of health and disease.",
        "abstract": "Traditionally regarded vestigial organ appendix reevaluated significant function health nutrition humans Serving safe house beneficial desired gut bacteria appendix protected resilient biofilms create secure environment make appendix abasin gut microbiota GM replenishing microbial population following disruption infections antibiotic use inflammatory bowel disease IBD Beyond simply hosting bacteria appendix active role function immune system Disruption Appendix Microbiome AM appendectomy found result lowered diversity gut microorganism increased risk various diseases potential therapeutic application particularly promising area research appendixs unique microbial environment impact immunity open new avenue treatments include modulating GM improve cancer treatment outcomes mitigating IBD regulating metabolic pathway obesity diabetes influencing neurotransmitter production neurological disorders addressing cardiovascular autoimmune diseases review highlight appendixs transformation misunderstood organ critical component gut health immunity explores function human appendix resilient reservoir desired microorganisms role disease progression Furthermore examines potential therapeutic application AM presenting exciting opportunity future research treatment innovations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40452061/"
    },
    {
        "pmid": "40441261",
        "title": "Multivessel versus culprit vessel only percutaneous coronary intervention in non-ST elevation myocardial infarction: Systematic review and meta-analysis.",
        "abstract": "Multivessel disease common nonST elevation myocardial infarction patients However whether multivessel percutaneous coronary intervention superior culprit vessel percutaneous coronary intervention unknown metaanalysis conducted including study compared multivessel percutaneous coronary intervention MVPCI culprit vessel percutaneous coronary intervention among nonST elevation myocardial infarction patients Relative risk RR mortality myocardial infarction MI repeat revascularization procedural complication calculated using random effect model Seventeen study included metaanalysis difference shortterm outcome mortality RR 0917 95 CI 06131371 P  672 MI RR 0960 95 CI 06121507 P  861 stent thrombosis RR 1338 95 CI 06552733 P  424 Longterm mortality repeat revascularization significantly lower MVPCI group RR 0746 95 CI 06440865 P  001 RR 0775 95 CI 06290954 P  016 respectively significant difference demonstrated 2 strategy shortterm outcomes However longterm outcome MVPCI group superior culprit vessel percutaneous coronary intervention nonST elevation myocardial infarction patient multivessel disease Longterm outcome included mortality repeat revascularization stent thrombosis MI However randomized controlled trial needed compare safety efficacy strategies",
        "mesh_terms": [
            "Humans",
            "Coronary Artery Disease",
            "Non-ST Elevated Myocardial Infarction",
            "Percutaneous Coronary Intervention",
            "Stents",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40441261/"
    },
    {
        "pmid": "40437559",
        "title": "Compliance to tobacco and alcohol zoning regulations around schools in Bangladesh, India, Pakistan and Sri Lanka using environmental mapping data.",
        "abstract": "built environment around school regularly accessed young people determined governments national regional policy country region Zoning regulation tobacco alcohol sale expected restrict availability access young people study aimed examine non compliance tobacco alcohol zoning regulation around school Bangladesh India Pakistan Sri Lanka representative sample geographic location Bangladesh India North Delhi India South Chennai Pakistan Sri Lanka built environment mapped systematically walking street within site boundary collect data different type tobacco alcohol retailer schools Data collected KoboToolBox map indicating zoning compliance created using ArcGIS Descriptive analysis outlet compliance zoning law conducted national school levels heterogeneity analysis done school type income level outlet type tobacco alcohol zoning regulation tobacco alcohol differed among setting ranging 50 100 tobacco absolute ban 500 onpremise alcohol Among five different setting within four countries 441 area studied including 3615 schools Noncompliance zoning law evident jurisdiction tobacco alcohol Within restricted zone around school location noncompliant zoning laws 1238 outlet selling tobacco 16 100 outlet selling alcohol identified supply noncompliance 370 shop within school buffer zone selling tobacco 021 shop selling alcohol Noncompliance tobacco alcohol zoning regulation observed around school Bangladesh India North South Pakistan Sri Lanka Within country higher percentage alcohol outlet location noncompliant tobacco except South India India Sri Lanka higher percentage supply noncompliance tobacco alcohol study call government strictly enforce existing zoning regulation expected restrict access tobacco alcohol young people",
        "mesh_terms": [
            "Humans",
            "Schools",
            "Pakistan",
            "Sri Lanka",
            "India",
            "Bangladesh",
            "Alcoholic Beverages",
            "Tobacco Products",
            "Alcohol Drinking",
            "Commerce"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40437559/"
    },
    {
        "pmid": "40424617",
        "title": "Effectiveness of a Health Education Program to Reduce Recurrence of Stroke by Controlling Modifiable Risk Factors in a Specialized Hospital in Bangladesh: Randomized Controlled Trial.",
        "abstract": "Health education could effective way increase knowledge regarding behavioral change prevent recurrence stroke however evidence ambiguous lack knowledge compliance treatment control modifiable risk factor unhealthy lifestyle increase risk stroke recurrence study aimed evaluate effectiveness health education program among patient stroke postdischarge family caregiver tertiary specialized hospital Bangladesh reduce stroke recurrence controlling modifiable risk factors parallel 11 openlabel prospective randomized controlled trial conducted Bangladesh total 432 patient firsttime stroke aged ≥18 year modified Rankin Scale mRS score 04 randomly enrolled National Institute Neuroscience  Hospital stratified patient age type stroke randomly allocated intervention group IG control group CG collected sociodemographic clinical data using structured questionnaire IG received self management education including monitoring blood pressure BP medication diet exercise 12 months CG received usual care outcome 1 recurrence 28 day stroke 2 adverse event related stroke 12month followup 432 patient n216 50 group stroke recurrence observed 14 65 patient IG 8 37 patient CG difference significant P19 Death lower IG n39 181 v n56 259 compared CG Cox regression analysis unadjusted model showed death significant hazard ratio HR 1531 95 CI 10172304 P04 however difference significant adjusting mRS score baseline HR 0818 95 CI 05401238 P34 Patients medication adherence significantly improved 6month P001 12month P002 followup intervention study failed demonstrate effectiveness health education reducing recurrence death strokerelated adverse events However health education enhanced medication adherence cause death could diagnosed due inadequate health care systems research diagnostic facility long observation period necessary explore underlying cause recurrence result suggest importance structuring acute care management patient stroke health care system Bangladesh ClinicalTrialsgov NCT05520034 httpsclinicaltrialsgovct2showNCT05520034",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Bangladesh",
            "Middle Aged",
            "Stroke",
            "Risk Factors",
            "Health Education",
            "Prospective Studies",
            "Adult",
            "Secondary Prevention",
            "Aged",
            "Recurrence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40424617/"
    },
    {
        "pmid": "40419517",
        "title": "Uncovering dendritic cell specific biomarkers for diagnosis and prognosis of cardiomyopathy using single cell RNA sequencing and comprehensive bioinformatics analysis.",
        "abstract": "Cardiomyopathy type cardiovascular disorder primary cause death globally killing million people year Cardiomyopathy detection early diagnosis crucial reducing negative health effects Thus study aim use single cell RNA sequencing bioinformatics analysis uncover dendritic cellspecific biomarkers gene ontology pathways regulatory interaction networks proteinchemical compound related molecular mechanism cardiomyopathy progression Two RNAseq datasets GSE65446 GSE155495 also evaluated identify significant biomarkers cardiomyopathy 123 mutual DEGs appeared scRNAseq RNAseq datasets addition DAVID online platform FunRich software utilized detect cell communication innate immune responses type 1 IFN antigen processing presentation allograft rejection viral infection significant gene ontology metabolic pathway cardiomyopathy proteinprotein interaction PPI network revealed five key hub protein ITGAX IRF7 MX1 HLAB IRF1 Following that several transcription factor GATA2 FOXC1 SREBF1 STAT3 NFKB1 well microRNA hsamir26a5p hsamir12923p etc predicted Prospective chemical substance tretinoin valproic acid arsenic trioxide predicted linked cardiomyopathy treatment acceptable value receiver operating characteristic ROC curve analysis revealed biomarkers play critical role cardiomyopathy study identifies molecular indicator RNA protein level may useful improving understanding molecular causes early diagnosis devising favorable cardiomyopathy treatment research needed validate predicted finding future clinical biomarkers",
        "mesh_terms": [
            "Humans",
            "Computational Biology",
            "Biomarkers",
            "Dendritic Cells",
            "Cardiomyopathies",
            "Prognosis",
            "Single-Cell Analysis",
            "Protein Interaction Maps",
            "Gene Regulatory Networks",
            "Sequence Analysis, RNA",
            "Gene Ontology",
            "Gene Expression Profiling"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40419517/"
    },
    {
        "pmid": "40418901",
        "title": "Developing comprehensive hypertension ontology: Addressing data integration gaps to improve healthcare results.",
        "abstract": "bObjectiveb Therefore objective study design hypertension ontology aim improving integration data representation knowledge better decision making hypertension management bMethodsb First performed systematic literature review SLR across ten different database aiming capturing essential concepts Using extracted data Hypertension Ontology HPO created Protégé loaded published BioPortal availability bResultsb HPO contains 114 class five property structure risk factors symptoms diagnosis treatment improves knowledge discovery data sharing capabilities surpasses existing hypertensionrelated ontology functionality bConclusionb HPO facilitates standardized hypertension management research context clinical practices Next Steps integration Realworld data Interoperability HER",
        "mesh_terms": [
            "Humans",
            "Hypertension",
            "Biological Ontologies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40418901/"
    },
    {
        "pmid": "40409656",
        "title": "A review of food hydrocolloids on cardiovascular health: Alginate, astragalus polysaccharides, carrageenan, fucoidan, lunasin, and psyllium.",
        "abstract": "Food hydrocolloids derived natural source plants algae microbes possess bioactive property significantly contribute cardiovascular health review focus six key hydrocolloids alginate astragalus polysaccharides carrageenan fucoidan lunasin psyllium also considering important natural hydrocoloids short chain fatty acid SCFAs plantderived food hydrocolloids plantderived gums plantderived mucilages pectin modified citrus pectin inulin naringenin chia seeds gelatine whey protein casein microbial exopolysaccharides gums ulvan laminarin Alginate brown seaweed aid cardiac tissue regeneration repair Astragalus polysaccharides Astragalus plant provide antioxidant antiinflammatory immunomodulatory benefits Carrageenan sourced red seaweed support lipid profile balance heart health Fucoidan another brown seaweed derivative offer antihypertensive lipidlowering effects Lunasin peptide found soybeans oats barley known cholesterollowering property antiinflammatory effects Psyllium rich soluble fiber help lower LDL cholesterol improve overall cardiovascular function hydrocolloids along mentioned compounds utilized drug formulations cosmetics processed foods dietary supplements enhancing food texture stability delivering health benefits Upon consumption absorbed bloodstream metabolized gut microbiota bioactive metabolites review examines effect cardiovascular function highlighting mechanism regulating vascular tone blood pressure vascular inflammation cardiac function consolidates current research emphasizing potential hydrocolloid related compound prevention management cardiovascular disease CVDs",
        "mesh_terms": [
            "Polysaccharides",
            "Humans",
            "Alginates",
            "Carrageenan",
            "Colloids",
            "Psyllium",
            "Cardiovascular Diseases",
            "Animals",
            "Cardiovascular System"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40409656/"
    },
    {
        "pmid": "40406922",
        "title": "Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021.",
        "abstract": "Nontraumatic subarachnoid hemorrhage SAH represents third common stroke type unique etiologies risk factors diagnostics treatments Nevertheless epidemiological study often cluster SAH stroke type leaving distinct burden estimate obscure estimate worldwide burden SAH Based repeated crosssectional Global Burden Disease GBD 2021 study global burden SAH 1990 2021 estimated Moreover SAH burden compared diseases association 14 individual risk factor investigated available data GBD 2021 study GBD study included burden estimate nontraumatic SAH among age 204 country territory 1990 2021 SAH 14 modifiable risk factors Absolute number agestandardized rate 95 uncertainty interval UIs SAH incidence prevalence mortality disabilityadjusted lifeyears DALYs well risk factorspecific population attributable fraction PAFs 2021 global agestandardized SAH incidence 83 95 UI 7395 prevalence 922 95 UI 8411006 mortality 42 95 UI 3748 DALY rate 1252 95 UI 11051426 per 100 000 people highest burden estimate found Latin America Caribbean Oceania highincome Asia Pacific Although absolute number SAH case increased especially region low sociodemographic index agestandardized burden rate decreased 1990 2021 incidence 288 95 UI 257316 prevalence 161 95 UI 148177 mortality 561 95 UI 407643 DALY rate 546 95 UI 428619 300 diseases SAH ranked 36th common cause death 59th common cause DALY world worldwide SAHrelated DALYs 716 95 UI 638786 associated 14 modeled risk factor high systolic blood pressure population attributable fraction PAF  516 95 UI 380626 smoking PAF  144 95 UI 124165 highest attribution Although global agestandardized burden rate SAH halved last 3 decades SAH remained one common cardiovascular neurological cause death disability world increasing absolute case numbers finding suggest evidence potential health benefit proactive public health planning resource allocation toward prevention SAH",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40406922/"
    },
    {
        "pmid": "40392832",
        "title": "Prevalence and determinants of medication adherence among hypertensive patients: An institution-based cross-sectional study.",
        "abstract": "Adherence antihypertensive medication key management strategy hypertension give rise necessity get clear picture medication adherence among patient hypertension Bangladesh study aim determine prevalence antihypertensive medication adherence associated factor among patient hypertension receiving treatment Hypertension Center Bangladesh institutionbased crosssectional study conducted 352 adult patient hypertension registered Rangpur Hypertension Research Center outcome variable study medication adherence antihypertensive drug measured using Morisky Medication Adherence Scale MMAS8 Descriptive analysis conducted show distribution study participants Pearsons chisquare test applied explore association categorical response explanatory variables bivariable multivariable logistic regression analysis conducted explore factor associated medication adherence statistical analysis conducted using Stata version 170 prevalence good medication adherence among patient hypertension HRC R 5483 Among various reason taking medicine irregularly forgetfulness 2029 common cause reported participants followed busy work schedule 771 Among study participants married patient found higher medicine adherence AOR 381 95 CI 1341089 unmarried patients Compared patient hypertension less equal 5 years patient suffering hypertension 610 year 68 AOR 032 95 CI 011095 patient suffering 10 year 72 AOR 028 95 CI 009084 lower odds medicine adherence respectively Patients diagnosed nonprofessionals 81 AOR 019 95 CI 006061 lower odds medicine adherence compared patient diagnosed health professionals study observed low medication adherence among patient hypertension forgetfulness busy work schedule reported primary reason nonadherence Patients married suffering long diagnosed health professional manifested significant influencing factor nonadherence",
        "mesh_terms": [
            "Humans",
            "Hypertension",
            "Female",
            "Male",
            "Cross-Sectional Studies",
            "Middle Aged",
            "Antihypertensive Agents",
            "Adult",
            "Prevalence",
            "Bangladesh",
            "Aged",
            "Medication Adherence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40392832/"
    },
    {
        "pmid": "40391953",
        "title": "Transforming healthcare: the impact of artificial intelligence on diagnostics, pharmaceuticals, and ethical considerations - a comprehensive review.",
        "abstract": "Interpretability result remains challenging health industry since patient may suffer lifethreatening consequence inaccurate diagnosis Artificial intelligence AI integration arisen prominent technology healthcare sector transforming field advancing early diagnostics surgeries ethical concerns present review analyzes multidimensional impact AI health sector enhancement medical accuracy diagnosis outcomes Implementing AI technique machine learning algorithm predictive analytics enables disease identification nascent stage boosting decisionmaking accuracy Advancements genomics demanded employment AI decoding genetic information supporting personalized targeted treatments review comprehensively examines application AIbased diagnostics addressing impact heartassociated diseases cancer pathogenesis general disease prediction Different machine learning algorithm aid identifying tumor behavior risk factors tailored therapy cancer treatment context cardiovascular disorders AIdriven methodology aid assessing patient data evaluating risk factors forecasting probable complication preventative care AIbased surgery employing da Vinci Surgical System highlight use AI increasing prediction surgical success rate Robotic automation orthopedics advance spine joint replacement surgeries offering realtime guidance enhancing patient recovery outcomes Broader improvement AI integration healthcare discussed focusing refining algorithm improved application",
        "mesh_terms": [
            "Humans",
            "Artificial Intelligence",
            "Delivery of Health Care",
            "Machine Learning"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40391953/"
    },
    {
        "pmid": "40390495",
        "title": "Analytical and biological assessment of Magnolia champaca L. stem bark: Integrating ATR-FTIR, GC-MS, thrombolytic activity, brine shrimp lethality and molecular docking.",
        "abstract": "Cancer cardiovascular disease two significant health challenge worldwide disease responsible morbidity mortality leading substantial burden healthcare system economic resources Numerous innovative therapy proposed combating cancer cardiovascular disease like thrombosis however many treatment involve synthetic drug may undesirable side effects Consequently current research aimed explore medicinal property phytochemical derived Magnolia champaca L investigation utilized vitro silico approaches identification phytocompounds employed using ATRFTIR GCMS Thrombolytic activity assayed using human venous blood cytotoxicity assessed lethality test using nauplii Artemia salina finally molecular docking analysis performed using docking software named AutoDock Vina clearly understand interaction GCMS identified secondary metabolite target proteins ATRFTIR spectrum Magnolia champaca specifies presence alkaloids polysaccharides flavonoid well glycosidic phytocompounds GCMS data identified 23 compound crude methanolic extract among 24Ditertbutylphenol 3Ethyl3hydroxyandrostan17one Hexadecanoic acid methyl ester Dinoctyl phthalate prominent vitro thrombolytic assay demonstrated TransSyringin CHF resulted significant blood clot lysis achieving 5939 ± 179  4566 ± 363  respectively comparing 7575 ± 296  standard streptokinase brine shrimp bioassay indicated moderate strong toxicological effect Specifically TransSyringin ethyl acetate fraction EAF demonstrated considerable cytotoxicity showing net value LCsub50sub 2239 µgml 6178 µgml respectively contrary 1145 µgml vincristine sulfate standard Molecular docking analysis conducted explore synergistic effect compound identified GCMS analysis tissue plasminogen activator human topoisomeraseII compound 3Ethyl3hydroxyandrostan17one Cadina1104diene 117Trimethyl4methylenedecahydro1Hcyclopropaeazulen7ol 1aR1aalpha4aalpha7beta7abeta7balpha demonstrated high binding affinity 77 73 71 kcalmol respectively tissue plasminogen activator streptokinase standard 65 kcalmol human topoisomeraseII 3Ethyl3hydroxyandrostan17one CaryophylleneI1 Cadina1104diene exhibited binding affinity 80 79 well 78 kcalmol correspondingly standard vincristine 81 kcalmol finding suggest Magnolia champaca contains active phytochemical significant potential diverse pharmacological applications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40390495/"
    },
    {
        "pmid": "40390001",
        "title": "Efficacy of using a digital health intervention model using community health workers for primary health services in Bangladesh: a repeated cross-sectional observational study.",
        "abstract": "study aim evaluate effectiveness digital health intervention model observing peoples health condition rural area Bangladesh repeated crosssectional design health outcome assessed sixmonth interval 18 months data presented paper obtained models pilot implementation one catchment area Bangladesh model involved community health worker CHWs using smart health kit Artificial IntelligenceAIbased mobile application provide monthly doorstep health education screenings risk assessments digital referrals Sociodemographic health measurement data presented proportion 95 confidence interval CIs Multivariate logistic regression used analyze association disease respective risk factors compared health vitals across three consecutive period determine effectiveness model improving health outcome time model served 32581 people 7090 household operation found 2176 served population overweight 818 prehypertension 1645 high blood glucose 11 child malnourished analysis risk factors found people aged math xmlnshttpwwww3org1998MathMathMLmrowmomo mtext40mtextmrow math associated developing hypertension diabetes cardiovascular diseasesCVD CVD associated hypertension stroke comparative analysis different period showed improvement BMI BP MUAC Blood glucose measurement show significant improvement study highlight feasibility effectiveness digital health intervention enhancing primary healthcare rural settings Integration AIdriven decision support CHWled health education screening improve early detection intervention management noncommunicable disease NCDs Scaling model publicprivate partnership offer costeffective approach bridging healthcare gap promoting universal health coverage",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Cross-Sectional Studies",
            "Community Health Workers",
            "Male",
            "Female",
            "Primary Health Care",
            "Adult",
            "Middle Aged",
            "Adolescent",
            "Young Adult",
            "Child",
            "Artificial Intelligence",
            "Telemedicine",
            "Mobile Applications",
            "Rural Population",
            "Digital Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40390001/"
    },
    {
        "pmid": "40354386",
        "title": "Study of the psychometric properties of the HLS-EU-12 questionnaire in rural Bangladesh.",
        "abstract": "Poorer health literacy lead limited knowledge disease lower adherence medication Several tool available measuring health literacy including HLSEUQ12 questionnaire study aimed examine psychometric property HLSEUQ12 questionnaire using Rasch measurement theory assess general health literacy among adult rural Bangladesh Baseline data collected cluster randomized control trial RCT Narail district Bangladesh 1 December 2020 31 January 2021 involving 307 adult aged 3075 hypertension HLSEUQ12 questionnaire 12 items validated using Rasch measurement model analyzed using RUMM2030 analysis focused differential item functioning DIF across gender age targeting multidimensionality response dependency item categorization sample consisted almost equal proportion female 502 male 498 control 508 intervention participant 492 Initial examination indicated tool poor overall fit Rasch model shown significant itemtrait interaction χ2  1005 df  48 p  0001 reliability measured person separation index PSI 0746 considered satisfactory overall item fit residual IFR M  0236 SD  1318 person fit residual PFR M  0186 SD  103 within acceptable range SD ± 14 item found ordered thresholds suggesting respondent difficulty differentiating response option 4point Likerttype scale item 12 Join sport club exercise class want to fit residual value outside acceptable range Removing item 12 resulted good overall fit χ2  6035 df  44 p  005 slight improvement PSI 0746 12 item vs0756 11 items None item showed significant DIF age gender two item showed residual correlation coefficient 020 indicating possible redundancy analysis demonstrated scales unidimensionality shown lower bound binomial 95 confidence interval CI observed proportion 52 within 95 confidence limit study demonstrated potential effectiveness HLSEUQ12 tool assessing health literacy among adult Bangladesh However study needed evaluate tool across different populations including indepth investigation item 12 determine inclusion removal ClinicalTrialsgov NCT04505150 Registered 7 August 2020",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Bangladesh",
            "Psychometrics",
            "Middle Aged",
            "Adult",
            "Rural Population",
            "Surveys and Questionnaires",
            "Aged",
            "Health Literacy",
            "Hypertension"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40354386/"
    },
    {
        "pmid": "40335470",
        "title": "Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019.",
        "abstract": "Chronic care manages longterm progressive conditions acute care address shortterm conditions Chronic condition increasingly strain health systems often unprepared demands study examines burden condition requiring acute versus chronic care including sequelae Conditions sequela Global Burden Diseases Study 2019 classified acute chronic care categories Data analysed age sex sociodemographic index presenting total number contribution burden metric DisabilityAdjusted Life Years DALYs Years Lived Disability YLD Years Life Lost YLL Approximately 68 DALYs attributed chronic care 27 due acute care Chronic care need increased age representing 86 YLDs 71 YLLs accounting 93 YLDs sequelae finding highlight chronic care need far exceed acute care need globally necessitating health system adapt accordingly",
        "mesh_terms": [
            "Humans",
            "Chronic Disease",
            "Female",
            "Male",
            "Global Burden of Disease",
            "Middle Aged",
            "Aged",
            "Adult",
            "Disability-Adjusted Life Years",
            "Young Adult",
            "Aged, 80 and over",
            "Health Services Needs and Demand",
            "Adolescent",
            "Acute Disease",
            "Persons with Disabilities",
            "Child",
            "Child, Preschool",
            "Infant",
            "Cost of Illness"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40335470/"
    },
    {
        "pmid": "40325720",
        "title": "Physiotherapy management of a patient with non-cardiac angina: A case report.",
        "abstract": "Cervicogenic angina noncardiac chest pain originating cervical spine pathology condition pain radiates cervical spine chest often mimicking symptom cardiac angina case report describes unique physiotherapy management 47yearold male noncardiac angina resulting cervical disc herniation C567 highlight effective treatment strategy aim increase awareness physiotherapys role managing noncardiac chest pain patient initially misdiagnosed postCOVD complications patient presented persistent neck chest pain later confirmed cervicogenic angina MRI clinical assessment treatment involved targeted physiotherapy program including postural education McKenzie exercises cervical traction ergonomic adjustments Sessions conducted twice weekly four weeks Assessment cervical range motion ROM showed improvements Following intervention patient experienced symptom relief recurrence threemonth followup patient reported significant improvement Visual analogue scale VAS Manual muscle strength MMT Neck disability index NDI case highlight potential cervical disc herniation mimic cardiacrelated chest pain underscore importance physiotherapy managing cases finding contribute limited literature physiotherapys role treating cervicogenic angina providing insight practitioner manual medicine",
        "mesh_terms": [
            "Humans",
            "Male",
            "Middle Aged",
            "Physical Therapy Modalities",
            "Neck Pain",
            "Intervertebral Disc Displacement",
            "Cervical Vertebrae",
            "Range of Motion, Articular",
            "Angina Pectoris",
            "Exercise Therapy",
            "Chest Pain"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40325720/"
    },
    {
        "pmid": "40312282",
        "title": "Evaluation of the Relationship Between Serum Uric Acid and Cardiovascular Disease: A Cross-Sectional Study in Bangladesh.",
        "abstract": "Serum uric acid SUA suggested associated obesity dyslipidaemia diabetes hypertension However whether uric acid independently associated risk myocardial infarction MI major type cardiovascular disease CVD remains debatable especially across different populations study aim examine relationship SUA level MI adult population group Bangladesh study included 392 participants 188 history MI CVD group 204 healthy individual without CVD control group Anthropometric blood pressure SUA biochemical parameter measured multivariate regression model used assess relationship elevated SUA level risk CVD mean level SUA significantly higher CVD group 76 ± 45 mgdL compared nonCVD group 53 ± 18 mgdL p  0001 prevalence hyperuricemia also observed higher CVD group 463 compared nonCVD group 182 p  0001 significant difference observed level blood glucose lipid profile CVD nonCVD group p  0001 cases significant difference observed mean level SUA prevalence hyperuricemia gender groups SUA divided four quartiles significant difference observed systolic blood pressure across quartile groups adjusting potential confounders regression models SUA found significant association CVD Elevated level SUA associated increased odds CVD among study participants Managing SUA level implementing intervention strategy could effective preventing controlling cardiovascular events",
        "mesh_terms": [
            "Humans",
            "Uric Acid",
            "Female",
            "Male",
            "Bangladesh",
            "Cross-Sectional Studies",
            "Middle Aged",
            "Adult",
            "Cardiovascular Diseases",
            "Hyperuricemia",
            "Myocardial Infarction",
            "Risk Factors",
            "Aged",
            "Case-Control Studies",
            "Prevalence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40312282/"
    },
    {
        "pmid": "40310083",
        "title": "Mental Health Sequelae of Cardiac Events: A Comprehensive Review of Biological Mechanisms, Prevalence, and Interdisciplinary Care Approaches.",
        "abstract": "Cardiovascular disease leading cause mortality worldwide postcardiac event myocardial infarction acute coronary syndrome sudden cardiac arrest causing significant physiological trauma psychological effects study explores complex interplay cardiac event mental health disorders focusing biological psychological pathway connect condition atrisk populations acute stress response following cardiac event involves activation sympathetic nervous system hypothalamicpituitaryadrenal axis leading release stress hormone inflammatory cytokines Prolonged activation system result neurotransmitter imbalances neuroinflammation epigenetic modifications increasing susceptibility mental health disorder depression anxiety posttraumatic stress disorder PTSD Women exhibit higher vulnerability condition due hormonal fluctuation pronounced stress response prevalence mental health disorder following cardiac event substantial PTSD rate particularly high among survivor myocardial infarction outofhospital cardiac arrest psychological condition associated poor physical recovery reduced quality life increased risk recurrent cardiac event mortality Resilience adaptive coping mechanism serve protective factors highlighting importance integrating mental health care within cardiac rehabilitation programs study emphasizes need early detection targeted interventions interdisciplinary approach improve mental health outcome patient recovering cardiac incidents Understanding psychiatric sequela cardiac event crucial cardiologists particularly management postmyocardial infarction patients ischemic attack survivors individual undergoing openheart surgery Early detection interdisciplinary intervention improve longterm outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40310083/"
    },
    {
        "pmid": "40306396",
        "title": "Coenzyme Q<sub>10</sub> alleviates oxidative stress, inflammation and fibrosis via activation of TGFβ1/TNF-α in FCA-Salt hypertensive rats.",
        "abstract": "Hypertension one common factor contributing cardiac remodeling link change heart kidney functions Several study reported beneficial effect Coenzyme Qsub10sub CoQsub10sub reducing oxidative stress due antioxidant properties However cardioprotective nephroprotective role CoQsub10sub toxicity induced fludrocortisone acetate FCA yet investigated Therefore evaluated CoQsub10sub effect FCAinduced cardiotoxicity nephrotoxicity rat model FCASalt analyzed various oxidative stress parameter antioxidant enzyme activity using biochemical assays addition examined inflammatory fibrosis via histological staining heart kidney tissues CoQsub10sub significantly reduced lipid peroxidation productmalondialdehyde MDA increased nitric oxide NO FCASalt rats Antioxidant enzyme activity also enhanced CoQsub10sub rats Histopathological examination detected tissue damage fibrosis FCASalt group significantly reduced CoQsub10sub Furthermore enzymelinked immunosorbent assay ELISA indicated activation Transforming growth factorβ1Tumor necrosis factorα TGFβ1TNFα CoQsub10sub Consequently study suggests CoQsub10sub effectively protect heart kidney health cardiotoxicity nephrotoxicity FCASalt hypertensive rat via TGFβ1TNFα pathway",
        "mesh_terms": [
            "Animals",
            "Ubiquinone",
            "Oxidative Stress",
            "Rats",
            "Transforming Growth Factor beta1",
            "Fibrosis",
            "Male",
            "Hypertension",
            "Tumor Necrosis Factor-alpha",
            "Inflammation",
            "Kidney",
            "Antioxidants",
            "Myocardium"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40306396/"
    },
    {
        "pmid": "40298380",
        "title": "Effects of Arsenic-induced Diabetic Vascular Diseases through Mitogen-activated Protein Kinase Signaling Pathway: In vitro and In vivo Studies.",
        "abstract": "Arsenic As environmental pollutant cause endocrine disruption Diabetes increase risk Blackfoot disease peripheral artery disease caused chronic exposure drinking water Taiwan Bangladesh however mechanism underlying increased risk remains unclear Therefore study aimed investigate mechanism underlying vascular damage hyperglycemic condition caused exposure using vivo vitro studies utilized animal model streptozotocininduced diabetes exposed drinking water 8 weeks Subsequently blood organ sample animal collected followup analysis Further cultured endothelial cell treated treatment glucose condition detected biomarkers finding revealed diabetes diabetes  group exhibited insulin resistance weight gain increased plasma triglyceride total cholesterol levels diabetes  group lower antioxidant activity caused artery exhibit prominent luminal narrowing increased thickness vivo study revealed glucose  groupinduced cell cycle arrest 9880 increase reactive oxygen specie ROS levels decreased cell viability mitochondrial membrane potential MMP However glucose  group treatment SP600125 U10126 treatment decreased ROS production 805 84 respectively restored MMP cell viability glucoseregulated protein 78 level increased well glucose  groups finding demonstrate exacerbates vascular damage individual diabetes associated complication activation mitogenactivated protein kinase signaling pathway",
        "mesh_terms": [
            "Animals",
            "Arsenic",
            "Diabetes Mellitus, Experimental",
            "Male",
            "MAP Kinase Signaling System",
            "Diabetic Angiopathies",
            "Humans",
            "Rats",
            "Reactive Oxygen Species",
            "Mice",
            "Rats, Sprague-Dawley"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40298380/"
    },
    {
        "pmid": "40289981",
        "title": "Current Attainments on Nanobiosensors for Diagnosing Atherosclerosis Biomarkers.",
        "abstract": "Atherosclerosis chronic disease caused inflammation blood vessel wall lead plaque formation endothelial lining Preexisting atherosclerosis contributes various cardiovascular problems including myocardial infarction congestive cardiac failure arrhythmias acute coronary syndrome associated higher postoperative mortality morbidity Rupturing atherosclerosis pose significant health concern triggering heart attack Therefore essential identify atherosclerosis early prevent health complication subsequent consequences Atherosclerosis typically diagnosed angiograms computerized tomography scan stress tests Additionally various biomarkers released inflammatory cell surrounding tissue artery wall pathogenesis atherosclerosis Quantifying biomarkers aid diagnosing determining severity atherosclerosis relation cardiovascular diseases review focus recent advancement understanding formation atherosclerosis implementation biomarkers nano biosensors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40289981/"
    },
    {
        "pmid": "40281139",
        "title": "Healthy lifestyle knowledge and age at hypertension diagnosis: a primary health care based survey in Bangladesh.",
        "abstract": "study examined relationship knowledge healthy lifestyle age hypertension diagnosis among hypertensive individual within Bangladeshi rural population crosssection study conducted among hypertensive adult 1880 years rural population obtained data 3600 adult hypertension 40 randomly selected community pharmacies gathered data demographics health knowledge measured vital signs including hypertension diagnosis year Multinomial logistic regression analysis used identify lifestyle knowledge factor hypertension age diagnosis hypertension mean age hypertension diagnosis 4584 years mean age hypertension diagnosis male participant higher female 481 v 444 years study found male individual primary education likely receive later hypertension diagnosis odds ratio  232 95 confidence interval 175310 odds ratio  596 95 confidence interval 3091148 respectively aged ≥65 poorest lacking physical exercise faced higher odds later diagnosis odds ratio  220 95 confidence interval 153315 odds ratio  237 95 confidence interval 178317 respectively Conversely family history hypertension reduces odds odds ratio  038 95 confidence interval 027055 Increased knowledge healthy lifestyle factor engagement healthrelated medium correlate later diagnosis highlighting influence education awareness hypertension detection age study reveals knowledge healthy lifestyle associated age hypertension diagnosis Targeting specific age group based health education program may reduce hypertensionrelated complications",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Middle Aged",
            "Hypertension",
            "Adult",
            "Bangladesh",
            "Health Knowledge, Attitudes, Practice",
            "Aged",
            "Adolescent",
            "Young Adult",
            "Cross-Sectional Studies",
            "Healthy Lifestyle",
            "Aged, 80 and over",
            "Primary Health Care",
            "Age Factors",
            "Health Care Surveys",
            "Risk Factors",
            "Risk Reduction Behavior"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40281139/"
    },
    {
        "pmid": "40274208",
        "title": "The Impact of Inclisiran on Lipid Profiles in Adults with Hyperlipidemia: A Meta-Analysis and Meta-Regression of Randomized Controlled Trials.",
        "abstract": "Hyperlipidemia one prominent risk factor heart diseases current treatment sometimes insufficient control it Inclisiran small interfering RNA targeting proprotein convertase subtilisinkexin type 9 PCSK9 provides novel longacting approach improve hyperlipidemia metaanalysis conducted following PRISMA guidelines total 5 185 study screened met inclusion criteria primary outcome reduction LDLC level compared control group Statistical analysis used randomeffect model calculate mean difference MD 95 confidence interval CI total 5 randomized controlled trial comprised 4072 patients divided Inclisiran arm n  2129 Control arm n  1943 Compared control study showed Inclisiran substantially reduces LDLC MD 5125 95 CI 5658 4592 p 000001 total cholesterol MD 2775 95 CI 3039 2510 p 000001 apolipoprotein B MD 3665 95 CI 4593 2737 p  000039 triglyceride MD 1239 95 CI 2149 328 p  002275 PCSK9 level MD 7700 95 CI 8689 6711 p  000014 lipoprotein a MD 2177 95 CI 2429 1924 p  0000018 Inclisiran also significantly increase HDLC level mean difference 586 MD 95 CI 477 695 p  00001 metaanalysis demonstrates Inclisiran significantly improves lipid profile hyperlipidemia reducing LDLC total cholesterol apolipoprotein B triglycerides PCSK9 lipoprotein a increasing HDLC levels innovative mechanism twiceyearly dosing enhance efficacy safety patient adherence",
        "mesh_terms": [
            "Humans",
            "Hyperlipidemias",
            "Randomized Controlled Trials as Topic",
            "Cholesterol, LDL",
            "Proprotein Convertase 9",
            "Lipids",
            "Triglycerides"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40274208/"
    },
    {
        "pmid": "40254235",
        "title": "Childhood exposure to polycyclic aromatic hydrocarbons (PAHs) and cardiometabolic indicators in childhood and adolescence: findings from a cohort study in rural Bangladesh.",
        "abstract": "Exposure polycyclic aromatic hydrocarbon PAHs associated cardiovascular disease adulthood study examining childhood origin scarce examine association childhood PAH exposure cardiometabolic risk indicator childhood adolescence along difference sex Urinary PAH metabolite Σ123hydroxyphenanthrene Σ123OH Phe 1hydroxypyrene 1OH Pyr Σ23hydroxyfluorene Σ23OH Flu measured 9yearolds MINIMat cohort Bangladesh n  196 using liquid chromatography tandem mass spectrometry Cardiometabolic indicator lipids Creactive protein CRP insulin resistance HOMA2 IR blood pressure anthropometry composite cardiometabolic risk score CMRS assessed 9 15 years Associations PAH metabolite logsub2subtransformed cardiometabolic indicator assessed using multivariableadjusted linear logistic regression models children urinary 1OH Pyr median 16 ngmL positively associated body mass index zscore 9 15 years triglyceridehighdensity lipoprotein HDL cholesterolHDL ratios waist circumference CMRS CRP 15 years sex stratification consistent association mainly observed girls especially outcome age 15 urinary 1OH Pyr Σ123OH Phe concentration inversely associated HDL positively associated cholesterolHDL ratio CMRS Urinary 1OH Pyr also positively associated girls triglycerideHDL ratio HOMA2 IR waist circumference CRP association childhood PAH exposure cardiometabolic indicator childhood adolescence differed sex girls increased adiposity indication altered lipid profile metabolic function detected boy seemed incongruently affected",
        "mesh_terms": [
            "Humans",
            "Child",
            "Bangladesh",
            "Female",
            "Male",
            "Polycyclic Aromatic Hydrocarbons",
            "Adolescent",
            "Cohort Studies",
            "Environmental Exposure",
            "Environmental Pollutants",
            "Rural Population",
            "Cardiovascular Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40254235/"
    },
    {
        "pmid": "40251654",
        "title": "Burden of non-communicable diseases in South Asia: a decomposition analysis.",
        "abstract": "study examines incidence prevalence deaths disabilityadjusted life year DALYs related noncommunicable disease NCDs South Asia exploring environmental metabolic behavioural risk factors exploring change death DALYs driven population growth aging mortality rates Using data Global Burden Disease GBD study 2021 estimated agestandardized incidence prevalence deaths DALYs four major NCDs cardiovascular diseases cancer diabetes chronic respiratory disease 2010 2021 Gender agespecific estimation conducted across NCDs 95 uncertainty interval decomposition analysis employed estimate change death DALYs attributable NCDs burden NCDs South Asia increased 300 incidence 2010 2021 overall prevalence decreased 100 yet agestandardized prevalence rate remains global rate 91570 per 100000 population Incidences cardiovascular respiratory disease declined 300 1300 respectively whereas diabetes cancer rose 2100 1300 South Asia Nepal faced highest environmental impact 234 DALYs Bangladesh greatest metabolic impact 2562 India highest behavioural factor 2395 Population growth aging primary driver change death DALYs across region finding emphasizes need targeted public health intervention addressing environmental metabolic behavioral risk NCDs South Asia alongside strategy support healthy aging effective disease management across diverse demographic groups",
        "mesh_terms": [
            "Humans",
            "Noncommunicable Diseases",
            "Male",
            "Disability-Adjusted Life Years",
            "Female",
            "Prevalence",
            "Middle Aged",
            "Adult",
            "Aged",
            "Asia",
            "Incidence",
            "Neoplasms",
            "Global Burden of Disease",
            "Young Adult",
            "Cardiovascular Diseases",
            "Adolescent",
            "Diabetes Mellitus",
            "Risk Factors",
            "Cost of Illness",
            "Infant",
            "Child, Preschool",
            "Aged, 80 and over",
            "Child",
            "Respiratory Tract Diseases",
            "Asia, Southern"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40251654/"
    },
    {
        "pmid": "40251230",
        "title": "Coupled split square resonator based metamaterial sensor for realtime monitoring of air bubbles in IV channels.",
        "abstract": "Air embolism caused undetected air bubble intravenous IV line pose critical risk medical treatments necessitating accurate reliable detection systems study address challenge developing novel metamaterialbased sensor realtime monitoring air bubble IV channels sensor employ Single Negative Complementary Split Square Resonator CSSR coupled polymerbased microfluidic channel PMC detect dielectric change caused air bubble flowing saline Unlike traditional optical ultrasonic methods proposed sensor offer compact costeffective fabricationfriendly solution maintaining high sensitivity 78 precision Experimental validation demonstrated capability detect even small air bubbles resonant frequency shift observed 66 GHz 69 GHz innovation provides robust tool enhancing patient safety preventing air embolisms potential application broader biomedical sensing scenarios addressing critical medical need advanced metamaterial technology work contributes significantly healthcare monitoring sensor design",
        "mesh_terms": [
            "Embolism, Air",
            "Humans",
            "Equipment Design"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40251230/"
    },
    {
        "pmid": "40229845",
        "title": "Efficacy and safety of dexamethasone versus intravitreal aflibercept implants for macular edema: a systematic review and meta-analysis.",
        "abstract": "Macular edema ME prevalent complication diabetic retinopathy DR retinal vein occlusion RVO contributes significantly vision impairment worldwide condition primarily driven elevated vascular endothelial growth factor VEGF proinflammatory cytokines resulting use antiVEGF agent aflibercept corticosteroid dexamethasone implants However evidence comparing clinical efficacy safety two modality remains limited systematic review metaanalysis aimed compare safety efficacy intravitreal aflibercept injection dexamethasone implant associated DR RVO study conducted according Preferred Reporting Items Systematic Reviews MetaAnalyses guideline registered PROSPERO CRD42024577212 comprehensive search PubMed Cochrane Web Science Scopus database performed August 30 2024 Nine studies involving 572 eyes included analysis Key outcome assessed included BestCorrected Visual Acuity BCVA Central Retinal Thickness CRT Intraocular Pressure IOP randomeffects model applied pooled effect size calculations heterogeneity addressed using sensitivity analyses treatment showed comparable efficacy improving BCVA reducing CRT across followup intervals 3 months dexamethasone implant demonstrated statistically significant superiority BCVA improvement MD  118 95 CI 089 147 P  0001 CRT reduction MD   6245 µm 95 CI  8567  3922 P  0001 compared aflibercept Similarly 12 months dexamethasone implant maintained greater efficacy CRT reduction MD   5873 µm 95 CI  7812  3934 P  0001 However dexamethasone implant associated increased IOP 3 6 month MD  104 mmHg 95 CI 056 152 P  0001 significant difference IOP observed treatment 12 months Intravitreal aflibercept injection dexamethasone implant effective modality management ME presenting distinct advantages Dexamethasone implant minimize frequency treatment achieving superior outcome term BCVA CRT However also associated heightened risk IOP elevation cataract formation Conversely aflibercept requires frequent administration may result logistical financial challenge patient health care providers Therefore personalized treatment strategy consider disease severity comorbidities individual preferences Future research prioritize patientcentered outcomes emphasizing quality life treatment cost also investigating conditionspecific response therapeutic interventions",
        "mesh_terms": [
            "Humans",
            "Dexamethasone",
            "Macular Edema",
            "Intravitreal Injections",
            "Recombinant Fusion Proteins",
            "Receptors, Vascular Endothelial Growth Factor",
            "Drug Implants",
            "Treatment Outcome",
            "Retinal Vein Occlusion",
            "Diabetic Retinopathy",
            "Visual Acuity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40229845/"
    },
    {
        "pmid": "40221679",
        "title": "Disrupting antimicrobial resistance: unveiling the potential of vitamin C in combating biofilm formation in drug-resistant bacteria.",
        "abstract": "Antimicrobial resistance AMR pose significant threat global health exacerbated protective mechanism biofilms formed drugresistant bacteria Extracellular polymeric substance EPS produced bacteria biofilms serve formidable shield impeding efficacy antimicrobial agents Here investigated potential vitamin C sodium ascorbate disrupt biofilm formation drugresistant bacteria isolated diabetic foot ulcer DFU patient studied antimicrobial antibiofilm activity vitamin C bacteria 117 study isolates primarily identified Escherichia coli n  52 Staphylococcus spp n  19 Klebsiella spp n  46 80 isolates exhibited Multiple Antimicrobial Resistance MAR index greater 02 classifying multidrug resistant MDR superbugs Among these 58 isolates demonstrated moderate strong biofilmforming ability selected experiment vitamin C effective concentration vitamin C inhibiting growth E coli Klebsiella spp isolates 90 estimated 125 mgml 25 mgml respectively allStaphylococcus spp isolates 0325 mgml Vitamin C exhibited notable antibiofilm effect studied isolates biofilm prevention concentration BPC 0625 125 016 mgml E coli Klebsiella spp Staphylococcus spp isolates respectively Furthermore combined oxacillin amoxicillin  drug found ineffective vitamin C significantly reduced ability MDR isolates form biofilms rendering susceptible drugs effect restoring efficacy expression recA gene early quantifiable marker onset SOS response biofilm production downregulated treatment E coli vitamin C Relative gene expression analysis revealed ciprofloxacininduced recA expression significantly inhibited MDR isolates E coli treated vitamin C concentration 0625 mgml BPC vitamin C finding reveal vitamin C alone combination ineffective antibiotics attenuates biofilm formation restores susceptibility multidrugresistant MDR isolates antimicrobial agents study underscore promise vitamin C nonlethal disruptor biofilmassociated antimicrobial resistance applicable",
        "mesh_terms": [
            "Biofilms",
            "Ascorbic Acid",
            "Anti-Bacterial Agents",
            "Microbial Sensitivity Tests",
            "Humans",
            "Drug Resistance, Multiple, Bacterial",
            "Bacteria",
            "Diabetic Foot",
            "Escherichia coli",
            "Klebsiella",
            "Staphylococcus"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40221679/"
    },
    {
        "pmid": "40213240",
        "title": "Cardiovascular outcomes and safety assessment of SGLT2i on heart failure patients: a systematic review and meta-analysis.",
        "abstract": "Sodiumglucose cotransporter 2 inhibitor SGLT2is used treating type 2 diabetes mellitus show promise improving outcome heart failure patients systematic review metaanalysis aim quantify benefit side effect SGLT2i heart failure patient reduced ejection fraction systematic search conducted using PubMed Cochrane Library Google Scholar keywords SodiumGlucose Cotransporter 2 Inhibitor Myocardial Infarction Cardiovascular Inclusion criterion randomized controlled trial involving patient heart failure Primary outcome hospitalization due heart failure cardiovascular mortality Secondary outcome included discontinuation due adverse effects amputation fractures urinary tract infections Eight randomized controlled trial included interventional group showed significantly lower hospitalization iPi  000001 cardiovascular death iPi  00008 Secondary outcomes including adverse effect like amputation fractures UTI statistically significant across groups SGLT2 inhibitors due natriuretic cardiometabolic vasomodulatory effects offer promising role reducing cardiovascular complication patient type 2 diabetes mellitus",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40213240/"
    },
    {
        "pmid": "40205509",
        "title": "Melioidosis with venous thrombosis and cellulitis in the left lower limb: a case report.",
        "abstract": "Melioidosis caused Burkholderia pseudomallei disease high case fatality rate wide variety disease manifestation causing diagnostic dilemma medical professionals Risk factor diabetes contribute worse prognosis treated appropriate antibiotic course management case report describes diabetic melioidosis case rare presentation venous thrombosis lower limb successful course treatment patient 48yearold Bangladeshi male admitted gradually increasing left knee pain intermittent highgrade fever 7 days examination palpable spleen high body temperature 102 °F pitting edema left lower limb admission treated empiric meropenem admission considering serious illness Doppler ultrasound left lower limb revealed superficial venous thrombosis thrombophlebitis involving long saphenous vein superficial vein saphenous territory knee patient enrolled eligible case research study called Acute Febrile Illness study Blood culture confirmed diagnosis melioidosis Doxycycline added treatment regimen research study team informed treating physician hospital diagnosis melioidosis discharged cotrimoxazole advised taken 3 months case report show u lack diagnostics detect melioidosis hospital setting Bangladesh successful treatment outcome proved importance routine surveillance rare unusual diseases addition endemic pathogens addition training essential improve knowledge raise awareness among clinician clinical diagnosis management melioidosis",
        "mesh_terms": [
            "Humans",
            "Male",
            "Melioidosis",
            "Middle Aged",
            "Venous Thrombosis",
            "Anti-Bacterial Agents",
            "Lower Extremity",
            "Cellulitis",
            "Burkholderia pseudomallei",
            "Meropenem",
            "Doxycycline",
            "Treatment Outcome",
            "Ultrasonography, Doppler"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40205509/"
    },
    {
        "pmid": "40189520",
        "title": "Associations between education and ideal cardiovascular health metrics across 36 low- and middle-income countries.",
        "abstract": "relationship education cardiovascular health CVH metric low middleincome country LMICs remains unclear study explores association education ideal cardiovascular health score CVHS well seven CVH metrics crosssectional study extracted data STEPwise approach surveillance survey 36 LMICs 2010 2020 assessed CVHS using sum score seven metric defined American Heart Association 1 ≥ 150 minweek moderate 75 minweek vigorous activity equivalent combination 2 BMI  25 kgmsup2sup nonAsians  23 kgmsup2sup Asians 3 fruit vegetable intake ≥ 45 serving per day 4 nonsmoking 5 blood pressure  12080 mmHg untreated 6 total cholesterol  200 mgdL untreated 7 fasting blood glucose  100 mgdL untreated ideal CVHS score ranged 5 7 disaggregated prevalence ideal CVHS seven metric education constructed Poisson regression model adjust socioeconomic factors Among 81327 adult participants overall ideal CVHS prevalence studied country highest among individual primary education 529 95 CI 510549 surpassing education level  480 95 CI 446513 P  0003 education 391 95 CI 365418 P  0001 tertiary education Five ideal physical activity BMI blood pressure total cholesterol blood glucose seven CVH metric peaked among participant primary secondary education instance prevalence ideal blood pressure among individual primary education 344 95 CI 327361 higher prevalence education levels ranging 286 323 pattern concentrated lowincome country lowermiddleincome countries uppermiddleincome countries prevalence ideal CVHS increased higher education levels ranging 154 individual education 331 tertiary education LMICs association education ideal CVHS along several CVH metrics exhibited un inverted Ushape may closely related different stage epidemiologic transition",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Developing Countries",
            "Adult",
            "Middle Aged",
            "Cardiovascular Diseases",
            "Educational Status",
            "Blood Pressure",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40189520/"
    },
    {
        "pmid": "40189503",
        "title": "ECG-based heart arrhythmia classification using feature engineering and a hybrid stacked machine learning.",
        "abstract": "heart arrhythmia refers set condition characterized irregular heart beats increasing mortality rate recent years Regular monitoring essential effective management early detection timely treatment greatly improve survival outcomes electrocardiogram ECG remains standard method detecting arrhythmias traditionally analyzed cardiolo gist clinical experts However incorporation automated technology computerassisted system offer substantial support accurate diagno si heart arrhythmias research focused developing hybrid model stack classifiers stateoftheart ensemble machinelearning technique accurately classify heart arrhythmia ECG signals eliminating need extensive human intervention conventional machinelearning bagging boosting ensemble algorithm also explored along proposed stack classifiers classifier trained different number feature 50 65 80 95 selected feature engineering technique PCA ChiSquare RFE dataset important ones outcome stack clas sifier XGBoost metaclassifier trained 65 important feature determined Principal Component Analysis PCA technique achieved best performance among models proposed classifier achieved perfor mance 9958 accuracy 9957 precision 9958 recall 9957 f1score promising arrhythmia diagnosis",
        "mesh_terms": [
            "Humans",
            "Arrhythmias, Cardiac",
            "Electrocardiography",
            "Predictive Value of Tests",
            "Machine Learning",
            "Heart Rate",
            "Signal Processing, Computer-Assisted",
            "Action Potentials",
            "Reproducibility of Results",
            "Diagnosis, Computer-Assisted",
            "Algorithms"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40189503/"
    },
    {
        "pmid": "40188336",
        "title": "Barriers to contraceptive use among people living with diabetes and/or hypertension: a qualitative study.",
        "abstract": "Pregnancy individual diabetes andor hypertension especially undiagnosed untreated uncontrolled result severe consequences including maternal child mortality Contraception crucial management pregnancy individual diabetes andor hypertension However decisionmaking experience related contraception use among population low middleincome country poorly understood study aim explore barrier contraception use among sexually active men woman living diabetes andor hypertension conducted qualitative study using empirical phenomenological approach interviewed participant diagnosed diabetes andor hypertension well stakeholder involved providing care individual living least one two condition family planning service providers Semistructured interview guide used data collected four focus group discussions four indepth interviews ten key informant interviews interview transcribed analysed thematically People living diabetes andor hypertension encounter misunderstanding various barrier come using contraception experience categorised four main theme nine subthemes theme identified were i lack awarenessinadequate knowledge misunderstanding ii social religious beliefs iii barrier available affordable contraceptives iv lack coordination facility providing family planning service treatment management diabetes andor hypertension Findings provide comprehensive understanding complexity consideration involved contraceptive userelated decisionmaking among individual diabetes andor hypertension finding used policymaking programme development promote contraceptive use improve reproductive health outcome population",
        "mesh_terms": [
            "Humans",
            "Qualitative Research",
            "Female",
            "Hypertension",
            "Adult",
            "Male",
            "Diabetes Mellitus",
            "Contraception Behavior",
            "Middle Aged",
            "Health Knowledge, Attitudes, Practice",
            "Contraception",
            "Interviews as Topic",
            "Pregnancy",
            "Focus Groups",
            "Health Services Accessibility"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40188336/"
    },
    {
        "pmid": "40178225",
        "title": "Health financing interventions and hypertension control: a narrative review and hypothetical model.",
        "abstract": "Financial incentive used extensively lowincome middleincome country LMICs improve health service coverage Little known effectiveness improving hypertension outcomes conducted narrative literature review document feature select supplyside payforperformance capitation demandside conditional cash transfer CCT vouchers financing intervention focused improving hypertension outcome primary care settings review confirmed paucity studies especially LMICs Payforperformance capitation small effect screening prescription practices blood pressure BP control CCTs mixed effect screening modest effect BP control Information causal pathways unintended consequences use voucher sparse developed conceptual model identifying pathway financing intervention influence hypertension outcomes Based model simulation context Bangladesh indicated payforperformance demand substantial financial resource could become favorable increased treatment coverage",
        "mesh_terms": [
            "Humans",
            "Hypertension",
            "Healthcare Financing"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40178225/"
    },
    {
        "pmid": "40169952",
        "title": "Navigating the complexities of end-stage kidney disease (ESKD) from risk factors to outcome: insights from the UK Biobank cohort.",
        "abstract": "global prevalence endstage kidney disease ESKD increasing despite optimal management traditional risk factor hyperglycaemia hypertension dyslipidaemia study examines influence cardiorenal risk factors socioeconomic status ethnic cardiovascular comorbidities ESKD outcome general population crosssectional study analysed data 502408 UK Biobank study participant recruited 2006 2010 Multivariable logistic regression model fitted assess risk factor ESKD result presented adjusted odds ratio aOR 95 confidence interval 95 CI total 1191 02 study participant reported ESKD Diabetes increased ESKD risk 62 162 136193 earlyonset diabetes before age 40 conferring higher odds compared lateronset after age 40 226 157324 Similarly earlyonset hypertension before age 40 compared later onset after age 40 increased ESKD odds 73 173 121244 Cardiovascular comorbidities including stroke hypertension myocardial infarction angina strongly associated ESKD 597 399872 535 438656 494 356678 489 347681 respectively Males 22 higher risk ESKD female 122 104143 additional year diabetes duration increased ESKD odds 2 102 101103 Nonwhite ethnicity compared white socioeconomically deprived compared least deprived quintiles 70 83 higher odds ESKD unit HbA1c rise increased odds ESKD 2 Compared microalbuminuria macroalbuminuria increased odds ESKD almost 10fold 947 7951127 normoalbuminuria reduced odds 73 027 022032 Early onset diabetes hypertension male sex nonwhite ethnicity deprivation poor glycaemic control prolonged hyperglycaemia significant risk factor ESKD finding highlight complexity ESKD need multifactorial targeted intervention highrisk populations applicable",
        "mesh_terms": [
            "Humans",
            "Kidney Failure, Chronic",
            "Male",
            "Female",
            "United Kingdom",
            "Middle Aged",
            "Risk Factors",
            "Cross-Sectional Studies",
            "Adult",
            "Aged",
            "Hypertension",
            "Cohort Studies",
            "Biological Specimen Banks",
            "Comorbidity",
            "Diabetes Mellitus",
            "Cardiovascular Diseases",
            "UK Biobank"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40169952/"
    },
    {
        "pmid": "40166646",
        "title": "STAT3 Signaling Pathway in Health and Disease.",
        "abstract": "Signal transducer activator transcription 3 STAT3 critical transcription factor involved multiple physiological pathological processes STAT3 play essential role homeostasis persistent activation implicated pathogenesis various diseases particularly cancer bonerelated diseases autoimmune disorders inflammatory diseases cardiovascular diseases neurodegenerative conditions interleukin6Janus kinase JAKSTAT3 signaling axis central STAT3 activation influencing tumor microenvironment remodeling angiogenesis immune evasion therapy resistance Despite extensive research precise mechanism underlying dysregulated STAT3 signaling disease progression remain incompletely understood United States Food Drug Administration USFDAapproved direct STAT3 inhibitor currently exist review provides comprehensive evaluation STAT3s role health disease emphasizing involvement cancer stem cell maintenance metastasis inflammation drug resistance systematically discus therapeutic strategies including JAK inhibitor tofacitinib ruxolitinib Src Homology 2 domain inhibitor S3I201 STATTIC antisense oligonucleotides AZD9150 nanomedicinebased drug delivery systems enhance specificity bioavailability reducing toxicity integrating molecular mechanisms disease pathology emerging therapeutic interventions review fill critical knowledge gap STAT3targeted therapy insight STAT3 signaling crosstalk epigenetic regulation resistance mechanism offer foundation developing nextgeneration STAT3 inhibitor greater clinical efficacy translational potential",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40166646/"
    },
    {
        "pmid": "40160076",
        "title": "Safety and Efficacy of Bivalirudin in Female Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.",
        "abstract": "woman independent predictor adverse event percutaneous coronary intervention PCI Whether newer anticoagulant bivalirudin safe effective female acute coronary syndrome ACS patient undergoing PCI compared conventional heparin less well defined Bangladeshi population aim evaluate safety efficacy Bivalirudin female ACS patient undergoing PCI One hundred 100 female ACS patient enrolled randomized controlled study underwent PCI May November 2019 BSMMU Among 35 patient randomly assigned receive bivalirudin 65 patient control group receive heparin without eptifibatide GPI glycoprotein IIbIIIa inhibitor outcome measure incidence 30day hemorrhagic complications stent thrombosis major adverse cardiac cerebral event MACCEs Bivalirudin treatment associated significantly lower incidence 30day net adverse clinical event NACEs 57 vs 276 p0009 bleeding 28 vs 169 p003 compared control regimen incidence MACCEs 28 vs 154 p005 stent thrombosis 00 vs 31 p0295 comparable two groups Multivariate analysis showed bivalirudin OR 0264 95 CI 00710977 p004 transradial access OR 0056 95 CI 00030967 p004 statin OR 0009 95 CI 000050168 p0001 independent protective factor 30day NACEs Bivalirudin safe effective female ACS patient undergoing PCI reduces hemorrhagic complication without increase ischemic event MACCEs compared conventional heparin",
        "mesh_terms": [
            "Humans",
            "Female",
            "Hirudins",
            "Percutaneous Coronary Intervention",
            "Acute Coronary Syndrome",
            "Peptide Fragments",
            "Recombinant Proteins",
            "Middle Aged",
            "Antithrombins",
            "Aged",
            "Treatment Outcome",
            "Heparin"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40160076/"
    },
    {
        "pmid": "40160068",
        "title": "Effectiveness of Serum Cystatin C Level for Predicting Acute Kidney Injury Following Adult On-pump Cardiac Surgery.",
        "abstract": "Acute kidney injury AKI following adult cardiac surgery procedure Cardiopulmonary bypass CPB linked higher risk morbidity death novel biomarker renal failure serum Cystatin C CysC prognostic value however wide range predictive accuracy reported study aimed evaluate whether early postoperative serum CysC measurement improves prediction AKI following adult cardiac surgery determine relationship measurement early postoperative serum CysC level postoperative early outcomes singlecenter prospective study 70 patient conducted National Institute Cardiovascular Diseases NICVD Dhaka Bangladesh July 2018 December 2019 underwent onpump cardiac surgery study participant chosen specifically normal renal function elective scheduled heart surgery CPB blood sample tested six measurement time point T1 preoperative T2 6 hour commencement CPB T3 12 hour commencement CPB T4 24 hour commencement CPB T5 36 hour commencement CPB T6 48 hour commencement CPB Serum cystatin C significantly higher 12 hour commencement CPB operation T3 onwards earliest significant predictive AUCs found T3 AUC 0983 p00001 95 CI 0960 1000 T46 AUC 1000 p00001 95 CI 1000 summary study found serum CysC useful early biomarker AKI adult following cardiac surgery extent marker correlate severity AKI",
        "mesh_terms": [
            "Humans",
            "Cystatin C",
            "Acute Kidney Injury",
            "Male",
            "Female",
            "Middle Aged",
            "Prospective Studies",
            "Biomarkers",
            "Cardiac Surgical Procedures",
            "Postoperative Complications",
            "Aged",
            "Adult",
            "Predictive Value of Tests",
            "Cardiopulmonary Bypass",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40160068/"
    },
    {
        "pmid": "40160060",
        "title": "Prevalence of Inducible Myocardial Ischemia in Patients with Cervical Spondylosis having Typical Chest Pain.",
        "abstract": "Globally prevalent noncommunicable disease ischemic heart disease Cervical spondylosis CS patient presenting typical chest pain may underlying myocardial ischemia MI often remain unexplored crosssectional analytical study carried University Cardiac Centre UCC Bangabandhu Sheikh Mujib Medical University BSMMU Dhaka Bangladesh September 2017 March 2018 study aimed investigate prevalence inducible myocardial ischemia among patient cervical spondylosis typical chest pain total 54 adult CS patient presenting typical chest pain included underwent dobutamine stress echocardiography using standard protocol Informed written consent taken inclusion Ethical measure taken compliance declaration Helsinki participant mean age ±SD 44876 year higher proportion female 648 all 13241 patient inducible myocardial ischemia dobutamine stress echocardiography ECG finding suggestive MI noted 7 13 patient 538 inducible myocardial ischemia 1 41 patient 24 without inducible myocardial ischemia 13 patient myocardial ischemia 7538 abnormal ECG 41 patient without inducible ischemia 124 abnormal ECG Single vessel involvement predominant finding 923 respectively 538 385 involvement left anterior descending right coronary artery territory independent predictor myocardial ischemia age Adjusted AOR 117 95 Confidence Interval CI 101  135 male sex AOR 2075 95 CI 111  35319 diabetes mellitus AOR 8373 95 172  406756 Nearly onequarter cervical spondylosis patient presenting typical chest pain underlying inducible myocardial ischemia large casecontrol study recommended determine extent disease predictors",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Myocardial Ischemia",
            "Cross-Sectional Studies",
            "Adult",
            "Spondylosis",
            "Middle Aged",
            "Prevalence",
            "Chest Pain",
            "Bangladesh",
            "Echocardiography, Stress",
            "Electrocardiography"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40160060/"
    },
    {
        "pmid": "40160054",
        "title": "Prevalence, Variants and Presentation of Anomalous Aortostial Origin of Coronary Arteries: A Registry Based Analysis of Ten Cases.",
        "abstract": "study aimed determining prevalence different pattern origin coronary artery clinical presentation patient underwent coronary angiography crosssectional study initially 2000 patient underwent coronary angiogram CAG chronic stable angina acute coronary syndrome required CAG preoperative evaluation surgery National Institute Cardiovascular Diseases NICVD Dhaka Bangladesh July 2019 December 2020 enrolled taking informed consent prevalence anomalous aorto ostial origin among 2000 study population 05 Among 10 patients male predominant 8800 mean age 510±30 years coronary artery anomaly common right coronary artery RCA left coronary artery 10 patients RCA arouse left coronary sinus 3 separate origin left anterior descending left circumflex artery 3 equal next common anomaly left coronary artery arising right coronary sinus 2 followed left circumflex artery arising right coronary sinus 1 double right coronary artery 1 Twenty percent 200 patient asymptomatic diagnosed coronary angiogram surgery Thirty percent 300 case presented chronic stable angina 500 total case presented acute coronary syndrome Anomalous origin coronary artery may present isolated defect part complex congenital heart disease Presentation prognosis varies widely asymptomatic sudden cardiac death according type various anomalies So congenital coronary artery anomaly pattern sorted risk stratification proper management",
        "mesh_terms": [
            "Humans",
            "Male",
            "Coronary Vessel Anomalies",
            "Female",
            "Middle Aged",
            "Prevalence",
            "Cross-Sectional Studies",
            "Bangladesh",
            "Coronary Angiography",
            "Registries",
            "Adult",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40160054/"
    },
    {
        "pmid": "40160053",
        "title": "Assessment of Waist Circumference, Waist to Hip Ratio and Serum TSH in Obese Female.",
        "abstract": "Obesity worldwide problem impacting every age group developed developing countries study aim investigate association obesity waist circumference WC waist hip ratio WHR serum TSH level adult obese female age ranged 1859 year comparison adult healthy nonobese female age goal identify strategy mitigate obesityrelated complication advocate better health outcome among them crosssectional type analytical study carried Department Physiology Mymensingh Medical College Mymensingh Bangladesh July 2023 June 2024 total mumber 200 female subject age ranged 1859 year included study Among one hundred 100 adult healthy nonobese female taken control group Group I one hundred 100 adult obese female taken study group Group II result calculated analyzed using SPSS Anthropometric measurement height m weight kg BMI Kgm² waist circumference WC waist hip ratio WHR measured Laboratory analysis serum TSH determined immunoradiometric assay IRMA method study significantly increased mean waist circumference 10208±512 cm p001 waist hip ratio 094±003 p001 serum TSH 0373±199μIUml p001 adult obese female adult healthy nonobese female Changes parameter linked secondary condition like HTN type 2 DM cardiovascular disease hypothyroidism etc significantly impact mortality morbidity rate So routine monitoring serum TSH level recommended prevent obesity related complication promote healthy life",
        "mesh_terms": [
            "Humans",
            "Female",
            "Adult",
            "Obesity",
            "Waist Circumference",
            "Thyrotropin",
            "Waist-Hip Ratio",
            "Cross-Sectional Studies",
            "Middle Aged",
            "Adolescent",
            "Young Adult",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40160053/"
    },
    {
        "pmid": "40160048",
        "title": "Proportion of Dry Eye among Patients with Type 2 Diabetes Mellitus with Diabetic Retinopathy.",
        "abstract": "Diabetic retinopathy dryness eye common complication type 2 diabetes mellitus progression diabetes mellitus patient seldom report symptom ocular surface problem due lack correlation symptom sign dry eye study designed find proportion dry eye among patient type 2 diabetes mellitus diabetic retinopathy cross sectional descriptive type observational study conducted Department Ophthalmology Mymensingh Medical College Bangladesh February 2021 September 2022 Total 224 patient type 2 diabetes mellitus diabetic retinopathy selected considering inclusion exclusion criteria patient underwent routine ophthalmic examination like visual acuity slit lamp examination fundus examination 90D volk lens Condensing lens indirect ophthalmoscopy Dry eye status assessed performing Tear film break time test Schirmer II tests Color fundus photograph HbA1c performed patients study examined 224 patient type 2 diabetes mellitus also diabetic retinopathy these 100 patient diagnosed dry eye patients 20 mild nonproliferative diabetic retinopathy 390 moderate nonproliferative diabetic retinopathy 230 severe nonproliferative diabetic retinopathy 360 proliferative diabetic retinopathy study 446 patient dry eye among patient type 2 diabetes mellitus diabetic retinopathy Significant association found dry eye status grading diabetic retinopathy p0001 gender patient p0036 duration diabetes mellitus p0002 HbA1c p0001 correlation found age patient dryness status",
        "mesh_terms": [
            "Humans",
            "Diabetes Mellitus, Type 2",
            "Diabetic Retinopathy",
            "Female",
            "Male",
            "Dry Eye Syndromes",
            "Cross-Sectional Studies",
            "Middle Aged",
            "Bangladesh",
            "Adult",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40160048/"
    },
    {
        "pmid": "40160047",
        "title": "Status of Lipid Profile among Patients with Chronic Kidney Disease.",
        "abstract": "Chronic kidney disease CKD increasing threat healthcare system world Primary cause CKD diabetes vascular diseases So optimal management CKD includes cardiovascular risk reduction treatment albuminuria avoidance potential nephrotoxin adjustment drug dosing Patients also require monitoring complication CKD hypocalcemia hyperkalemia dyslipidemia metabolic acidosis hyperphosphatemia vitamin deficiency secondary hyperparathyroidism anaemia crosssectional study executed Department Biochemistry Mymensingh Medical College collaboration Department Nephrology Mymensingh Medical College Hospital Mymensingh Bangladesh July 2022 June 2023 subject selected based inclusion exclusion criterion purposive nonrandom sampling sum 120 subject included study them 60 selected case CKD patient another 60 apparently normal healthy person selected control study serum lipid profile measured analytical study value showed mean±SD serum TC 14985±3884 Group 17892±4185mgdl Group II Serum TG 12277±3688 Group 17593±6350mgdl Group II Serum LDLC 9513±2443 Group 11560±4562 mgdl Group II Serum HDLC 4862±870 4155±279mgdl Group Group II respectively Statistical analysis done using statistical package social science SPSS window package version 260 statistical significance difference case control evaluated using Students unpaired t test careful evaluation present study found mean serum total cholesterol TC Triglyceride TG Low density lipoprotein LDLC level significantly increased High density lipoprotein HDLC level significantly decreased CKD patients",
        "mesh_terms": [
            "Humans",
            "Renal Insufficiency, Chronic",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Adult",
            "Middle Aged",
            "Lipids",
            "Bangladesh",
            "Triglycerides"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40160047/"
    },
    {
        "pmid": "40160041",
        "title": "Comparison of Serum Albumin and Bilirubin among Obese and Non-obese Adults.",
        "abstract": "Obesity significant global health concern point 1 3 people globally clinically obese Obesity condition excessive amount body fat linked several health disorder include metabolic syndrome cardiovascular disease well liver diseases Serum albumin bilirubin biochemical marker used diagnose treat various healthrelated conditions Hence relationship obesity serum marker well established described complex Although obesity affect liver important examine effect obesity serum albumin bilirubin status compared nonobese subjects study aim assess serum albumin bilirubin concentration obese nonobese adult compare nonobese adults crosssectional study conducted Department Biochemistry Mymensingh Medical College Mymensingh Bangladesh collaboration Department Endocrinology Medicine Mymensingh Medical College Hospital Mymensingh Bangladesh July 2023 June 2024 subject selected based inclusion exclusion criterion purposive nonrandom sampling total 200 participant took part study them 100 selected case obese adults another 100 nonobese adult selected control study serum albumin bilirubin level measured analytical study value expressed mean±SD Statistical analysis done using SPSS Windows package version 260 statistical significance difference case control calculated using Students unpaired t test Pearsons correlation used determine level significance see correlation BMI parameters careful evaluation mean±SD value serum albumin 351±059 gdl 412±048 gdl case control group respectively mean±SD value serum bilirubin 038±018 mgdl 057±016 mgdl case control group respectively study revealed mean serum albumin bilirubin level significantly decreased obese adults significant negative correlation found BMI serum albumin bilirubin levels Analyzing finding crosssectional study significant alteration serum albumin bilirubin level observed among obese adults",
        "mesh_terms": [
            "Humans",
            "Bilirubin",
            "Obesity",
            "Adult",
            "Cross-Sectional Studies",
            "Female",
            "Male",
            "Serum Albumin",
            "Middle Aged",
            "Biomarkers",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40160041/"
    },
    {
        "pmid": "40147576",
        "title": "Transforming Growth Factor-β-mediated attenuation of cardio-renal oxidative stress, inflammation and fibrosis by L-arginine in fludrocortisone acetate induced-hypertensive rats.",
        "abstract": "Uncontrolled hypertension primary contributor tissue damage multiple organs including heart kidneys study explored protective role Larginine mineralocorticoidinduced rat model hypertension induce hypertension subsequent organ damage rat nephrectomized unilaterally fed mineralocorticoid fludrocortisone acetate dietary salt FCASalt rat treated Larginine 28 days subsequent test performed Biochemical analysis revealed increased level inflammation oxidative stress biomarkers plasma heart kidney FCAsalttreated rats Larginine treatment decreased oxidative stress marker malondialdehyde MDA 18  22  18  heart kidney plasma respectively Larginine also attenuated advanced oxidative protein product AOPP activity superoxide dismutase SOD increased 62  45  16  heart kidney plasma respectively Largininetreated animal compared FCASalt group Significant augmentation also revealed nitric oxide NO catalase CAT reduced glutathione GSH plasma level kidney function biomarkers uric acid creatinine significantly improved Larginine treatment Furthermore Larginine remarkably reduced elevated plasma cytokine IL1β IL17A TNFα TGFβ1 FCAsaltinduced hypertensive rats Histopathological data showed reduction fibrosis tissue damage Larginine FCAsalttreated group propose Larginine could effective agent preventing cardiac renal dysfunction hypertensive rats",
        "mesh_terms": [
            "Animals",
            "Arginine",
            "Oxidative Stress",
            "Male",
            "Hypertension",
            "Rats",
            "Kidney",
            "Fludrocortisone",
            "Fibrosis",
            "Inflammation",
            "Myocardium",
            "Transforming Growth Factor beta",
            "Biomarkers",
            "Rats, Wistar"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40147576/"
    },
    {
        "pmid": "40147157",
        "title": "Optimizing stability of heart disease prediction across imbalanced learning with interpretable Grow Network.",
        "abstract": "Heart disease prediction model often face stability challenge applied public datasets due significant class imbalances unlike balanced benchmark datasets imbalance adversely affect various stage prediction including feature selection sampling modeling leading skewed performance one class often favored another enhance stability study proposes Grow Network GrowNet architecture dynamically configures based datas characteristics enhance GrowNets stability study proposes use TriDyn Dependence feature selection Adaptive Refinement sampling ensure selection relevant feature across imbalanced data effectively manage class imbalance training evaluated benchmark UCI heart disease dataset GrowNet outperformed models achieving specificity 92 sensitivity 88 precision 90 F1 score 90 evaluation three public datasets Behavioral Risk Factor Surveillance System BRFSS heart disease case constitute 6 data demonstrated GrowNets ability maintain balanced performance average specificity sensitivity AUCROC 7767 8167 8967 respectively model exhibited instability represents 228 improvement handling class imbalance compared prior studies Additional test two public datasets National Health Interview Survey NHIS confirmed GrowNets robustness generalizability average specificity sensitivity AUCROC 805 825 90 respectively model continued demonstrate instability enhance transparency study incorporates SHapley Additive exPlanations SHAP analysis enabling healthcare professional understand decisionmaking process identify key risk factor heart disease bronchitis midlife renal dysfunction elderly depressive disorder individual aged 3544 study present robust interpretable model assist healthcare professional costeffective early heart disease detection focusing key risk factors ultimately improving patient outcomes",
        "mesh_terms": [
            "Humans",
            "Heart Diseases",
            "Machine Learning",
            "ROC Curve",
            "Risk Factors",
            "Algorithms",
            "Neural Networks, Computer"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40147157/"
    },
    {
        "pmid": "40146996",
        "title": "Current status of elevated blood pressure and hypertension among adolescents in Asia: a systematic review.",
        "abstract": "Hypertension among adolescent Asia emerging public health concern directly associated early onset cardiovascular risks such also lead health issue challenge health care future existing study predominantly focussed adult populations sought provide targeted insight adolescent hypertension across Asia elucidating impact rapid lifestyle environmental change younger population Therefore systematic review aimed evaluate prevalence trend elevated blood pressure BP hypertension among adolescent aged 1019 year across Asia address gap regionspecific data determine demographic risk factors Following PRISMA guidelines searched PubMed EMBASE Science Direct Web Science Google Scholar Scopus crosssectional study adolescent hypertensionelevated BP Asia published January 2019 June 2024 narratively synthesised findings 2634 retrieved studies 39 met inclusion criteria covering 200 000 adolescent Asia prevalence hypertension range 07 urban Bangladesh 245 urban Malaysia urban area generally showing higher rate rural area eg India 84 urban vs 57 rural region East Asia highest overall prevalence 1425 followed West Asia 1414 South Asia 1377 Southeast Asia 1316 Central Asia 1237 Males higher prevalence rate for example 223 Chinese male vs 20 females increasing prevalence adolescent hypertension urban Asia significant public health concern Although extensive research conducted East South Asia dearth study Western Southeast Central Asia emphasising need future research Standardised diagnostic criterion targeted intervention crucial addressing regional disparity reducing longterm cardiovascular risks",
        "mesh_terms": [
            "Humans",
            "Adolescent",
            "Hypertension",
            "Asia",
            "Prevalence",
            "Child",
            "Young Adult",
            "Male",
            "Risk Factors",
            "Female",
            "Cross-Sectional Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40146996/"
    },
    {
        "pmid": "40133544",
        "title": "Coastal residency and its association with diagnosed hypertension based on findings from a cross-sectional study in rural Bangladesh.",
        "abstract": "high prevalence hypertension coastal region pose significant public health challenge due factor high salt intake air pollution poor diets limited healthcare access increased stress levels However disparity diagnosed hypertension coastal noncoastal area Bangladesh remain underexplored study aim investigate address prevalence diagnosed hypertension among adult regions 20202021 crosssectional study conducted Bangladesh assess hypertension prevalence coastal noncoastal regions study included 3917 adult six districts including noncoastal coastal regions Prevalence ratio PRs determined using modified Poisson regression model quantify relationship hypertension prevalence two regions study find 438 112 3917 respondent 446 female 117 mean age 4473 years diagnosed hypertension Notably adult residing coastal area higher prevalence hypertension 134 95 confidence interval 118150 noncoastal counterpart 95 95 CI 83107 coastal areas prevalence ranged 78 1824 age group 164 55  age group noncoastal areas prevalence ranged 29 1824 age group 158 55  age group result multivariable analysis revealed adult coastal area 29 likely hypertension noncoastal area aPR129 95 CI 107156 Moreover age physical activity occupation body mass index BMI identified factor associated development hypertension within regions Hypertension major health issue across Bangladesh coastal region facing added challenge high salinity drinking water coastal noncoastal area experience high rate undiagnosed hypertension environmental factor unique coastal area may intensify issue Targeted intervention account environmental socioeconomic factor essential addressing growing health concern regions",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Female",
            "Hypertension",
            "Adult",
            "Male",
            "Cross-Sectional Studies",
            "Middle Aged",
            "Rural Population",
            "Prevalence",
            "Young Adult",
            "Adolescent",
            "Risk Factors",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40133544/"
    },
    {
        "pmid": "40124766",
        "title": "Dyskalemia Prior to and After Initiation of a Fixed Dose Combination of Telmisartan and Amlodipine in Adults with Hypertension in Bangladesh.",
        "abstract": "World Health Organization recommends fixeddose combination FDC pill treating hypertension Antihypertensive FDC pill often contain reninangiotensin inhibitor RASI diuretic Thus screening monitoring dyskalemia hypokalemia hyperkalemia starting class medication recommended significant barrier implementation resourcelimited settings However need blood test may overemphasized prevalence dyskalemia patient hypertension uncommon incidence dyskalemia rare initiation FDC conducted communitybased blood pressure BP screening program Dhaka Bangladesh determined prevalence dyskalemia defined K  30 K  55 mmolL untreated adult SBP ≥140 mmHg andor DBP ≥90 mmHg Among baseline serum K ≥30 ≤50 mmolL creatinine clearance ≥30 mlmin determined incidence dyskalemia 2 month initiation daily FDC telmisartan 40 mg amlodipine 5 mg Secondary outcome BP change medication adherence symptoms 20222023 recruited 1073 adult SBP ≥140 mmHg andor DBP ≥90 mmHg mean age 54 years 71 men mean baseline BP 15794 SD 1293 mmHg prevalence hypokalemia hyperkalemia 16 02 respectively FDC initiated 1017 eligible patients 864 completed 2month followup visit Incident hypokalemia occurred 15 patients case incident hyperkalemia mean change serum potassium initiating FDC 005 053 mmolL followup 92 BP 14090 mmHg mean SBP change 298 mmHg 1 selfreported mild symptom eg leg swelling one death undetermined cause Given low prevalence incidence hyperkalemia evident reduction BP study suggests initiating FDC telmisartan amlodipine may practical safe option newly diagnosed hypertension especially resourceconstrained setting blood test cannot easily obtained",
        "mesh_terms": [
            "Humans",
            "Male",
            "Hypertension",
            "Female",
            "Bangladesh",
            "Amlodipine",
            "Telmisartan",
            "Middle Aged",
            "Antihypertensive Agents",
            "Drug Combinations",
            "Adult",
            "Incidence",
            "Prevalence",
            "Blood Pressure",
            "Hypokalemia",
            "Hyperkalemia",
            "Follow-Up Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40124766/"
    },
    {
        "pmid": "40124123",
        "title": "Multicentre randomised controlled trial protocol comparing structured physical exercise programme (SPEP) and medication versus conventional care for glycaemic control in type 2 diabetes mellitus.",
        "abstract": "One widespread noncommunicable disease world type 2 diabetes mellitus T2DM increase risk cardiovascular mortality morbidity addition elevated blood pressure lipid disorders physical activity exercise programme shown great impact reducing cholesterol glucose level So study aim generate proper Structured Physical Exercise Programme SPEP glycaemic control people T2DM study doubleblinded multicentre randomised controlled trial participant T2DM enrolled three Diabetic Centres Bangladesh participant allocated experimental control group 11 ratio group receive 18 sessions6 week intervention additional 24week followup Warmup exercises stretching aerobic exercise provided along medication experimental conventional approach provided control group glucometer measure primary outcome capillary blood glucose level secondary outcome cardiorespiratory fitness T2DMrelated comorbidities quality life measured 6min walktest selfstructured questionnaire SF36 outcome measured baseline posttest 6 week followup 24 weeks CTRI202308057032",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40124123/"
    },
    {
        "pmid": "40118158",
        "title": "Acute kidney injury, coagulopathy, and deep vein thrombosis following a haemotoxic snakebite: A case report from a resource-limited setting.",
        "abstract": "green pit viper Trimeresurus gramineus venomous snake commonly encountered South Asia particularly Bangladesh responsible many snakebite incidents Management envenoming challenging due lack specific antivenom requiring symptomatic supportive care address complications following case report represents complexity managing envenomation associated renal venous thrombotic complications 35yearold female admitted left lowerlimb swelling ecchymosis following snakebite transferred primarylevel hospital acute kidney injury serum creatinine 40 mgdL venominduced consumption coagulopathy VICC high level ddimer 15 mgL prothrombin time 28 seconds activated partial thromboplastin time 120 sec Duplex ultrasound confirmed presence femoral vein thrombosis patient treated fresh frozen plasma along supportive measures renal function improved creatinine level normalizing days management green pit viper envenomation requires close monitoring coagulation parameter renal function along supportive care occurrence unusual complications deep vein thrombosis necessitates conservative individualized approach treatment research needed better understand pathophysiology improve therapeutic strategy managing sequela envenomations",
        "mesh_terms": [
            "Snake Bites",
            "Humans",
            "Acute Kidney Injury",
            "Adult",
            "Female",
            "Venous Thrombosis",
            "Animals",
            "Crotalid Venoms",
            "Trimeresurus",
            "Blood Coagulation Disorders",
            "Bangladesh",
            "Disseminated Intravascular Coagulation",
            "Antivenins",
            "Resource-Limited Settings"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40118158/"
    },
    {
        "pmid": "40115248",
        "title": "Dietary Phytochemicals in Health and Disease: Mechanisms, Clinical Evidence, and Applications-A Comprehensive Review.",
        "abstract": "Phytochemicals bioactive compound found plant play key role promoting health preventing diseases Present fruits vegetables grains seed oils compound considered safe consumption due coevolution adaptation mammal plants Due wideranging biological effects attracted considerable research interest comprehensive review explores mechanism action health benefits application dietary phytochemicals particular focus key group polyphenols flavonoids carotenoids Research show dietary phytochemical interact nuclear membrane receptors influence metabolic pathways affect epigenetic modifications review highlight broad range biological activity compounds including antioxidant antibacterial antiinflammatory antidiabetic anticancer effects contribute healthpromoting properties Clinical evidence support role prevention management disease cardiovascular disorders metabolic conditions cancer diet rich phytochemical linked lower risk disease Phytochemicals also cutting edge application food preservation dietary supplements emerging medical treatments Additionally identified advancement extraction identification techniques particularly metabolomics enhance application areas Despite promising benefits challenge bioavailability regulatory barriers need robust clinical trial persist However innovative delivery system like nanoparticles liposomes encapsulation offer potential solution enhance bioavailability improving absorption stability review concludes emphasizing potential personalized nutrition combination therapy enhance health benefit dietary phytochemical stressing need advancement extraction methods clinical trials bioavailability",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40115248/"
    },
    {
        "pmid": "40108484",
        "title": "Solid Lipid Nanoparticles for the Management of Hypertension: Advancements and Challenges.",
        "abstract": "Cardiovascular disease CVDs remain global health challenge hypertension emerging leading risk factor Hypertension characterized elevated arterial blood pressure BP significantly increase risk stroke CVDs Despite advancement antihypertensive medication effectiveness hypertension treatment often hindered poor bioavailability limited drug efficacy quest nanoparticles NPs offer promising avenue addressing limitation associated conventional antihypertensive drug hypertension treatment Among several NPs solid lipid nanoparticles SLNs emerged potential candidate presenting multifaceted approach revolutionize drug delivery within domain SLNs characterized lipophilic matrix stabilized surfactants offer scalability compatibility biological system compared several polymerbased nanosystems encapsulating antihypertensive drugs SLNs enhance drug solubility bioavailability provide sustained release thereby improving treatment efficacy context review provides overview pathophysiology hypertension role SLNs drug delivery Various preparation technique SLNs discussed highlighting versatility potential pharmaceutical applications Furthermore role SLNs management hypertension thoroughly examined focus enhancing physicochemical property antihypertensive drugs Overall SLNs represent promising strategy optimizing hypertension treatment addressing limitation conventional drug delivery systems enhancing drug stability bioavailability efficacy SLNs offer new possibility improving patient outcome reducing global burden cardiovascular diseases review aim contribute ongoing research development innovative therapy hypertension management",
        "mesh_terms": [
            "Humans",
            "Nanoparticles",
            "Hypertension",
            "Antihypertensive Agents",
            "Lipids",
            "Animals",
            "Drug Delivery Systems"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40108484/"
    },
    {
        "pmid": "40107706",
        "title": "Risk factors for non-communicable diseases among Bangladeshi adults: an application of generalised linear mixed model on multilevel demographic and health survey data.",
        "abstract": "study examines risk factor associated noncommunicable disease NCDs specifically diabetes mellitus DM hypertension HTN among adult Bangladesh lowermiddleincome country Given rising prevalence DM HTN significant public health burden research aim identify key socioeconomic demographic lifestylerelated determinant inform targeted interventions study used nationally representative crosssectional data extracted Bangladesh Demographic Health Survey conducted 20172018 Bangladesh study included 8013 woman 6691 men aged 18 older eligible blood pressure blood glucose measurements Type 2 DM HTN HTN significantly associated higher odds diabetes adjusted AOR128 95 CI 114 143 diabetes associated increased odds HTN AOR124 95 CI 111 139 Individuals aged 40 year older 748 higher odds diabetes AOR1748 95 CI 158 1993 321 time likely HTN AOR4208 95 CI 3781 4685 Overweight individual 215 time higher odds HTN compared normal weight AOR2154 95 CI 198 234 Wealthier individual also showed significantly higher odds DM HTN study highlight strong association DM HTN identifies age overweight status higher socioeconomic class key risk factors finding underscore need integrated public health strategy targeting NCD prevention management Bangladesh research explore longitudinal trend impact targeted intervention reducing burden NCDs",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Adult",
            "Male",
            "Female",
            "Risk Factors",
            "Middle Aged",
            "Hypertension",
            "Cross-Sectional Studies",
            "Health Surveys",
            "Noncommunicable Diseases",
            "Young Adult",
            "Adolescent",
            "Diabetes Mellitus, Type 2",
            "Aged",
            "Socioeconomic Factors",
            "Prevalence",
            "Linear Models"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40107706/"
    },
    {
        "pmid": "40106483",
        "title": "Understanding climate-sensitive diseases in Bangladesh using systematic review and government data repository.",
        "abstract": "Understanding effect climate change health outcome crucial effective policy formulation intervention strategies However Low MiddleIncome Countries like Bangladesh true extent effect remains unexplored due data scarcity study aim assess available evidence climate changerelated health outcome Bangladesh compare actual national occurrences explore challenge related climate change health data first conducted systematic review summarize climatesensitive disease examined existing literature Bangladesh review result compared 28 million sample governments data repository representing reported case climatesensitive disease 20172022 comparison aimed identify discrepancy disease currently occurring Bangladesh related climate change available knowledge existing research Additionally also explored limitation data recorded government data repository available literature Bangladesh report specific climatesensitive diseases including Diarrhea Dengue Cholera Malaria Pneumonia Cardiovascular Diseases Hypertension UrinaryTract Infections Malnutrition also considered studies represents segment total 510 reported climatesensitive disease Bangladesh 143 disease responsible 9066 total occurrences common form disease diarrhea gastroenteritis presumed infectious 2851 pneumonia 1888 anxiety disorders panic disorders generalized anxiety disorder 132 others 1315 Additionally UrinaryTract infection 787 cholera 303 typhoid fever 327 frequently reported climatesensitive diseases also explored several challenge related available data government repository include inadequate collection patients comprehensive sociodemographic information absence unique patient identifier finding underscore urgent need tackle data challenge understanding climatesensitive disease Bangladesh Policies program required prioritize digitalization healthcare system implement unique patient identification number facilitate accurate tracking analysis health data Climate Change including rising temperature extreme weather event like cyclone floods pose significant global health threat 1 World Health Organization estimate climate change already cause least 150000 death annually global level number projected double 2030 Beside impact climate change farreaching leading forced displacement malnutrition increased incidence disease dengue diarrhea pneumonia 2 Additionally climate change established link mental health issues like anxiety depression 3 effect particularly severe Low MiddleIncome Countries LMICs due limited resource inadequate infrastructure coping erratic weather disaster 4 undertook comprehensive mixedmethod study incorporating systematic review existing study conducted Bangladesh along analysis government data repository detailed description component presented below",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Climate Change",
            "Diarrhea",
            "Government"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40106483/"
    },
    {
        "pmid": "40101017",
        "title": "Association Between Abdominal Obesity, Body Mass Index, and Hypertension in India: Evidence From a Large Nationally Representative Data.",
        "abstract": "Hypertension prevalence rising among individual abdominal obesity Southeast Asia including India relationship abdominal obesity body mass index BMI hypertension remains underexplored study examines association factor nationally representative Indian population aged 2054 year males N  78 832 females N  559 059 analyzed data National Family Health Survey 201921 NFHS5 Hypertension defined systolic blood pressure SBP ≥ 140 mm Hg diastolic blood pressure DBP ≥ 90 mm Hg use blood pressurelowering medication Abdominal obesity defined waisthip ratio 090 men 085 women BMI category underweight 185 kgmsup2sup normal 185250 kgmsup2sup overweight 250300 kgmsup2sup obese ≥300 kgmsup2sup Multivariable logistic regression adjusted demographic lifestyle factor used assess link BMI abdominal obesity hypertension Individuals obesity abdominal obesity significantly higher odds hypertension male 33 time 95 confidence interval CI 2937 female 28 time 95 CI 2629 odds compared normal BMI abdominal obesity gender showed increased SBP DBP 3050 mm Hg abdominal obesity present regardless BMI Indian health program emphasize risk high BMI abdominal obesity reduce hypertension",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Obesity, Abdominal",
            "Hypertension",
            "Adult",
            "Body Mass Index",
            "India",
            "Middle Aged",
            "Prevalence",
            "Risk Factors",
            "Health Surveys",
            "Waist-Hip Ratio",
            "Blood Pressure",
            "Cross-Sectional Studies",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40101017/"
    },
    {
        "pmid": "40094069",
        "title": "Burden and Predictors of Statin Use for Primary and Secondary Prevention of Cardiovascular Disease in Bangladesh: Evidence from a Nationally Representative Survey.",
        "abstract": "Largescale randomized trial established efficacy safety statin therapy preventing cardiovascular disease CVDs among individual increased risk ie primary prevention preexisting cardiovascular disease ie secondary prevention Consequently recent international guidelines including ACCAHA expanded eligibility criterion statin therapy assess current burden statineligible population Bangladesh evaluate current state statin use identify factor associated nonuse statins analysed data 3140 adult aged 40 69 year nationally representative WHOSTEPS Bangladesh 2018 survey Statin therapy eligibility primary prevention assessed using WHO2019 ACCAHA2018 guideline separately Individuals previous history CVD eligible secondary prevention guidelines Modified Poisson regression model identified factor associated statin use analysis conducted using appropriate survey weights Among participants 443 141 reported previous history CVD without CVD 112 95 CI 97129 323 95 CI 300346 eligible statin use primary prevention according WHO2019 ACCAHA2018 guidelines respectively Among adult eligible according WHO2019 guideline 69 95 CI 41115 using statins among eligible according ACCAHA2018 guideline 33 95 CI 2151 using statins secondary prevention 235 95 CI 169316 adult prior CVD using statins Nonuse higher among younger adults without regular health visit cholesterol measurements Mymensingh Rajshahi divisions Bangladesh approximately one twenty eligible individual us statin primary prevention CVD one five individual secondary prevention Appropriate population health intervention needed scale statin use mitigate burden CVD",
        "mesh_terms": [
            "Humans",
            "Hydroxymethylglutaryl-CoA Reductase Inhibitors",
            "Cardiovascular Diseases",
            "Middle Aged",
            "Male",
            "Female",
            "Bangladesh",
            "Primary Prevention",
            "Adult",
            "Secondary Prevention",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40094069/"
    },
    {
        "pmid": "40086257",
        "title": "Maternal hypertensive disorders among Individuals of reproductive age (15-49 Years) in South Asia: A global Burden of Disease study (1990-2021) with future Projections.",
        "abstract": "Maternal hypertensive disorder HDP remain major contributor maternal perinatal morbidity mortality worldwide particularly South Asia healthcare disparity persist study aim analyze trend maternal hypertensive disorder across South Asia 1990 2021 leveraging data Global Burden Disease GBD study evaluate effectiveness healthcare intervention provide actionable recommendations conducted retrospective analysis using GBD 2021 data Bangladesh Bhutan India Nepal Pakistan Health trend prevalence incidence maternal mortality ratio MMR analyzed using descriptive statistic Join point regression approach allowed u identify significant change trend studied period study revealed significant decline prevalence MMR associated maternal hypertensive disorder across region Notable reduction observed Bangladesh Bhutan India Nepal Pakistan showed minimal improvement indicating ongoing healthcare challenges analysis underscore substantial regional disparities particularly Pakistan reported higher prevalence rate MMR across age groups finding suggest targeted healthcare intervention effectively reduce burden maternal hypertensive disorder South Asia However persistent disparity Pakistan highlight need regionspecific strategy address gap healthcare access quality Strengthening healthcare policy improving intervention coverage could mitigate burden HDP South Asia",
        "mesh_terms": [
            "Humans",
            "Female",
            "Adult",
            "Pregnancy",
            "Middle Aged",
            "Retrospective Studies",
            "Young Adult",
            "Adolescent",
            "Global Burden of Disease",
            "Prevalence",
            "Hypertension, Pregnancy-Induced",
            "Maternal Mortality",
            "Incidence",
            "Asia",
            "Asia, Western",
            "Bhutan",
            "Bangladesh",
            "Asia, Southern"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40086257/"
    },
    {
        "pmid": "40049185",
        "title": "Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.",
        "abstract": "Despite well documented consequence obesity childhood adolescence future risk excess body mass noncommunicable disease adulthood coordinated global action excess body mass early life still insufficient Inconsistent measurement reporting barrier specific targets resource allocation interventions Article report current estimate overweight obesity across childhood adolescence progress time forecast inform specific actions Using established methodology Global Burden Diseases Injuries Risk Factors Study 2021 modelled overweight obesity across childhood adolescence 1990 2021 forecasted 2050 Primary data model included 1321 unique measured selfreported anthropometric data source 180 country territory survey microdata reports published literature data used estimate agestandardised global regional national overweight prevalence obesity prevalence separately child young adolescent aged 514 years typically school cared child health services older adolescent aged 1524 years increasingly school cared adult services sex 204 country territory 1990 2021 Prevalence estimate 1990 2021 generated using spatiotemporal Gaussian process regression models leveraged temporal spatial correlation epidemiological trend ensure comparability result across time geography Prevalence forecast 2022 2050 generated using generalised ensemble modelling approach assuming continuation current trends every agesexlocation population across time 19902050 estimated obesity vs overweight predominance using log ratio obesity percentage overweight percentage 1990 2021 combined prevalence overweight obesity child adolescent doubled obesity alone tripled 2021 93·1 million 95 uncertainty interval 89·696·6 individual aged 514 year 80·6 million 78·283·3 aged 1524 year obesity superregion level 2021 prevalence overweight obesity highest north Africa Middle East eg United Arab Emirates Kuwait greatest increase 1990 2021 seen southeast Asia east Asia Oceania eg Taiwan province China Maldives China 2021 female age groups many country Australasia eg Australia highincome North America eg Canada already transitioned obesity predominance male female number country north Africa Middle East eg United Arab Emirates Qatar Oceania eg Cook Islands American Samoa 2022 2050 global increase overweight not obesity prevalence forecasted stabilise yet increase absolute proportion global population obesity forecasted greater 1990 2021 substantial increase forecast 2022 2030 continue 2031 2050 2050 superregion obesity prevalence forecasted remain highest north Africa Middle East eg United Arab Emirates Kuwait forecasted increase obesity still expected largest across southeast Asia east Asia Oceania eg TimorLeste North Korea also south Asia eg Nepal Bangladesh Compared aged 1524 years superregions except Latin America Caribbean highincome superregion greater proportion aged 514 year forecasted obesity overweight 2050 Globally 15·6 12·717·2 aged 514 year forecasted obesity 2050 186 million 141221 compared 14·2 11·415·7 aged 1524 year 175 million 136203 forecasted 2050 young male aged 514 years living obesity 16·5 13·318·3 overweight 12·9 12·213·6 female aged 524 years older male aged 1524 years overweight remain prevalent obesity regional level following population forecast transitioned obesity vs overweight predominance 204150 child adolescent males female aged 524 years north Africa Middle East Tropical Latin America male aged 514 year east Asia central southern subSaharan Africa central Latin America female aged 514 year Australasia female aged 1524 year Australasia highincome North America southern subSaharan Africa male aged 1524 year highincome North America overweight obesity increased substantially every world region 1990 2021 suggesting current approach curbing increase overweight obesity failed generation child adolescents Beyond 2021 overweight childhood adolescence forecast stabilise due increase population obesity Increases obesity expected continue population world regions substantial change forecasted occur 2022 2030 immediate action needed address public health crisis Bill  Melinda Gates Foundation Australian National Health Medical Research Council",
        "mesh_terms": [
            "Humans",
            "Adolescent",
            "Child",
            "Prevalence",
            "Female",
            "Male",
            "Forecasting",
            "Global Burden of Disease",
            "Pediatric Obesity",
            "Child, Preschool",
            "Young Adult",
            "Global Health",
            "Overweight",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40049185/"
    },
    {
        "pmid": "40047332",
        "title": "Prevalence of Undiagnosed Hypertension in Bangladesh: A Systematic Review and Meta-Analysis.",
        "abstract": "Undiagnosed hypertension UHTN remains significant public health concern Bangladesh leading severe complication due delayed diagnosis management systematic review metaanalysis examined prevalence UHTN among adult aged 18 year older using data study conducted Bangladesh published 2010 2024 comprehensive search major database yielded 1028 records nine relevant studies encompassing total 28949 participants selected evaluated quality using NewcastleOttawa Scale providing valuable insight prevalence UHTN within Bangladeshi population pooled prevalence UHTN 11 95 CI 619 based randomeffects model substantial heterogeneity Isup2sup  995 p  00001 Subgroup analysis revealed higher prevalence rural area 13 95 CI 435 compared urban area 12 95 CI 154 elevated occupational risk among banker 17 95 CI 094 funnel plot asymmetry noted Eggers test p  03113 indicated significant publication bias Sensitivity analyses including LeaveOneOut Analysis affirmed robustness pooled estimate finding underscore notable geographic occupational sociodemographic disparity UHTN prevalence highlighting need nationwide screening program targeted community awareness campaigns particularly underserved rural areas research imperative explore causal factor inform effective prevention management strategies",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Prevalence",
            "Hypertension",
            "Rural Population",
            "Adult",
            "Female",
            "Male",
            "Middle Aged",
            "Risk Factors",
            "Urban Population",
            "Mass Screening",
            "Undiagnosed Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40047332/"
    },
    {
        "pmid": "40023610",
        "title": "Chronic activation of β-adrenergic receptors leads to tissue water and electrolyte retention.",
        "abstract": "βAdrenergic receptor βARs expressed membrane various cell types activation affect body water balance modulating renal sodium water excretion cardiovascular function metabolic processes However βARassociated body fluid imbalance well characterized present study hypothesized chronic βAR stimulation increase electrolyte water content tissue level evaluated effect isoproterenol nonselective βAR agonist electrolyte water balance tissue level Continuous isoproterenol administration 14 day induced cardiac hypertrophy associated sodiumdriven water retention heart increased total body sodium potassium water content tissue level increased water intake blood pressure mice greater urine output response isoproterenolinduced body water retention isoproterenolinduced change reduced propranolol nonselective β receptor inhibitor Isoproterenoltreated mice even without excessive water intake higher total body electrolyte water contents tissue water retention associated lower dry body mass suggesting βAR stimulation absence excess water intake induces catabolism water retention finding suggest βAR activation induces tissue sodium potassium retention leading body fluid retention without excess water intake characterization βARinduced electrolyte fluid abnormality improves understanding pharmacological effect βAR inhibitors SIGNIFICANCE STATEMENT study shown chronic βadrenergic receptor βAR stimulation cause cardiac hypertrophy associated sodiumdriven water retention heart increase accumulation body sodium potassium water tissue level characterization βARinduced abnormality electrolyte water balance tissue level improves understanding role βAR physiology pathophysiology pharmacological effect βAR inhibitors",
        "mesh_terms": [
            "Animals",
            "Receptors, Adrenergic, beta",
            "Isoproterenol",
            "Mice",
            "Male",
            "Water-Electrolyte Balance",
            "Adrenergic beta-Agonists",
            "Blood Pressure",
            "Mice, Inbred C57BL",
            "Cardiomegaly",
            "Sodium",
            "Electrolytes",
            "Adrenergic beta-Antagonists",
            "Body Water",
            "Potassium",
            "Drinking",
            "Water"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40023610/"
    },
    {
        "pmid": "40008223",
        "title": "Prevalence of Hypertension and Its Determinants Among Adult People Living in Riverine Island, Sirajganj, Bangladesh: A Cross-Sectional Study.",
        "abstract": "Assessing prevalence hypertension associated determinant riverine island population crucial due unique socioenvironmental characteristic restricted healthcare access increase sensitivity hypertensionrelated problem lead targeted interventions So study investigates concerning issue hypertension focusing prevalence influential factor among adult Sirajganjs Riverine Island employing crosssectional approach research utilized structured questionnaire total 309 people took part study via facetoface interview following convenience sampling technique investigator performed frequency analysis getting prevalence HTN variables percentage binary logistic regression analysis getting associated determinants Analysis conducted using statistical package social science SPSS version 25 prevalence hypertension 41 among individuals People illiterate 123 time hypertensive key risk factor discovered including smoking ipi  004 adding salt meal ipi  0001 eating fatty fattype food ipi  0001 sleeping late ipi  0001 worrying lifestyle future ipi  0001 exercising ipi  003 Males 143 time hypertensive AOR  143 95 CI 11720 ipi  0002 females Smokers 421 time hypertensive AOR  421 95 CI 1121713 ipi  004 nonsmokers Consumers oilfat food 218 time hypertensive AOR  218 95 CI 178254 ipi  0001 others Respondents worried lifestyle future 338 time hypertensive AOR  338 95 CI 127601 ipi  0001 others People consume healthy diet refrain smoking Regular physical activity going bed early recommended Medical camp workshop held riverine island promote healthy lifestyle prevent hypertension",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40008223/"
    },
    {
        "pmid": "40002867",
        "title": "Therapeutic Potential of Medicinal Plants and Their Phytoconstituents in Diabetes, Cancer, Infections, Cardiovascular Diseases, Inflammation and Gastrointestinal Disorders.",
        "abstract": "Conditions like diabetes mellitus DM cancer infections inflammation cardiovascular disease CVDs gastrointestinal GI disorder continue major global impact mortality morbidity Medicinal plant used since ancient time ethnomedicine eg Ayurveda Unani Traditional Chinese Medicine European Traditional Medicine treatment wide range disorders Plants rich source diverse phytoconstituents antidiabetic anticancer antimicrobial antihypertensive antioxidant antihyperlipidemic cardioprotective immunomodulatory andor antiinflammatory activities review focus 35 plant commonly reported treatment major disorders particular emphasis traditional uses phytoconstituent contents pharmacological properties mode action Active phytomolecules therapeutic potential include cucurbitane triterpenoids diosgenin limonoids azadiradione gedunin exhibit antidiabetic properties cucurbitane triterpenoids specifically activating Glucose Transporter Type 4 GLUT4 translocation Capsaicin curcumin demonstrate anticancer activity deactivating NFκB arresting cell cycle G2 phase Antimicrobial activity observed piperine reserpine berberine dictamnine chelerythrine allitridin latter two triggering bacterial cell lysis Quercetin catechin genistein exhibit antiinflammatory properties genistein specifically suppressing CD8 cytotoxic cell function Ginsenoside Rg1 ginsenoside Rg3 demonstrate potential treating cardiovascular diseases ginsenoside Rg1 activating PPARα promoter PI3KAkt pathway contrast ternatin tannins quercitrin exhibit potential gastrointestinal disorders quercitrin regulating arachidonic acid metabolism suppressing cyclooxygenase COX lipoxygenase activity study warranted fully investigate clinical therapeutic benefit plant phytoconstituents well elucidate underlying molecular mechanism action",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40002867/"
    },
    {
        "pmid": "39982855",
        "title": "Broad-Spectrum Therapeutic Potentials of the Multifaceted Triterpene Lupeol and Its Derivatives.",
        "abstract": "Lupeol LUP naturally occurring pentacyclic triterpene found various fruits vegetables medicinal plant evident possess diverse pharmacological activities study aimed consolidate finding based updated database reports Findings suggest LUP derivative promising biological roles including anticancer effects Notably LUP induces apoptosis cell cycle arrest cancer cell sparing normal cells highlighting selective cytotoxicity modifying pathway NFκB phosphatidyl inositol 3kinase PI3KAkt LUP demonstrates anticancer activity reducing LDL oxidation 344 causing cancer cell undergo apoptosis leaving healthy cell unaffected Moreover strong antioxidant antiinflammatory properties thus may act condition like arthritis asthma cardiovascular diseases broadspectrum antimicrobial activity used alternative conventional antibiotics LUP nanoformulations PEGylated liposomes improved biopharmaceutical profile test systems also showed neuroprotective effects particularly Alzheimers Parkinsons diseases Taken together LUP multitarget therapeutic approach various disease pathological conditions advocating inclusion future clinical trials",
        "mesh_terms": [
            "Pentacyclic Triterpenes",
            "Humans",
            "Apoptosis",
            "Neuroprotective Agents",
            "Antioxidants",
            "Anti-Inflammatory Agents",
            "Antineoplastic Agents, Phytogenic",
            "Animals",
            "Antineoplastic Agents",
            "Molecular Structure",
            "Lupanes"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39982855/"
    },
    {
        "pmid": "39975522",
        "title": "ECG Signal Classification of Cardiovascular Disorder using CWT and DCNN.",
        "abstract": "Cardiovascular Diseases CVD requires precise efficient diagnostic tools manual analysis Electrocardiograms ECGs laborintensive necessitating development automated method enhance diagnostic accuracy efficiency research aimed develop automated ECG classification using Continuous Wavelet Transform CWT Deep Convolutional Neural Network DCNN transform 1D ECG signal 2D spectrogram using CWT train DCNN accurately detect abnormality associated CVD DCNN trained datasets PhysioNet MITBIH MITBIH arrhythmia dataset integrated CWT DCNN enable simultaneous classification multiple ECG abnormality alongside normal signals analytical observational research employed CWT generate spectrogram 1D ECG signals input DCNN trained diverse datasets model evaluated using performance metrics precision specificity recall overall accuracy F1score proposed algorithm demonstrates remarkable performance metric precision 100 normal signals average specificity 100 average recall 9765 average overall accuracy 9867 average F1score 9881 model achieves approximate average overall accuracy 9867 highlighting effectiveness detecting CVD integration CWT DCNN ECG classification improves accuracy classification capabilities addressing challenge manual analysis algorithm reduce misdiagnoses primary care enhance efficiency larger medical institutions contributing automated diagnostic tool cardiovascular disorders significantly improve healthcare practice field CVD detection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39975522/"
    },
    {
        "pmid": "39953666",
        "title": "Risk of major adverse cardiovascular events in CYP2C19 LoF genotype guided clopidogrel against alternative antiplatelets for CAD patients undergoing PCI: Meta-analysis.",
        "abstract": "Selection rational antagonist P2Ysub12sub receptor CAD patient inherit CYP2C19 LoF allele remains still conflicting study compared clinical outcome CAD patient inheriting CYP2C19 LoF allele undergoing PCI treated clopidogrel alternative antagonist P2Ysub12sub receptor thorough literature search performed across multiple scientific database following PRISMA guideline PICO model Setting statistical significance p  005 RevMan software used calculate risk ratio RRs Estimation pooled analysis revealed significant 62 increased risk major adverse cardiovascular event MACE CAD patient inheriting CYP2C19 LoF allele treated clopidogrel treated alternative P2Ysub12sub receptor antagonist prasugrel ticagrelor RR 162 95 CI 142186 p  000001 addition Asian CAD patient found significantly higher risk MACE RR 193 95 CI 149249 p  000001 juxtaposed CAD patient ethnicity RR 151 95 CI 129178 p  000001 Conversely two treatment groups taking clopidogrel prasugrelticagrelor possess CYP2C19 LoF alleles significant difference bleeding event observed RR 094 95 CI 079111 p  047 CAD patient undergoing PCI inherited CYP2C19 LoF allele treated clopidogrel associated significantly higher risk MACE treated alternative antagonist P2Ysub12sub receptor is prasugrel ticagrelor",
        "mesh_terms": [
            "Humans",
            "Cytochrome P-450 CYP2C19",
            "Clopidogrel",
            "Platelet Aggregation Inhibitors",
            "Percutaneous Coronary Intervention",
            "Coronary Artery Disease",
            "Ticagrelor",
            "Prasugrel Hydrochloride",
            "Purinergic P2Y Receptor Antagonists",
            "Genotype",
            "Risk Factors",
            "Alleles",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39953666/"
    },
    {
        "pmid": "39946042",
        "title": "Comments on \"Research trends on the relationship between air pollution and cardiovascular diseases in 2013-2022 - A scientometric analysis\".",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39946042/"
    },
    {
        "pmid": "39922254",
        "title": "Novel evidence of arsenic-related excess adiposity and its implication in the risk of cardiometabolic diseases.",
        "abstract": "Arsenic exposure associated obesity excess adiposityrelated disorders including cardiometabolic diseases Previously many human study attempted establish association arsenic exposure obesity mainly body mass index BMI failed provide concrete evidence study aimed investigate arsenicrelated adiposity relationship cardiometabolic diseases 524 participants 126 398 respectively chosen low higharsenic exposure area Bangladesh Obesity body fat adiposity participant measured anthropometric measure BMI waist circumference WC triceps skinfold thickness TSFT serum biomarker leptin Sarcopenic characteristic assessed lean body mass LBM serum creatinine levels Insulin resistance measured Homeostatic Model Assessment Insulin Resistance HOMAIR hypertension hyperglycemia considered risk factor cardiometabolic diseases significant positive association drinking water hair nail arsenic concentration level WC TSFT adjusting potential confounders However significant association BMI Increased arsenic exposure level associated increased leptin level Regression coefficient β  100 95 confidence interval CI 053 146 water β  144 95 CI 042 246 hair β  147 95 CI 032 261 nail arsenic Notably leptin level inverse association LBM β  787 95 CI 1330 245 creatinine level β  1565 95 CI 2150 981 Furthermore elevated leptin level associated arsenic exposure connected higher HOMAIR level β  019 95 CI 014 024 higher odds hypertension Odds ratio OR  131 95 CI 112 153 hyperglycemia OR  130 95 CI 113 147 Taken together result study demonstrated unique association arsenic exposure adiposity could promote arsenicinduced cardiometabolic disorder mirroring distinctive characteristic ageassociated sarcopenic obesity",
        "mesh_terms": [
            "Humans",
            "Arsenic",
            "Male",
            "Bangladesh",
            "Adult",
            "Female",
            "Adiposity",
            "Middle Aged",
            "Cardiovascular Diseases",
            "Obesity",
            "Environmental Exposure",
            "Water Pollutants, Chemical",
            "Insulin Resistance",
            "Nails",
            "Young Adult",
            "Hair",
            "Leptin",
            "Body Mass Index"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39922254/"
    },
    {
        "pmid": "40824342",
        "title": "The distinct subtypes and prognosis of acute myocardial infarction in antiphospholipid syndrome patients.",
        "abstract": "Acute myocardial infarction AMI divided myocardial infarction coronary artery disease MICAD nonobstructive coronary artery MINOCA according severity artery stenosis Antiphospholipid syndrome APS present AMI subtype prognosis fully understood study conducted based APS cohort Peking Union Medical College Hospital According coronary angiography AMI patient classified MICAD MINOCA Thrombotic APS tAPS patient enrolled explore risk factor AMI study enrolled 36 APSAMI patients 26 72 patient MICAD 10 28 MINOCA 345 tAPS patient without coronary artery disease APS cohort selected control group risk factor AMI male smoking history anticardiolipin antibody aCL antiβ2 glycoprotein antibody aβ2GPI Secondary APS aCL common MINOCA 70 VS 231 P  0018 100 1010 VS 654 P  0039 previous atherosclerotic cardiovascular disease less common MINOCA 0 VS 50 P  0006 MINOCA patient tended receive immunosuppression anticoagulation therapy 577 MICAD patient received revascularization total 13 361 patient experienced AMI recurrence mean followup 4225 months occurred MICAD group 60 813 recurrence once Hydroxychloroquine found possible protective factor AMI recurrence HR 0106 P  0032 Male smoking history aCL aβ2GPI risk factor AMI APS patients APSMINOCA group significantly better prognosis Hydroxychloroquine might prevent AMI recurrence Key Points • Acute myocardial infarction AMI patient antiphospholipid syndrome APS younger typical AMI patients 45 women • subtype myocardial infarction nonobstructive coronary artery MINOCA myocardial infarction coronary artery disease MICAD prognosis AMI APS patient remains unknown • MINOCA associated secondary APS aCL MICAD previous ASCVD • MINOCA significantly better prognosis Hydroxychloroquine might prevent AMI relapse",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824342/"
    },
    {
        "pmid": "40824018",
        "title": "Heart matters: Understanding heart attacks.",
        "abstract": "Coronary heart disease CAD leading cause myocardial infarctions heart attacks often caused atherosclerosis Heart attack worldwide health issue result tissue damage even death due occlusion blood flow heart order treat prevent diagnose cardiovascular diseases one must aware causative factors Symptoms present differently genders therefore difficult clinical picture diagnosis treatment Methods prevention therapy modern world described role microvascular disease woman becomes acknowledged necessary develop advanced diagnostic criterion therapeutic strategies etiology clinical epidemiology method prevention diagnosis treatment heart attack discussed study",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824018/"
    },
    {
        "pmid": "40823532",
        "title": "Cardiovascular diseases in the elderly: possibilities for modulating autophagy using non-coding RNAs.",
        "abstract": "Autophagy crucial mechanism implicated aging cardiovascular disease two closely interconnected conditions Modulation autophagy expected profound impact cellular aging maintenance cardiovascular function physiological pathological conditions Consequently modulation autophagy could effective strategy counteracting ageinduced vascular cardiac remodelling well alleviating cardiovascular disease present review comprehensively elucidates multifaceted impact autophagy aging cardiovascular system comprehensively analyse vascular cardiac tissues including vascular cardiac malignancies distinct contexts also emphasize significance noncoding RNAs ncRNAs epigenetic regulation gene expression role biomarkers cardiovascular pathology maintaining clear distinction vascular cardiac tissues Preclinical clinical model described herein highlight importance ncRNAs disease treatment considering involvement modulation autophagy within cardiocirculatory system Finally conducted comprehensive metaanalysis transcriptomic data underscore paramount importance autophagy demonstrating process frequently dysregulated cardiac vascular cell pathological conditions finding presented herein emphasize importance investigating novel strategy modulating autophagy potential therapeutic approach management agerelated cardiovascular disorders",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823532/"
    },
    {
        "pmid": "40823190",
        "title": "Cardiovascular safety of biologic therapies in patients with severe asthma: a nationwide cohort study in Belgium.",
        "abstract": "last decades biologic therapy approved severe allergic andor eosinophilic asthma Limited study investigated effect biologics acute cardiovascular events reported conflicting results aimed investigate potential cardiovascular risk antiimmunoglobulinIgE omalizumab antiinterleukinIL5IL5 receptor IL5R therapy mepolizumab benralizumab patient severe asthma compared nonbiologic users Adult asthma patient eligible biologics identified Belgian nationwide data 2017 2022 Inverse probability treatment weighted Cox regression used investigate cardiovascular outcome allcause mortality controlling age sex obesity smoking comorbidities comedication exacerbations frailty cohort study consisted 171865 patient mean age 64 years 55 females including 1826 11 antiIgE user 2398 14 antiIL5IL5R users AntiIgE exposure associated significantly lower risk mortality aHR 048 95 CI 040058 congestive heart failure aHR 079 95 CI 065095 peripheral artery disease aHR 066 95 CI 051086 stroke aHR 054 95 CI 036081 AntiIL5IL5R use associated significantly lower risk mortality aHR 035 95 CI 029042 congestive heart failure aHR 063 95 CI 052076 arrythmia aHR 078 95 CI 068090 peripheral artery disease aHR 069 95 CI 054087 compared nonbiologic users significant difference risk myocardial infarction pulmonary embolism observed nationwide observational study biologic therapy patient severe asthma associated significantly lower risk allcause mortality specific cardiovascular disease compared nonbiologic users None",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823190/"
    },
    {
        "pmid": "40822962",
        "title": "Correlation study on the risk of cardiovascular adverse events in diabetic foot patients based on machine learning - a retrospective cohort study.",
        "abstract": "Diabetic Foot DF serious complication diabetes closely related major adverse cardiovascular event MACE mortality However research predictive model MACE risk DF patient sufficient purpose study construct prognostic model MACE risk patient diabetic foot ulcer provide reference tool clinical individualized management study retrospectively collected data DF patient hospitalized met inclusion exclusion criterion tertiary firstclass comprehensive hospital mainly engaged metabolic disease Tianjin January 2018 January 2020 followup outcome occurrence MACE within 5 year discharge Multiple imputation MI method used fill missing data Based processed data term modeling methods top three frequently used method used Logistic regression random forest RF support vector machine SVM used respectively analyze influencing factors performance model compared using confusion matrix ROC curve AUC value data set divided training set test set according proportion 8020 Finally model effect verified test set study finally included total 504 patient DF Among them 147 case 2917 experienced MACE event within five years AUC RF model study 070 AUC Logistic regression model 062 AUC SVM model 060 three model established research good clinical predictive ability Among them clinical prediction model based RF best effect effectively predict risk MACE DF patients helping clinical medical staff formulate personalized treatment plans",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40822962/"
    },
    {
        "pmid": "40822873",
        "title": "Heavy Metal Contamination: Sources, Health Impacts, and Sustainable Mitigation Strategies with Insights from Nigerian Case Studies.",
        "abstract": "Heavy metal contamination gradually become highly significant global issue due continual existence environment bioaccumulation ecosystems posing deleterious risk human health major objective review investigate sources pathways toxicological impact heavy metal cadmium lead mercury arsenic elucidating health consequence plausible mitigation strategies Furthermore review explores dual origin heavy metal contamination natural geological process anthropogenic activity industrial emissions mining agricultural practices heavy metal seep soil water food chains leading bioaccumulation biomagnification causing significant health risks including cardiovascular diseases neurological disorders reproductive toxicity Additionally addition indigenous case study Nigeria lead poisoning Zamfara State contamination Great Kwa River Cross Rivers State underscore disproportionate impact heavy metal pollution developing nations key finding review via selected case study revealed socioeconomic environmental dimension issue providing contextual understanding regionspecific vulnerability health outcomes address problems review evaluates already existing mitigation strategies including chelation therapy phytoremediation proposing sustainable costeffective solution reducing exposure mitigating impacts emphasizes importance integrative approach involving policy community engagement technological innovation fight heavy metal contamination effectively conclusion review contributes understanding heavy metal toxicity giving showcasing much important insight source health implication contamination integrating theoretical perspective practical solutions review provides robust framework informing policy maker advancing sustainable environmental management practices",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40822873/"
    },
    {
        "pmid": "40822638",
        "title": "Prospects and Challenges of Different Delivery Systems in Breast Tumors Therapy.",
        "abstract": "Breast cancer BC prevalent malignancy women emergence targeted therapy advancement comprehensive treatment protocol significantly improved survival outcome patient earlystage BC However individual refractory BC particularly received multiple line therapy presented distant metastasis diagnosis continue face challenge due limitation conventional antibody cytotoxic agent meeting therapeutic needs Thus development novel effective treatment BC along strategy prevent recurrence remains urgent priority Research shown nanodrug delivery system modify pharmacokinetic profile traditional chemotherapeutic agents thereby markedly reducing adverse drug reactions Furthermore study demonstrated innovative approaches hyaluronic acidbased systems ultrasoundmediated microbubbles antibodydrug conjugate ADCs enable targeted controlled drug release offering advantage including high drug efficacy reduced toxicity significant antitumor effects Among these ADCs gained increasing attention BC therapy recent years article provides comprehensive review development progress various drug delivery system BC treatment offering indepth analysis potential application clinical practice",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40822638/"
    },
    {
        "pmid": "40822380",
        "title": "Efficacy and Safety of Guben Kechuan Granules in the Treatment of Chronic Bronchitis: A Multi-Center and Randomized Controlled Trial.",
        "abstract": "Chronic bronchitis CB inflammatory respiratory disease characterized high prevalence treatment challenges recent years integration traditional Chinese medicine TCM conventional therapy gained widespread application CB management showing promising clinical benefits multicenter randomized controlled trial led ChinaJapan Friendship Hospital Beijing China enrolled 300 CB patient aged 1875 years Participants randomized 221 three groups Guben Kechuan Granules experimental group n120 Guilong Kechuanning Capsules positive drug control n120 subject education blank control n60 treatment lasted 24 weeks followed 24week followup Efficacy assessed symptom evaluation acute exacerbation CB AECB incidence pulmonary function tests immunological assessments quality life measures Safety evaluated based adverse event reporting Data analysis conducted using SAS 94 software enrolled patients 299 participant 997 completed full analysis 298 included safety assessment 278 entered perprotocol efficacy analysis Compared blank control group Guben Kechuan Granules significantly reduced time first AECB well duration severity frequency AECB episode all p005 24 week treatment symptom score cough 2185±1973 expectoration 2274±1866 wheezing 2133±1876 showed substantial improvement p005 benefit persisted throughout 24week followup p005 Additionally significant improvement observed mobility selfcare daily activities overall health status experimental group all p005 However significant change observed lung function parametersincluding FEV1FVC FEV1pred PEF MMEF FVC FEV1across three group 24 week treatment serious adverse event reported experimental group followup Guben Kechuan Granules demonstrated significant efficacy safety CB management alleviating clinical symptoms reducing AECB incidence severity enhancing patients quality life trial registered 4 September 2022 Registration number ChiCTR2200063321 Sources funding Traditional Chinese Medicine Inheritance Innovation TenHundredThousand Talents Program Qihuang Program grant number2019QTL003 Chinese Clinical Trials Registry httpswwwchictrorgcnshowprojhtmlproj177683",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40822380/"
    },
    {
        "pmid": "40821854",
        "title": "Engineering chimeric PCSK9 for a vaccine against atherosclerosis.",
        "abstract": "Cardiovascular diseases especially atherosclerosis main cause death whole world risk reduced lowering serum lowdensity lipoprotein cholesterol targeting proprotein convertase 9 PCSK9 genome editing neutralization monoclonal antibodies Vaccination PCSK9 represents alternative potentially longlasting efficacy must overcome challenge immunogenicity endogenous protein also elicit lower antibody response due B cell tolerance contrast previously reported weakly immunogenic PCSK9 peptides developed designed chimeric PCSK9 maintains surface epitope elicits B cell immune response PCSK9specific antibodies comparable humanbased vaccines eliminates natural protein cell epitope impairs selfantigenmediated cell cytotoxicity upon vaccination demonstrated vaccination chimerabased vaccine generates humoral immunity decreased cell reactivity atherosclerosis mouse model effect persisted 20 weeks evidenced reduction circulating PCSK9 cholesterol lower atherosclerotic disease burden aorta demonstrates therapeutic improvement atherosclerosis animal model proofofconcept rational design vaccine endogenous proteins",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821854/"
    },
    {
        "pmid": "40821847",
        "title": "The dual role of Piezo1 in tumor cells and immune cells: a new target for cancer therapy.",
        "abstract": "Piezo1 mechanosensitive ion channel play pivotal multifaceted role tumor progression immune evasion therapeutic resistance transducing extracellular mechanical stimulisuch matrix stiffness fluid shear stressinto intracellular calcium influx tumor cells Piezo1 promotes proliferation invasion metastasis activating oncogenic signaling contributes immunosuppressive TME regulation cancerassociated fibroblast CAFs extracellular matrix ECM remodeling immune compartment Piezo1 integrates mechanical cue metabolic epigenetic reprogramming orchestrate function cells macrophages natural killer NK cells Notably Piezo1 deficiency impairs TH9 cell differentiation diminishes cell cytotoxicity enhances activity regulatory cell Tregs Furthermore Piezo1 expression correlate distinct tumor immune phenotypes cold tumors response immunotherapy making promising predictive biomarker treatment efficacy Given dual regulatory role tumor biology immune modulation targeting Piezo1such combination programmed death1 PD1 blockadeoffers potential strategy reverse immunosuppression enhance antitumor immunity review summarizes emerging insight Piezo1s role cancer progression immune regulation highlight translational potential novel target cancer immunotherapy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821847/"
    },
    {
        "pmid": "40821806",
        "title": "The impact of immune checkpoint inhibition on atherosclerosis in cancer patients.",
        "abstract": "emergence immune checkpoint inhibitor ICIs provided new perspective cancer immunotherapy Immune checkpoint inhibitor significantly improve survival prognosis patient various advanced cancer inhibiting immune checkpoint molecules thereby releasing suppression cell tumor microenvironment cytotoxic Tlymphocyteassociated protein 4 CTLA4 programmed cell death protein 1 PD1 Immune checkpoint inhibitor ICI therapy effective give rise distinct immunerelated adverse event irAEs including cardiovascular toxicities necessitating focused research effort better understand address specific complications myocarditisassociated toxicity extensively studied article review latest clinical preclinical literature epidemiology pathogenesis ICIrelated atherosclerosis explores pathophysiological mechanism ICIs promote atherosclerosis discusses risk assessment identification monitoring methods intervention strategy ICI treatment related atherosclerosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821806/"
    },
    {
        "pmid": "40821687",
        "title": "Tuberculous endocarditis: a case-based proposal for new diagnostic criteria.",
        "abstract": "Tuberculous endocarditis TBE rare often fatal manifestation iMycobacterium tuberculosisi Although diagnosis possible advanced techniques lack standardized diagnostic criterion complicates timely recognition management 79yearold man history Bentall procedure annuloaortic ectasia presented fever chest pain Imaging revealed infective endocarditis aortic root abscess vegetations Histopathology identified granulation tissue multinucleated giant cells iM tuberculosisi confirmed via PCR culture literature review TBE case performed develop systematic diagnostic criteria diagnosis TBE established histopathology molecular methods Based case prior reports diagnostic criterion TBE developed categorized Definitive Probable Possible criterion incorporate clinical microbiological histological imaging finding aid diagnosis patients treatment included surgical intervention combined antimicrobial therapy aligning strategy designed improve outcomes case underscore importance considering TBE infective endocarditis cases especially atypical features proposed diagnostic criterion aim improve recognition guide management TBE emphasizing multidisciplinary approach better patient outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821687/"
    },
    {
        "pmid": "40821318",
        "title": "Transient Bilateral Atrial Thrombi in a Patient With Multiple Sclerosis and Massive Pulmonary Embolism: A Case Report and Review of the Literature.",
        "abstract": "Pulmonary embolism PE present complex atypical feature challenge diagnosis management particularly coexisting intracardiac thrombus neurological symptoms report case 67yearold woman multiple sclerosis MS presented bilateral PE biatrial thrombi subsequent embolic stroke Despite initial imaging suggesting possible atrial septal defect ASD route paradoxical embolism transthoracic echocardiography cardiac magnetic resonance imaging failed confirm intracardiac shunt case underscore diagnostic difficulty differentiating stroke MS relapse well limitation imaging modality transient thrombotic shuntrelated phenomena patient managed therapeutic anticoagulation resulted thrombus resolution clinical improvement case highlight need high clinical suspicion multidisciplinary evaluation patient overlapping cardiovascular neurological presentations especially setting chronic inflammatory disease MS",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821318/"
    },
    {
        "pmid": "40821317",
        "title": "Optimizing Cardiovascular Care in Aging Populations: A Comprehensive Review of Geriatric Cardiology.",
        "abstract": "narrative review conducted searching recent literature database like Cochrane PubMed using keywords older adults cardiovascular disease frailty polypharmacy identified literature included cohort studies scientific statements systematic reviews metaanalyses narrative review last 15 year focusing comprehensive care recent evidencebased update geriatric cardiology Inclusion criterion aging population elderly cardiovascular condition applied review excluded article pregnant woman children study animals article written English thematic synthesis conducted identify key challenge strategy geriatric cardiovascular care focusing multimorbidity cognitive impairment integrative care models narrative review document definitions findings recent update practical approach implemented geriatric practice addressing diagnostic therapeutic challenge geriatric cardiology disadvantage traditionaldisease focused model elderly frailty multimorbidity polypharmacy overcoming them health inequity disparity cardiogeriatric populations finally area needing future research policies global rise aging population contributed cardiovascular disease CVDs becoming dominant health concern among older adult often present range coexisting conditions geriatric syndrome complicate standard cardiovascular care making collaborative multidisciplinary patientcentered strategy essential improve health outcome functional independence narrative review aimed exploring efficacy integrated evidencebased multidisciplinary cardiovascular care model improving clinical outcome quality life QoL among geriatric adults objective evaluates compare impact model versus traditional practices also exploring key challenge recent innovation cardiovascular care aging populations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821317/"
    },
    {
        "pmid": "40821166",
        "title": "In-Hospital Outcomes of Acute Myocarditis in Adults With Systemic Inflammatory Disease: A Perspective on the Nationally Representative Sample Within the United States.",
        "abstract": "Background Systemic inflammatory disease SID associated adverse cardiovascular CV event due derangement innate immunity Understanding association acute myocarditis AMC crucial preemptive management strategy improving patient outcomes Methods identified compared adult 18 years SID versus nonSID hospitalized AMC using large nationally representative inpatient database 2016 2021 standardized diagnostic codes Six SIDs selected based distribution human leukocyte antigen HLA risk allcause mortality major adverse cardiac cerebrovascular event ischemic stroke cardiac arrest acute heart failure AHF ventricular arrhythmia VA complete atrioventricular block acute myocardial infarction AMI use circulatory support assessed adult AMC admission without SID adjusting confounders SID divided six cohorts systemic lupus erythematosus SLE rheumatoid arthritis RA psoriasis PS inflammatory bowel disease IBD Hashimotos thyroiditis multiple sclerosis MS subgroups Results Overall 34540 adult admission AMC Prevalence AMC nonSID 96 3454035865 mean age nonSID similar across four cohorts relatively older RA MS 608 595 years respectively cohort also higher proportion female PS IBD cohorts Hypertension peripheral vascular disease smoking frequently seen SIDAMC cohort time obesity regularly seen RA MS diabetes mellitus DM commonly seen SLE MS hyperlipidemia frequent SLE RA PS MS RAAMC cohort significantly higher adjusted odds using mechanical circulatory support adjusted odds ratio aOR 28 CI 122655 p  0015 adjusting sex dyslipidemia DM chronic kidney disease CKD However odds outcome acute VA mortality major adverse cardiovascular event statistically significant Conclusions RAAMC cohort 280 likely require mechanical circulatory support hospitalization AMC suggesting worse AHF cardiogenic shock outcomes Prospective study would necessary examine cardiovascular outcome cohort",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821166/"
    },
    {
        "pmid": "40820695",
        "title": "Application of Ozaki technique in the treatment of aortic valve disease in children: a 15-year retrospective review.",
        "abstract": "steady improvement efficacy Ozaki technique child past decade active widely used child aortic valve disease Ozaki technique obvious advantage traditional prosthetic valve replacement preserve natural motion aortic annulus preserve coordination left ventricle sinus Valsalva aorta naturally dilates aortic root systole restores physiological laminar flow pattern retains continuous growth potential aortic annulus good early midterm valve durability need anticoagulation short learning curve time easy promote suitable wide range people significant economic benefits especially developing country serious shortage medical resource large number CHD patients Theoretically Ozaki technique considered patient age adults children acquired congenital aortic valve disease including previous mechanical bioprosthetic Ross procedures currently support concept using Ozaki technique surgical repair method child severe aortic valve disease specific strategy made individually according patients condition article review past present surgical indications surgical procedures advantages prognosis prospect Ozaki technique treating aortic valve disease children",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40820695/"
    },
    {
        "pmid": "40820579",
        "title": "Kaempferol: A Dietary Flavonoid with Potential Protective Effects Against Kidney Diseases.",
        "abstract": "Globally kidney disease represent significant public health challenge high mortality rate considerable threat human health Despite widespread use pharmacological treatments renal dialysis renal transplantation treatment kidney diseases approach often fail address patients therapeutic need fully result development novel preventive tactic specialized treatment approach crucial Kaempferol flavonoid compound various biological activities gained attention potential treating neurological cardiovascular metabolic cancerrelated conditions owing exceptional antiinflammatory antioxidant anticancer antiapoptotic properties Studies shown kaempferol highly effective protecting kidney effectively address range kidney diseases including diabetic nephropathy renal fibrosis urinary stones renal cell carcinoma Furthermore demonstrated markedly enhance renal damage resulting sepsis pharmaceutical agents heavy metals review comprehensively review available evidence therapeutic role kaempferol various common kidney disease elucidates specific molecular mechanism kaempferols nephroprotective effects addition provides insight reference scientific research clinical drug development nutritional supplementation kaempferol kidney diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40820579/"
    },
    {
        "pmid": "40820538",
        "title": "[Research progress on the biomarkers of sepsis-induced cardiomyopathy].",
        "abstract": "Sepsis constitutes one principal cause death globally mortality rate patient complicated sepsisinduced cardiomyopathy SIC surge 50 Early identification patient sepsis particularly SIC implementing clinical intervention vital measure reduce mortality recent years biomarkers diagnosis prognosis SIC emerged rapidly Among classical myocardial injury biomarkers cardiac troponin cTn brain natriuretic peptide BNP soluble growth stimulation gene 2 protein sST2 predictive value prognosis SIC Meanwhile hearttype fatty acidbinding protein hFABP possess relatively high value diagnosis Moreover plasma metabolites microRNA miRNA well recently identified marker related sepsis cardiovascular disease also demonstrate outstanding predictive value diagnosis prognosis SIC instance exosomal miR1505p blood miR155 blood miR378a3p blood miR213p blood miR233 blood miR23b blood miR135 lipocalin LCN heme oxygenase1 HO1 fibroblast growth factor21 FGF21 growth differentiation factor15 GDF15 show varying degree predictive value come diagnosing SIC S100A8A9 protein triglycerideglucose TyG index angiotensinogen II Ang II lactoferrin correlated prognosis SIC Meanwhile discovered combination multiple biomarkers outperforms single biomarker certain combination exhibit superior diagnostic performance However study use singlecenter clinical data certain limitation still call highquality evidence support Therefore identifying biomarker combination supported highquality evidence bedside application potential possess high sensitivity specificity crucial importance prevention diagnosis treatment SIC review carried current article report biomarkers predictive value diagnosis prediction multiple biomarkers combination hope continuously optimizing diagnostic strategy specific identification early SIC",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40820538/"
    },
    {
        "pmid": "40820376",
        "title": "A Miniaturized Centrifugal Pump ECMO System Enhances Hemocompatibility in Small Animal Models.",
        "abstract": "Extracorporeal membrane oxygenation ECMO fundamental treatment cardiovascular severe pulmonary diseases small animal model providing critical insight organ protection cardiopulmonary bypass ECMO therapy Conventional roller pumps however induce hemolysis organ injury repetitive compressionshear exposure severely limiting utility centrifugal pump reduce shear stress effective large animal ECMO flow range priming volume unsuitable small animals Here present miniaturized fully integrated ECMO system optimized centrifugal pump tailored small animal models system reduces shear stress minimizes blood damage enhances organ protection Integrated multiparameter sensor enable realtime monitoring blood flow pressure temperature thereby streamlining setup improving perioperative support 6h experiment system demonstrated significant hemolysis suppression improved renal function with reduced level Neutrophil GelatinaseAssociated Lipocalin NGAL stable hemodynamics innovation offer safer extracorporeal support small animal study cardiovascular diseases organ recovery ECMO mechanisms furthering research therapeutic interventions addressing key limitation existing pumps system provides reliable platform exploring hemodynamic pathophysiological process ECMO treatment establishing foundation future preclinical investigations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40820376/"
    },
    {
        "pmid": "40819859",
        "title": "Rationale and design of SCOPE trial: a prospective, multicentre, open-label, randomised controlled trial to evaluate the overall efficacy and safety of a <i>s</i>hort-term anticoagulation strategy versus <i>co</i>nventional single antiplatelet therapy in patients with severe aortic stenosis without indications for anticoagulation or dual antiplatelet therapy <i>p</i>ost-transcatheter aortic valve r<i>e</i>placement.",
        "abstract": "transcatheter aortic valve replacement TAVR become wellestablished standard care patient symptomatic severe aortic stenosis optimal antithrombotic strategy postTAVR remains subject debate particularly patient without clear indication anticoagulation dual antiplatelet therapy study aim investigate safety efficacy rivaroxaban compared antiplatelet monotherapy specific patient population study designed prospective multicentre openlabel randomised controlled trial total 454 patients successfully undergone TAVR indication longterm anticoagulation dual antiplatelet therapy consecutively enrolled seven centre across China Participants randomly assigned receive either anticoagulation rivaroxaban 2015 mg conventional antiplatelet therapy aspirin clopidogrel 1 month Followup evaluation scheduled 1 3 6 12 month postprocedure initial 1month antithrombotic therapy regimen may adjusted investigator based patients clinical imaging followup results primary endpoint hierarchical composite cardiovascular death first occurrence myocardial infarction stroke first occurrence lifethreatening disabling major bleeding grade 3 higher hypoattenuated leaflet thickening reduced leaflet motion 12 month postTAVR win ratio method employed analyse primary endpoint trial approved Ethics Committee Beijing AnZhen Hospital relevant result disseminated publication peerreviewed journal presentation conferences ChiCTR2400087453",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40819859/"
    },
    {
        "pmid": "40819789",
        "title": "Liraglutide attenuates doxorubicin-induced cardiomyocyte ferroptosis via DHHC7-mediated STAT3 palmitoylation.",
        "abstract": "study aimed investigate liraglutides protective effect doxorubicin DOXinduced cardiotoxicity ferroptosis elucidate underlying mechanism involving signal transducer activator transcription 3 STAT3 signaling posttranslational palmitoylation vivo model chronic DOXinduced cardiotoxicity established male C57BL6 J mice Cardiac function assessed via echocardiography Ferroptosis marker malondialdehyde MDA glutathione GSH iron Fesup2sup reactive oxygen specie ROS mitochondrial ultrastructure evaluated myocardial tissue H9c2 cardiomyocytes Bioinformatics analysis GSE193861 dataset identified ferroptosisrelated differentially expressed genes STAT3 DHHC7 modulated using short hairpin RNA shRNA knockdown cardiomyocytespecific adenoassociated virus 9 AAV9mediated overexpression Molecular interaction assessed via coimmunoprecipitation acylbiotin exchange assays western blotting Liraglutide administration significantly attenuated DOXinduced cardiac dysfunction cardiomyocyte ferroptosis Bioinformatics identified STAT3 central regulator liraglutide restoring DOXimpaired STAT3 phosphorylation nuclear translocation thereby enhancing transcription antiferroptotic enzyme glutathione peroxidase 4 GPX4 STAT3 knockdown abolished liraglutides protection Mechanistically liraglutide upregulated palmitoyltransferase DHHC7 rescuing DOXsuppressed STAT3 palmitoylation DHHC7 knockdown palmitoylation inhibition abrogated liraglutidemediated STAT3 phosphorylation antiferroptotic effects Crucially cardiomyocytespecific DHHC7 overexpression replicated liraglutides cardioprotection mitigating DOXinduced ferroptosis dysfunction demonstrate novel cardioprotective axis wherein liraglutide enhances DHHC7dependent STAT3 palmitoylation facilitating phosphorylation nuclear translocation transcriptional activation GPX4 suppress ferroptosis study provides first evidence DHHC7mediated STAT3 palmitoylation essential liraglutides efficacy identifying promising therapeutic target DOX cardiotoxicity",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40819789/"
    },
    {
        "pmid": "40819563",
        "title": "Rapamycin coated selenium nanoparticles relieve oxidative senescence of vascular endothelium by mitophagy.",
        "abstract": "Rapamycin RPM extends longevity various specie combat vascular senescence related diseases Selenium nanoparticles SeNPs attracted attention potential therapy cardiovascular disease due excellent antioxidant drugcarrying capacity However RPM coated SeNPs RPMSeNPs reported potential preventing endothelial oxidative senescence remains unclear present study RPMSeNPs generated selenite RPM ascorbic acid reduction Stability dispersity SeNPs increased coating RPM resulting average diameter 6751 ± 207 nm RPMSe molar ratio 1120 Notably RPMSeNPs exhibited ameliorative effect oxidative endothelial senescence mouse aorta MAECs induced paraquat hydrogen peroxide respectively evidenced decreased SAβgal activity lower SASP levels decreased endothelial dysfunction Mechanically RPMSeNPs reduced oxidative stress endothelial cell upregulating GPX4 particularly mitochondrial GPX4 mtGPX4 mitigated ROS relieved mitochondrion dysfunction downregulating PI3KAktmTOR pathway RPMSeNPs inhibited ULK1 phosphorylation Ser757 subsequently leading activation mitophagy reversal mitochondrial dysfunction including mitochondrial membrane potential collapse ATP deficiency Thus result suggest RPMSeNPs rescue endothelial cell oxidative stress induced senescence upregulating mtGPX4 activating mitophagy result provide insight mechanism functionalizing SeNPs potentially treating senescencerelated diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40819563/"
    },
    {
        "pmid": "40819542",
        "title": "The role of MMPs and TIMPs in regenerative medicine: From pathological ECM remodeling to therapeutic applications.",
        "abstract": "Regulation extracellular matrix ECM dynamic mediated matrix metalloproteinases MMPs tissue inhibitor TIMPs involvement many process well recognized specific impression regenerative medicine remains area active investigation review highlighted impact MMPs six fundamental phenomenatissue remodelling angiogenesis cell migration cell proliferation growth immunogenicity apoptosis emphasizing significance regenerative medicine Also review offer novel contribution evaluating phenomenon across individual organs approach distinguishes previous literature often lacked organspecific perspective context regenerative medicine tissue engineering regard role MMPs investigated across various conditions including neurodegenerative disorders cardiovascular diseases cancer musculoskeletal disorders liver lung complications skin pathologies ophthalmologic diseases approach give detailed understanding MMPs behaviour across different biological environments offering insight contextdependent functions Furthermore review discusses current challenge MMP research lack selectivity available MMP inhibitors well future direction including potential role adjuvant therapy use gene editing technology CRISPR bioengineered delivery system nano particle precisely modulate local tissue regeneration improve drug delivery",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40819542/"
    },
    {
        "pmid": "40818936",
        "title": "\"The association of cardiometabolic diseases and related medications with cognitive performance: a cross-sectional observational study from Central Poland\".",
        "abstract": "Global ageing rising prevalence cardiometabolic disease dementia becomes increasingly important public health topic relation evoked extensive research effort aimed finding link cardiovascular health cognitive decline Cardiometabolic medications widely prescribed beneficial effect vascular health closely examined potential influence cognitive health capacity modify risk dementia crosssectional study 1735 individual Central Poland investigated cardiometabolic diseases treatments cognitive function Cognitive performance evaluated using MiniMental State Examination MMSE dichotomized ≥ 24 point  24 points logistic regression revealed strong association age OR107 95 CI 105108 p  0001 stroke OR143 95 CI 130184 p  0001 worse MMSE dichotomized score Similarly insulin usage linked increased risk low MMSE OR133 95CI 106173 p  0008 contrast BMI OR096 95CI 094098 p  0001 lipid disorder OR069 95 CI 048092 p  001 use calcium channel blocker OR071 95 CI 048094 p  004 alphablocker OR054 95 CI 023086 p  0004 angiotensin II receptor antagonist OR 056 95 CI 029083 p  0001 associated normal cognitive function Rsup2sup  008 p  0001 result present complex connection cardiometabolic disorders treatment cognitive functioning research highlight necessity tailored approach prescribing cardiovascular medications considering potential link cognitive health Especially role angiotensin II receptor antagonist merit studies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818936/"
    },
    {
        "pmid": "40818851",
        "title": "Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis.",
        "abstract": "pharmacological therapy shown certainty improve cardiovascular prognosis patient kidney failure chronic haemodialysis aimed investigate effect steroidal mineralocorticoid receptor antagonist spironolactone cardiovascular outcome patient haemodialysis high risk cardiovascular events ALCHEMIST investigatorinitiated multicentre doubleblind randomised placebocontrolled eventdriven trial conducted 64 university hospitals general hospitals nonprofit private practice dialysis centre France Belgium Monaco Adult patient aged 18 year older kidney failure chronic haemodialysis least one cardiovascular comorbidity risk factor enrolled 4week runin period openlabel oral spironolactone 25 mg every day Participants randomly assigned 11 oral spironolactone titrated 25 mg per day placebo randomisation sequence computer generated stratified centre block 4 6 permutation treatment within block random assignment doubleblinded primary endpoint time first major adverse cardiovascular event cardiovascular death nonfatal myocardial infarction acute coronary syndrome stroke hospitalisation heart failure analysed intentiontotreat population also performed updated metaanalysis doubleblind randomised controlled trial mineralocorticoid receptor antagonist patient haemodialysis incorporating data ALCHEMIST study registered ClinicalTrialsgov NCT01848639 June 13 2013 Nov 24 2020 1442 patient locally screened eligibility 823 patient included trial 794 entered runin period 644 patient randomly assigned spironolactone n320 placebo n324 444 69 patient men 200 31 women trial stopped prematurely due lack funding sponsor Median followup 32·6 month IQR 17·348·4 primary endpoint occurred 78 24 320 patient spironolactone group 10·66 per 100 patientyears 95 CI 8·5413·31 79 24 324 patient placebo group 10·70 per 100 patientyears 8·5913·35 hazard ratio HR 1·00 95 CI 0·731·36 p0·98 Hyperkalaemia 6 mmolL reported 135 42 patient spironolactone group 134 41 placebo group HR 1·12 95 CI 0·881·43 metaanalysis mineralocorticoid receptor antagonist reduce allcause cardiovascular mortality nonfatal cardiovascular event increase odds hyperkalaemia event serum potassium concentration 6 mmolL patient kidney failure haemodialysis high risk adverse cardiovascular outcomes spironolactone reduce incidence major cardiovascular events updated metaanalysis show mineralocorticoid receptor antagonist reduce allcause cardiovascular mortality Therefore offlabel use spironolactone setting supported available evidence French Ministry Health",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818851/"
    },
    {
        "pmid": "40818772",
        "title": "Mortality Outcomes and ACE Inhibitor Use in Patients with Idiopathic Pulmonary Fibrosis.",
        "abstract": "ACE inhibitor ACEi widely used antihypertensive agent proven cardioprotective effects Previous mechanistic clinical study suggested ACEi therapy may slow disease progression reduce mortality idiopathic pulmonary fibrosis IPF ACEi use associate reduced allcause realworld population IPF patients so association also present COPD patients retrospective analysis conducted using electronic health record Clinical Practice Research Datalink CPRD GOLD database 2019 linked HES Admitted Patient Care ONS death registration data Patients IPF COPD stratified based ACEi use defined ≥3 prescription within five year preceding diagnosis matched age gender smoking history using propensity score matching Multivariable Cox regression analysis performed adjusting age gender body mass index smoking status index multiple deprivation diabetes mellitus chronic kidney disease common cardiovascular comorbidities IPF cohort competing risk analysis used account causespecific mortality study included 3579 patient IPF matched COPD control mean age 74 years 36 female Among IPF cohort 1326 37 ACEi users compared 1061 30 amongst COPD patients ACEi use associated improved survival independent coexisting comorbidities IPF patient HR  089 95 CI  081098 p  0013 similar association found COPD patient HR  109 95 CI  095125 p  0234 ACEi therapy independently associated reduced allcause mortality IPF COPD Prospective trial warranted confirm finding IPF populations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818772/"
    },
    {
        "pmid": "40818766",
        "title": "Rationale, design and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 LVAD recipients (ENVAD-HF).",
        "abstract": "notable improvement longterm survival hemocompatibilityrelated events heart failure HF emerging leading cause death contemporary left ventricular assist device LVAD population prospective randomized controlled trial RCTs investigated use HF therapy LVAD recipients observational data suggest benefit neurohormonal blockers especially achieving blood pressure BP target associated improved outcomes ENVADHF investigatorinitiated prospective multicenter randomized openlabel parallel group pilot study HeartMate 3 HM3 LVAD recipient evaluate safety tolerability insight efficacy sacubitrilvalsartan compared standard care SOC managing BP Medically stable LVAD recipient recent HM3 implantation ambulatory followup eligible participation randomized 11 receive sacubitrilvalsartan SOC used treating BP titrated aiming mean arterial pressure MAP goal 7590 mmHg 12month followup primary endpoint designed assess safety efficacy sacubitrilvalsartan compared SOC composite freedom allcause death deterioration renal function hyperkalemia symptomatic hypotension occurrence primary endpoint assessed first three month overall duration trial 12 months endpoint include clinical patientreported outcomes biomarker echocardiography assessment followup ENVADHF enrolled 60 patient February 2021 March 2024 17 females mean age 57±12 years 67 ambulatory followup 55 ischemic etiology 25 receiving LVAD destination therapy mean baseline MAP 87±7 mmHg median NTproBNP 2552 15953543 pgmL ENVADHF first prospective RCT pharmacological therapy management BP stable HM3 LVAD recipient achieving target enrolment provide data safety tolerability insight efficacy sacubitrilvalsartan versus SOC used treating BP",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818766/"
    },
    {
        "pmid": "40818651",
        "title": "Impact of Sodium-glucose Cotransporter 2 Inhibitor on Recurrence and Cardiovascular Outcomes after Catheter Ablation for Atrial Fibrillation in Patients with Chronic Kidney Disease.",
        "abstract": "effect sodiumglucose cotransporter 2 inhibitor SGLT2i atrial fibrillation AF recurrence catheter ablation patient chronic kidney disease CKD remains uncertain investigate whether SGLT2i associated reduced risk AF recurrence catheter ablation CKD patients prospective ChineseAF Registry identified 628 AF patient CKD receiving initial catheter ablation January 2019 December 2023 Patients stratified SGLT2i group n119 nonSGLT2i group n509 based discharge prescriptions Propensity scorederived overlap weighting OW employed balance baseline characteristics primary outcome AF recurrence threemonth blanking period mean followup duration 131 ± 53 months patient SGLT2i group lower rate AF recurrence compared nonSGLT2i group OW adjustment 218 26119 v 312 159509 adjusted HR 056 95 CI 032098 P  0044 Additionally SGLT2i group demonstrated substantially lower rate composite outcome cardiovascular mortality cardiovascular hospitalization thrombotic events adjusted HR 038 95 CI 020073 P  0004 substantial reduction observed cardiovascular hospitalization adjusted HR 033 95 CI 016068 P  0002 SGLT2i treatment associated reduced risk AF recurrence composite outcome cardiovascular mortality cardiovascular hospitalization thrombotic events CKD patient receiving catheter ablation AF",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818651/"
    },
    {
        "pmid": "40818367",
        "title": "Ex vivo calcium imaging of sympathetic neurons in intact mouse stellate ganglia.",
        "abstract": "Sympathetic hyperactivity common feature cardiovascular disease including hypertension sympathetic neuron hyperactive week angiotensin II AngII hypertension Nerve firing increase intracellular Casup2sup wanted develop Casup2sup imaging method quantify activity across many neuron once describe method ex vivo Casup2sup imaging intact mouse stellate ganglia imaged ganglion control AngII 700 ngminKg hypertensive mouse determine could identify Casup2sup parameter reflected hyperactivity expressed GCaMP6s tyrosine hydroxylase THpositive neuron THsupGCaMP6ssup Male female THsupGCaMP6ssup mouse 1725 week old used Images obtained baseline conditions stimulation nicotine 10 μM stimulation potassium chloride KCl 40 mM positive control GCaMP6s expression Differential fluorescence response quantified using opensource MATLAB processing tool additional MATLAB script composed analyze characterize feature fluorescent responses peak Casup2sup response nicotine treatment trended higher left right stellates AngIItreated mice distribution peak response differed significantly left ganglia Decay time similar groups compared peak Casup2sup response nicotine treatment vs KCl found altered frequency distribution nicotine KCl response left right stellates AngII mice raising possibility selective modulation cholinergic responses Calcium imaging allowed simultaneous analysis multiple cell within ganglia recapitulate bilateral hyperactivity identified electrophysiology",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818367/"
    },
    {
        "pmid": "40818322",
        "title": "Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and redox homeostasis in pancreatic ductal adenocarcinoma.",
        "abstract": "Metabolic reprogramming pancreatic ductal adenocarcinoma PDAC pose significant challenge efficacy gemcitabinebased chemotherapy Aberrant activation intracellular pyrimidine metabolism key factor contributing reduced effectiveness gemcitabine Combining gemcitabine metabolic regulator targeting critical pathway may alleviate gemcitabine resistance study focus abnormal activation dihydroorotate dehydrogenase DHODH PDAC cells pivotal enzyme de novo pyrimidine synthesis pathway diminishes cellular sensitivity gemcitabine catalyzes reduction ubiquinone ubiquinol playing essential role maintaining cellular redox homeostasis address challenges developed GE11 peptidemodified polyphenoliron chelate nanoparticles codelivery long carbon chainmodified gemcitabine DHODH inhibitor leflunomide peptide modification enabling nanoparticles target PDAC cell high expression epidermal growth factor receptor nanoparticles demonstrated ability induce mitocytosis achieve deep tumor penetration PDAC tissues Upon drug release core lesion three components modified gemcitabine leflunomide iron ion synergistically enhanced tumor cell killing alleviating gemcitabine resistance disrupting cellular redox homeostasis induce multimodal cell death situ pancreatic cancer mouse model strategy exhibited superior antitumor efficacy compared standard AG chemotherapy regimen nabpaclitaxel gemcitabine even 63fold lower gemcitabine concentration finding underscore potential approach highly effective therapeutic strategy PDAC treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818322/"
    },
    {
        "pmid": "40818264",
        "title": "IL-1 Pathway Inhibition in Recurrent Pericarditis Management: Real-World Adoption of Corticosteroid Sparing in RESONANCE.",
        "abstract": "Recurrent pericarditis RP guideline recommend secondline corticosteroid aspirinnonsteroidal antiinflammatory drugscolchicine complication protracted use underscore importance corticosteroidsparing strategies Given clinical trial evidence supporting interleukin IL1 pathway inhibition US Food Drug Administration approval rilonacept RP objective assess temporal trend corticosteroidsparing treatment RP multicenter registry RESONANCE REgiStry NAtural history recurreNt periCarditis pEdiatric adult patients NCT04687358 combine retrospective prospective data clinical practice single observation period Patients receiving treatment idiopathic postprocedural RP included Demographics treatment intensification quantified 313 patient aspirinnonsteroidal antiinflammatory drugscolchicine treatment median disease duration 19 years 1 preenrollment recurrence 44 n  138 intensified treatment rilonacept approval RP 71 n  10 patient intensified corticosteroid secondline therapy 29 n  4 intensified IL1 pathway inhibition rilonacept approval proportion patient intensifying secondline IL1 pathway inhibition increased 64 2023 n  27 rilonacept 57 anakinra 7 whereas proportion patient intensifying corticosteroid decreased 33 n  14 P  002 Approximately 59 n  35 secondline corticosteroid initiator later transitioned IL1 pathway inhibition patient starting secondline IL1 pathway inhibition 5 n  3 rilonacept 25 n  4 anakinra subsequently used corticosteroid 30 days RESONANCE IL1 pathway inhibition increasingly replaced corticosteroid secondline therapy patient starting corticosteroid transitioned IL1 pathway inhibition transitioned secondline IL1 pathway inhibition longterm corticosteroids finding may inform treatment algorithm patientprovider decisionmaking",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818264/"
    },
    {
        "pmid": "40818181",
        "title": "Canagliflozin inhibits hepatic stellate cells activation and proliferation by inhibiting PP2A-mediated β-catenin dephosphorylation to attenuate hepatic fibrosis.",
        "abstract": "Hepatic fibrosis HF leading cause death worldwide yet currently safe effective treatment available Canagliflozin novel glucoselowering drug shown improve nonalcoholic steatohepatitis NASH However therapeutic effect HF underlying molecular mechanism remain unclear study HF induced mouse via intraperitoneal injection CClsub4sub Additionally immortalized hepatic stellate cell HSCs including HSCT6 LX2 cells used vitro experiments finding revealed Canagliflozin inhibited activation proliferation HSCs thereby downregulated expression level fibrotic marker αSMA Collagen I ultimately alleviating HF investigation demonstrated Canagliflozin inhibits protein phosphatase 2 PP2A activity HSCs turn prevents PP2Amediated dephosphorylation βcatenin attenuates Wntβcatenin signaling Wntβcatenin signaling considered key mechanism promote activation proliferation HSCs also crucial pathway development HF Moreover increased activity PP2A found promote expression fibrotic marker αSMA Collagen I HSCs conclusion study indicates Canagliflozin ameliorate HF via inhibiting PP2Amediated dephosphorylation βcatenin HSCs inhibition PP2A HSCs may represent potential therapeutic target cancer treatment also management HF",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818181/"
    },
    {
        "pmid": "40818069",
        "title": "Cost-Effectiveness and Cost-Utility Analysis of Tongxinluo Capsules Compared With Conventional Therapy for the Treatment of Acute Myocardial Infarction.",
        "abstract": "Tongxinluo TXL capsule traditional Chinese medicine compound proven effective acute myocardial infarction AMI costeffectiveness unclear economic evaluation utilized individual data clinical trial compare major adverse cardiac cerebrovascular event MACCEs 30 day qualityadjusted life year QALYs 1 year intervention group TXL combined conventional therapy control group placebo plus conventional therapy healthcare perspective lifetime costutility analysis CUA conducted using Markov model sensitivity analysis performed evaluate robustness results total 3777 patient TXL 1889 placebo 1888 included analysis 30day total cost TXL placebo group ¥38561 5399 ¥39217 5490 respectively showing statistical difference 30day MACCEs rate 339 TXL group 524 placebo group p  0006 indicating TXLs superiority effectiveness 30 days lifetime TXL group incurred higher total cost ¥97108 13595 vs ¥92033 12885 gained QALYs 670 vs 630 incremental costeffectiveness ratio TXL ¥12421QALY 1739 1 Gross Domestic Product per capital threshold ¥89358 12510 2023 China Sensitivity analysis confirmed robust results revealing TXL likely accepted placebo willingness pay exceeds ¥12500 1739 TXL costeffective option compared placebo AMI",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818069/"
    },
    {
        "pmid": "40817904",
        "title": "South Asian Representation in Cardiovascular Disease Randomized Controlled Trials: A Systematic Review.",
        "abstract": "One 4 individual worldwide South Asian ancestry therefore increased risk cardiovascular disease CVD However South Asian representation CVD randomized controlled trial RCTs well known aim systematic review measure South Asian representation CVD RCTs extract postrandomization primary outcome estimate population conducted systematic review identify major CVD RCTs published 2018 2022 study manually screened reviewed identify South Asian participant representation rates protocol systematic review prospectively registered PROSPERO South Asian Representation Cardiovascular Clinical Trials CRD42023396522 included 310 RCTs representing 1036737 total 32764 32 South Asian participants South Asian participant 754 enrolled trial South Asia 652 enrolled single trial India excluding trial South Asian individual represented 11 total trial participants South Asian representation highest trial studying coronary artery disease 90 whereas South Asian individual identified trial studying heart failure cardiac arrest valvular heart disease Postrandomization data available 28197 South Asian individuals representing 73 participant postrandomization data South Asian individual underrepresented major CVD RCTs effort extend enrollment initiative RCTs South Asian individual urgently needed extent underrepresentation driver elevated cardiovascular disease risk merit study",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817904/"
    },
    {
        "pmid": "40817236",
        "title": "MicroRNA-4516 in extracellular vesicles-derived mesenchymal stem cells suppressed integrin αV-mediated lung fibrosis.",
        "abstract": "Idiopathic pulmonary fibrosis IPF characterized recruitment lung fibroblast site within lung interstitium along differentiation myofibroblasts induced transforming growth factor TGFβ1 mediator fibrosis which turn lead accelerated contractile lung fibrotic process excessive extracellular matrix ECM deposition Extracellular vesicle EVs small particle released cell contain physiologically active substances including messenger RNAs microRNAs miRNAs proteins Although EVs derived mesenchymal stem cell MSCs expected promising drug various intractable diseases including IPF underlying mechanism remain elusive study aimed elucidate mechanism underlying effect MSCEVs lung fibroblastmediated antifibrotic processes ability TGFβ1stimulated lung fibroblast migrate toward fibronectin contract threedimensional type collagen gel evaluated Using miRNA array aimed identify miRNAs associated fibrotic mechanism MSCEVs Furthermore effect MSCEVs analyzed mouse model bleomycin BLMinduced lung fibrosis including resulting histopathology degree fibrosis downstream signaling pathways Administration MSCEVs resulted significant suppression TGFβ1stimulated collagen gel contraction migration expression αsmooth muscle actin ECM Upon treatment MSCEVs lung fibroblast derived fibrotic lung showed greater inhibition response normal lung fibroblasts effect mediated via integrin αVmediated focal adhesion kinase signaling MAPK pathway including JNK p38MAPK andor ERK12 signaling miR4516 identified MSCEVs human lung fibroblasts recapitulated effects Administration MSCEVs resulted significant accumulation attenuation BLMinduced fibrotic lung tissue along reduced expression integrin αV lung interstitium Collectively finding study indicate MSCEVs may represent promising novel therapeutic strategy address pulmonary fibroblastmediated mechanism lung fibrosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817236/"
    },
    {
        "pmid": "40816899",
        "title": "Utilization of telemedicine in the care of children with obesity.",
        "abstract": "Obesity chronic relapsing progressive disease increasing prevalence significantly impact health quality life even children associated increased risk metabolic cardiovascular disease insulin resistance type 2 diabetes mellitus hypertension dyslipidemia metabolic dysfunctionassociated steatotic liver disease Additionally obesity lead development sleep apnea syndrome orthopedic issues psychological complications cornerstone care educating whole family healthy lifestyle however may often challenging due obstacle time constraints limited access specialists low longterm adherence families Telemedicine offer innovative approach improving obesity treatment child digital tools online consultations smart applications wearable technologies enables effective monitoring dietary physical activity habits support mental health reduces time financial burden families Studies indicate combining inperson remote support along active involvement family members lead higher success rate weight reduction healthy lifestyle maintenance article focus use telemedicine treatment obesity children providing overview method applied field effectiveness context current scientific knowledge",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816899/"
    },
    {
        "pmid": "40816891",
        "title": "Dyslipidemias as rare diseases.",
        "abstract": "Dyslipidemias mostly considered disease mass incidence However also several dyslipidemias occur within framework rare diseases genetically determined review focused three selected disease new therapy available significantly change prognosis patients Homozygous familial hypercholesterolaemia associated extreme elevation LDL cholesterol leading premature manifestation atherosclerotic cardiovascular disease first decade life Thanks new hypolipidemic drug evinacumab lomitapide patient today much better prognosis past Lipodystrophies heterogeneous group disease characterized progressive loss adipose tissue leading metabolic abnormalities Due new causal metreleptine therapy help patient managing metabolic complication significantly Familial chylomicronemia associated increased risk atherosclerotic cardiovascular disease accompanied extremely high level triglycerides leading frequent attack acute pancreatitis potentially fatal Therapy volanesorsen lead reduction hypertriglyceridemia thereby reducing risk developing acute pancreatitis Although disease rare necessary think diagnose early Interdisciplinary cooperation essential search treatment patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816891/"
    },
    {
        "pmid": "40816766",
        "title": "<i>miR-153</i> prevents NRF2 nuclear translocation to drive hypoperfusion-related cognitive deficits by targeting <i>KPNA5</i>.",
        "abstract": "imiRNAibased therapeutic represent promising approach treating multiple diseases yet key regulatory imiRNAsi chronic cerebral hypoperfusion CCHrelated cognitive impairment remains unclear Here identify imiR153i consistently upregulated male female mild cognitive impairment MCI latestage Alzheimers disease AD patients well basal forebrain male female postmortem AD specimen male CCH rats Knockdown imiR153i basal forebrain alleviated CCHinduced cognitive deficits Mechanistically imiR153i directly targeted Karyopherin alpha 5 KPNA5 nuclear transport protein facilitates nuclear factor erythroid 2related factor 2 NRF2 nuclear translocation imiR153i suppressed iKPNA5i via two binding site 3UTR impairing NRF2mediated antioxidant response promoting oxidative stress KPNA5 bound three nuclear localization sequence NRF2 protein interaction Restoration imiR153iKPNA5NRF2 axis basal forebrain alleviated oxidative stress damage male CCH rats effect observed hippocampus finding reveal potential role imiR153iKPNA5NRF2 axis CCHrelated cognitive declinebSignificance Statementb Impairment basal forebrain recognized early event pathogenesis Alzheimers disease AD patients iMicroRNAsi imiRNAsi emerged promising therapeutic candidate disease involving complex pathological processes study reveal critical role imiR153i AD progression uncover novel mechanism underlying chronic cerebral hypoperfusion CCHinduced cognitive decline basal forebrain rats demonstrate imiR153i negatively regulates KPNA5 expression basal forebrain thereby inhibiting nuclear translocation NRF2 promoting oxidative stressinduced neuronal damage finding identify imiR153i potential therapeutic target CCHassociated cognitive impairment and notably provide first evidence implicating KPNA5 pathophysiology neurodegenerative diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816766/"
    },
    {
        "pmid": "40816584",
        "title": "A systematic review and meta-analysis of randomized controlled trials on the efficacy and safety of Tanshinone IIA sodium sulfonate injection as adjunctive therapy for stroke.",
        "abstract": "Tanshinone IIA core ingredient Salvia miltiorrhiza Bge effect blood circulation promotion blood stasis removement widely used cardiovascular cerebrovascular disease treatment adjunctive therapy Stroke remains leading cause disability death posing serious public health threat Tanshinone IIA sodium sulfonate injection STS derived Salvia miltiorrhiza Bge Danshen widely used China adjunctive therapy ischemic stroke However clinical efficacy safety remain uncertain metaanalysis aim evaluate efficacy safety STS treating ischemic stroke focusing effect blood circulation biomarkers metaanalysis conducted based PICOS framework incorporating randomized controlled trial RCTs comprehensive literature search across eight database performed updated February 2024 RCTs screened using defined search strategy inclusion criteria quality included trial independently assessed two investigator following Cochrane Handbook version 510 Metaanalyses performed using RevMan 53 publication bias assessed Stata 170 Twentytwo trial involving 2289 participant included pooled result showed STS significantly improved effective rate reduced NIHSS STS also decreased whole blood viscosity including lowshear highshear plasma viscosityand lowered red cell aggregation index day 7 14 Additionally reduced level total cholesterol TC triglyceride TG lowdensity lipoprotein cholesterol LDLC Ddimer Dr fibrinogen Fib hematocrit HCT Pselectin S100B neuronspecific enolase NSE 14 days Ddimer level remained significantly lower STS also increased highdensity lipoprotein cholesterol HDLC cerebral blood flow marker Vm Qm mean blood pressure MBP However significant difference found activity daily living ADL compared conventional treatment evidence publication bias analysis effective rate adverse effects Tanshinone IIA sodium sulfonate injection appears relatively safe neuroprotective agent adjunctive use ischemic stroke associated improved NIHSS score beneficial change hemorheology lipid profiles cerebral blood flow coagulation parameters serum biomarkers S100B Pselectin NSE PROSPERO CRD4202024093",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816584/"
    },
    {
        "pmid": "40815470",
        "title": "Paeoniflorin improves atherosclerosis by regulating the gut microbiota and fecal metabolites.",
        "abstract": "Atherosclerosis AS chronic inflammatory disease key factor cardiovascular disease Paeoniflorin PF monomer component extracted red white paeony roots used prevention treatment cardiovascular diseases specific mechanism remains unclear ApoEsupsup mouse fed highfat diet randomly divided model group PF treatment group positive control group control group fed nonhighfat diet mouse PF group treated 100 mgkg PF100 50 mgkg PF50 25 mgkg PF25 PF gavage positive control group administered 10 mgkg atorvastatin calcium tablet gavage 8 week gavage PF delayed weight gain reduced elevated level serum total cholesterol triglycerides lowdensity lipoprotein cholesterol ApoEsupsup mice induced highfat diet Concomitantly PF alleviated aortic plaque formation downregulated TLR4 NFκB expression term underlying mechanism PF altered linoleic acid metabolism tryptophan metabolism steroid biosynthesis well improved abnormality galactose metabolism glycerophospholipid metabolism metabolic pathways Moreover PF restored dysbiosis Firmicutes Bacteroidota Actinobacteriota Finally increased abundance iLactobacillusi iBifidobacteriumi beneficial bacteria result suggest PF improves highfat dietinduced alleviates highfat dietinduced intestinal barrier damage moreover antiatherosclerotic effect may related improvement intestinal metabolic disorder altered abundance microbiotabIMPORTANCEbAtherosclerosis AS chronic progressive disease mainly characterized vascular endothelial cell damage inflammation lipid deposition Inflammatory immunerelated mechanism play key role occurrence development AS study showed paeoniflorin improve blood lipid levels reduce arterial inflammation restore intestinal permeability regulate metabolites increase abundance beneficial flora alleviate occurrence AS Thus finding may contribute understanding traditional Chinese medicine exerts holistic effect modulating microbiotametabolite axis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815470/"
    },
    {
        "pmid": "40815361",
        "title": "Efficacy analysis of intraventricular/intrathecal polymyxin B sulphate injections in the treatment of Post-neurosurgical CNS infections in neurocritical ill patients: a prospective observational study.",
        "abstract": "Intracranial infection due carbapenemresistant organism CRO pose substantial challenge neurosurgical intensive care unit NICU increasing prevalence infection caused carbapenemresistant Acinetobacter CRAB carbapenemresistant Klebsiella pneumoniae CRKP necessitates development novel treatment strategies prospective observational study aim evaluate efficacy safety intraventricularintrathecal polymyxin B sulfate PBS NICU patient neurosurgery enrolled patient diagnosed hospitalacquired postneurosurgical central nervous system CNS infection caused CRO Fudan Universityaffiliated Huashan Hospital January 2021 December 2023 Detailed information demographic characteristics course CRO infection treatment followup data recorded patient collected study Upon diagnosis external device immediately removed treatment regimen included local intraventricularintrathecal PBS injections systemic antibiotics cerebrospinal fluid CSF drainage Fisher exact test theχsup2sup test Student ttest used statistical analysis appropriate Among 27 patient included study 13 infected CRAB 14 CRKP mean age 494 ± 1654 years 963 patient undergone surgical procedure prior diagnosis 667 involved combined surgeries onset infection mean Glasgow Coma Scale GCS score 60 ± 217 average APACHE II score 173 ± 380 mean SOFA score 59 ± 220 total bacterial clearance rate CSF 815 2227 CRAB case achieving clearance rate 923 CRKP case achieving 714 p  0163 clinical cure rate 692 913 CRAB 642 914 CRKP Importantly mean duration onset CNS infection initiation intraventricularintrathecal injection 43 ± 501 days mean duration treatment 99 ± 392 days time achieve negative CSF culture averaged 106 ± 702 days significant difference found CRAB CRKP groups except variation sex ratio finding study verified efficacy safety intraventricularintrathecal PBS treating CROrelated intracranial infection neurosurgical patients combination local PBS administration systemic antibiotic therapy offer efficient treatment approach complex infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815361/"
    },
    {
        "pmid": "40815096",
        "title": "Empowering Healthcare Professionals: Preventing Vascular Non-Communicable Diseases in the Transgender Community.",
        "abstract": " Introduction health disparity faced transgender genderdiverse TGD individual accessing healthcare particularly context noncommunicable disease NCDs cerebrovascular diseases significant public health concern paper highlight importance early identification NCDs cerebrovascular disease TGD populations emphasizing need culturally competent care comprehensive healthcare strategies Genderaffirming hormone therapy GHT play crucial role health transgender individuals Yet associated increased cardiovascular risk particularly among transgender female undergoing estrogen therapy Studies show higher prevalence hypertension hypercholesterolemia prediabetes smoking TGD population reinforcing need regular cardiovascular monitoring targeted preventive strategies Early identification NCDs cerebrovascular disease sign symptom essential mitigating longterm health complication improving patient outcomes Proactive screening timely intervention enhance quality life reduce healthcare disparities contribute costeffective care strategies Strengthening integration diagnostic tool promoting inclusive healthcare policy foster greater trust engagement transgender individual healthcare providers Overall paper underscore need inclusive healthcare policy practice address unique healthcare need TGD individuals improve health outcomes reduce disparity within vulnerable population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815096/"
    },
    {
        "pmid": "40814909",
        "title": "RETRACTION: The Impact of Long-Term Antihypertensive Treatment on Wound Healing After Major Non-Cardiac Surgery in Patients With Cardiovascular Diseases: A Meta-Analysis.",
        "abstract": "Y Liu C Ma X Tang S Liu Y Jin The Impact LongTerm Antihypertensive Treatment Wound Healing Major NonCardiac Surgery Patients Cardiovascular Diseases MetaAnalysis International Wound Journal 21 no 4 2024 e14858 httpsdoiorg101111iwj14858 article published online 28 March 2024 Wiley Online Library httponlinelibrarywileycom retracted agreement journal Editor Chief Professor Keith Harding John Wiley  Sons Ltd Following investigation publisher party concluded article accepted solely basis compromised peer review process editor therefore decided retract article author respond notice regarding retraction",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814909/"
    },
    {
        "pmid": "40814811",
        "title": "Doxorubicin-Induced Toxicity and Bisoprolol-Protective Efficacy for Cardiomyocytes Monitored by Scanning Electrochemical Microscopy.",
        "abstract": "Cardiotoxicity chemotherapy drug major adverse effect cancer chemotherapy strongly compromise therapeutic outcomes application cardioprotective agent effective strategy mitigate cardiotoxicity clinic However effect chemotherapeutic drug doses well efficacy cardioprotective agent function cardiomyocytes especially different stage cardiotoxicity well explored partly owing lack realtime functional parameter cardiomyocytes drug treatment Herein constructed iin vitroi doxorubicin DOXinduced cardiotoxicity DIC model culturing neonatal rat primary cardiomyocytes polyacrylamide PA gel stiffness around 200 kPa adding DOX different concentration mimic mild moderate severe stage chemotherapeutic druginduced cardiotoxicity used scanning electrochemical microscopy SECM monitor respiratory activity contraction frequency membrane permeability cardiomyocytes DOX treatment iin situi SECM result obtained demonstrated 02550 μM DOX dosage led decreased respiratory activity contraction frequency accompanied increased membrane permeability cardiomyocytes also used SECM evaluate cardioprotective effect bisoprolol a clinically approved βblocker cardiovascular diseases cardiomyocytes DOX treatment obtained optimal protective efficacy 10 μM DOXtreated cardiomyocytes work provides iin situi functional information living cardiomyocytes chemotherapeutic drug cardioprotective agent treatments contributing better understanding pathological feature prevention strategy chemotherapyinduced cardiotoxicity",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814811/"
    },
    {
        "pmid": "40814613",
        "title": "Serum Syndecan-1 is Associated With Kidney and Cardiovascular Outcomes in Idiopathic Nephrotic Syndrome.",
        "abstract": "Idiopathic nephrotic syndrome INS associated important kidney cardiovascular morbidities tested hypothesis serum syndecan1 marker endothelial glycocalyx injury help identify patient risk unfavorable kidney cardiovascular outcomes included 348 child adult INS ini  35 unbiopsied ini  141 minimal change disease MCD ini  172 focal segmental glomerulosclerosis FSGS Nephrotic Syndrome Study Network NEPTUNE cohort 34 healthy participant ini  22 adults ini  12 children measured baseline serum syndecan1 level using enzymelinked immunosorbent assay evaluated relationship kidney cardiovascular outcomes performed iin vitroi study test whether INS serum different therapeutic may alter syndecan1 expression human glomerular endothelial cell GEnC Serum syndecan1 higher patient INS control high approximately onethird patient without proteinuria subnephrotic proteinuria Patients receiving steroids regardless disease activity showed higher syndecan1 immunosuppression Syndecan1 higher proteinuric patient MCD FSGS time serum collection syndecan1 modestly correlated proteinuria kidney function longitudinal analyses serum syndecan1 associated composite 40 decline kidney function kidney failure dyslipidemia Compared controls INS serum relapse increased syndecan1 expression cultured GEnC partially fully mitigated dexamethasone metalloprotease inhibitor added respectively culture media Baseline serum syndecan1 associated unfavorable kidney outcome cardiovascular risk factor INS",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814613/"
    },
    {
        "pmid": "40814438",
        "title": "Chemical profiling of unpolished pigmented chakhao amubi rice produced lipid-lowering and cardioprotective effects via reducing oxidative stress and improving digestibility behaviour.",
        "abstract": "current research work designed study amylose content total phenolic content TPC total flavonoid content TFC total anthocyanin content TAC digestibility unpolished chakhao amubi CA rice extract along antioxidant antihyperlipidemic activity addition profiling bioactive polyphenolic compound present unpolished CA rice flour evaluated Based result obtained vitro antioxidant hypolipidemic activity rice extract CAEtOH ethanol selected vivo study Effect CAEtOH 45 day treatment evaluated highfathighsugar HFHS induced Wistar rats unpolished CA rice produce higher level TPC 34653 mg GAE100 g DW TFC 63422 mg QUE100 G DW TAC 87334 mg C3G100 g DW compared polished rice CAEtOH extract showed strong antioxidant activity lowest ICsub50sub value vitro antioxidant assays unpolished CA black rice extract exhibited significant HMG CoA reductase inhibitory activity Sinapic acid 62020 mg100 gm ocoumaric acid 20080 mg100 gm rosamarinic acid 19930 mg100 gm pcoumaric acid 15660 mg100 gm present abundantly fraction RDS SDS RS unpolished CA rice flour significantly different ipi  005 compared standard corn starch lower CAEtOH200 mgkg higher CAEtOH400 mgkg dos unpolished CA rice extract significantly p  0001 reduce body weight HFHS induced rats Oral administration unpolished CA rice extract reduced level TC TG LDLC VLDLC LDH SGOT SGPT ALP CKNAC ApoA1 ApoB ApoBApoA1 CRP LPa LPO AIP AC CPI CRR significantly ipi  0001 improved hyperlipidemic rat model addition HDLC GSH CAT SOD GPx level elevated Thus current result suggested unpolished CA black rice could effective oxidative stress dyslipidaemia cardiovascular disease due availability numerous functional moiety phenolic compounds",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814438/"
    },
    {
        "pmid": "40814364",
        "title": "Transcripts of splicing factors with time-varying associations with survival outcomes in colorectal cancer.",
        "abstract": "Identifying variable timevarying association help guide patient stratification treatment strategies Timevarying association refer association variable interest outcome change time association gene transcript never examined colorectal cancer CRC present study examined transcript splicing factor association prognosis CRC performed analysis using Cox PH model Cox model timevarying coefficient appropriate transcript premRNA processing factor 38A iPRPF38Ai identified significantly associated progressionfree survival two year postdiagnosis that making transcript candidate lateoutcome marker CRC explorative analysis showed transcript correlated alternative splicing gene involved RNA binding mitochondrial protein synthesis Overall study first time revealed association pattern splicing factor transcript time CRC identified transcript iPRPF38Ai candidate lateoutcome marker provided mechanistic insight outcome heterogeneity CRC",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814364/"
    },
    {
        "pmid": "40814312",
        "title": "Multiple Model Predictive Control of the Cardiovascular System using Vagal Nerve Stimulation.",
        "abstract": "Vagal nerve stimulation VNS currently investigation treatment various cardiovascular disease include heart failure arrhythmia hypertension preclinical clinical studies VNS stimulation parameter heuristically determined openloop therapeutic efficacy remains inconclusive strongly suggesting need closedloop approach optimize patientspecific stimulation parameters paper develop multiple model predictive control algorithm automated regulation heart rate mean arterial pressure optimally adjusting amplitude frequency electrical pulse applied three location vagal nerve multiple local model identified previously reported pulsatile rat cardiac model emulates symptom hypertension rest exercise states computational expense proposed method verified simulation rigorous hardwareintheloop implementation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814312/"
    },
    {
        "pmid": "40814275",
        "title": "Prediction of Sinus Rhythm Maintenance After Electrical Cardioversion Using Spectral and Vector Cardiographic ECG Analysis.",
        "abstract": "Electrical cardioversion ECV remains treatment option atrial fibrillation AF study aimed find predictor SR maintenance ECV using spectral vector cardiographic VCG analysis ECGs Consecutive patient AF referred elective ECV prospectively enrolled digital ECG recording obtained ECV analyzed using spectral VCG analysis AF activity analyzed using spectral analysis determine dominant frequency DF RI regularity index OI organizational index QRS complex analyzed using vectorcardiography determine dXmean dYmean dZmean derivation VCG signals used Lasso Logistic Regression LLR fivefold crossvalidation feature selection build combined predictive model SR maintenance model training evaluation data split 6040 ratio training testing respectively total 80 patient enrolled age 702 ± 106 years 49 61 men BMI 297 kgmsup2sup 3month followup AF recurrence present 36 patient 45 best single VCG parameter predict SR maintenance dZMean OR 018 95 CI 006051 p  0001 VCGdomain parameter combined LLR model showed area curve AUC 078 spectral analysis domain best predictor DF OR 354 95 CI 1281025 p  0006 spectral feature led AUC 076 combined LLR model Clinical feature form model since feature passed feature selection Combining VCG spectral analysis feature led LLR model AUC 079 combination spectral analysis AF activity VCG analysis ventricular activity provided accurate predictive information either analysis alone",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814275/"
    },
    {
        "pmid": "40814213",
        "title": "Facilitators, barriers, and insights using an HFA-PEFF-based clinical decision support system: A proof-of-concept study.",
        "abstract": "Knowing heart failure HF preserved ejection fraction HFpEF difficult diagnose clinical decision support system CDSS functional morphological biomarker domains built Therefore research aimed analyse possibility implementing CDSS compliance physician CDSS recommendations well identify obstacle facilitator usage mixedmethods study conducted 1 year period Institute Cardiovascular Diseases Vojvodina Sremska Kamenica Serbia retrospective component included analysis patient symptom andor sign HF ejection fraction EF ≥50 Heart Failure Association pretest assessment echocardiography natriuretic peptide functional testing final aetiology HFAPEFF score used build CDSS calculate probability score patients prospective component involved electronic survey used gain feedback physician CDSS sample included 225 patients 194 862 HFAPEFF score 56 suggesting probable HFpEF syndrome clinically documented discharge report 32 165 patients response rate survey 833 including physician different level education Barriers CDSS usage included lack echocardiographic skill knowledge phenotype profiling HFpEF patients increase explainability transparency well staff education mentioned main facilitators CDSS demonstrated reasonable effectiveness diagnosing classifying patient symptom HF measured EF ≥50 conducted survey highlighted physician education CDSS HFpEFrelated domains key factor battle HFpEF",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814213/"
    },
    {
        "pmid": "40814104",
        "title": "Unveiling the UHR threshold in American adult: a new biomarker for early diabetes detection from NHANES study.",
        "abstract": "study examines association serum uric acid highdensity lipoprotein cholesterol ratio UHR biomarker risk prediabetes diabetes relationship remains underresearched provide insight diabetes prevention study utilized data 13975 American participant National Health Nutrition Examination Survey 20112018 Logistic regression models restricted cubic spline RCS analysis subgroup analysis employed examine association UHR prediabetesdiabetes median UHR 104 6382 457 case prediabetes diabetes detected higher UHR associated increased risk prediabetes diabetes showing 39 increased risk per standard deviation increment OR 139 95 CI 133146 Consistent result observed UHR categorized Participants highest UHR quartile exhibited significantly higher risk prediabetesdiabetes lowest quartile OR 263 95 CI 230301 RCS analysis revealed nonlinear association threshold value 1250 threshold higher UHR significantly associated prediabetesdiabetes OR 117 95 CI 115119 threshold association significant Subgroup analysis highlighted marked gender disparity woman exhibiting stronger association research found positive link UHR prediabetes diabetes prevalence nonlinear relationship noted significant association observed UHR threshold 1250 especially females",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814104/"
    },
    {
        "pmid": "40814089",
        "title": "Management and safety of same day bilateral intravitreal anti-VEGF injections in a treat-and-extend regimen.",
        "abstract": "Antivascular endothelial growth factor VEGF intravitreal injection treatment IVTs gold standard various neovascular retinal diseases including neovascular agerelated macular degeneration nAMD diabetic macular edema DME macular edema due retinal vein occlusion RVO day bilateral IVTs commonly performed offlabel worldwide reduce patient burden despite limited safety data study evaluates safety management bilateral day antiVEGF injection within treatandextend regimen TER proposes clinical guideline coordination bilateral treatment retrospective observational study analysed electronic health record 428 included patient treated bilaterally ranibizumab 05mg aflibercept 2mg VISTA Augenklinik Binningen Switzerland 2015 2019 Patients included bilateral macular edema due nAMD DME RVO received least two cycle day bilateral antiVEGF injection within TER Treatment coordination followed one four strategies Equal TER Coordinated TER Mixed TER pro nata PRN Asynchronous TER Unilateral IVTs also recorded period patient cohort Ocular systemic adverse event AEs compared unilateral bilateral injection using Fishers exact test total 15825 antiVEGF injection administered 4766 bilateral day injection Formula see text 6293 unilateral injections Treatment interval synchronised according visual acuity potential disease activity treatment regime bilateral IVTs established provided manuscript frequently reported ocular AEs conjunctival haemorrhage sicca symptoms Systemic AEs cerebrovascular cardiovascular event rare significant difference bilateral unilateral injections Bilateral day intravitreal antiVEGF injection within TER regimen appear safe significant increase ocular systemic AEs compared unilateral treatment Coordinating bilateral IVTs using clinical guideline presented study may reduce treatment visits ease patient burden improve compliance Larger prospective study needed confirm safety support standardised guideline bilateral IVTs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814089/"
    },
    {
        "pmid": "40813723",
        "title": "Sudden cardiac arrest mortality in China: temporal trends and risk factors.",
        "abstract": "Sudden cardiac death SCD account half sudden death cases posing significant health burden China However epidemiological data SCD scarce due lack central data registry heterogeneity case definitions study aim provide reliable estimate incidence risk factor SCD China national regional level 2013 2021 well current status prevention multicause mortality data 2013 2021 obtained National Mortality Surveillance System China Deaths related cardiac arrest identified Crude agestandardized mortality rate calculated time region Joint point regression applied identify significant change study period Subgroup analysis multilevel negative binomial analysis performed understand SCD risk factors firstline prevention measure current implementation China developed country also determined published articles 2013 2021 crude mortality rate sudden cardiac arrest increased markedly 836 death per 100000 population 2013 1859 death per 100000 population 2021 considerable difference among regions Subgroup analysis negative binomial regression result indicated male elderly higher risk SCD SCD may associated poor medical conditions half SCDs occurred outside hospitals approximately 60 SCDs related ischemic heart disease underlying cause Currently developed country widely adopted primary prevention emergency treatment measures however utilization rate measure China relatively low improved continuous rise prevalence cardiovascular disease related risk factor China burden SCD expected increase addition strengthening clinical pathway sudden cardiac arrest case prehospital hospital settings also necessary enhance public awareness knowledge firstline practical training largescale policy governmental communitybased projects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813723/"
    },
    {
        "pmid": "40813585",
        "title": "Collagen VI microfibril structure reveals mechanism for molecular assembly and clustering of inherited pathogenic mutations.",
        "abstract": "Collagen VI link cell surface extracellular matrix provide mechanical strength mammalian tissues linked human disease including muscular dystrophy fibrosis cardiovascular disease osteoarthritis Collagen VI assembles heterotrimers three different αchains microfibrils many gap knowledge molecular assembly process Here determine structure heterotrimeric minicollagen VI construct collagen VI microfibrils mammalian tissue using cryogenicelectron microscopy structure reveal cysteinerich coiled coil region involved trimerisation well microfibril assembly Furthermore structure show pathogenic mutation located interaction site involved different step collagen VI assembly trimericcoiled coil region mediates heterotrimerisation cluster mutation triplehelical region involved microfibril formation microfibril structure provides template understanding supramolecular assembly offer platform rationale design therapeutic collagen VI pathologies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813585/"
    },
    {
        "pmid": "40813376",
        "title": "Hypertrophic cardiomyopathy.",
        "abstract": "Hypertrophic cardiomyopathy HCM common inherited cardiomyopathy represents leading cause morbidity mortality HCM sarcomeric disease characterized genetically determined defect sarcomere proteins leading left ventricular hypertrophy hypercontractility diastolic dysfunction phenotypic spectrum disease heterogeneous ranging mild form remain stable asymptomatic many years childhoodonset severe case result progressive heart failure ventricular arrhythmias Multiimaging technique including echocardiography cardiac magnetic resonance pivotal diagnostic prognostic assessment HCM decades therapeutic approach limited invasive septal reduction therapy nonspecific pharmacological treatment heart failure last 10 years however indepth understanding pathological mechanism HCM led development targeted therapies myosin inhibitors proven safe effective improving functional capacity reducing symptoms Innovative therapeutic approaches gene therapy aim target genetic variant underpinning condition currently investigation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813376/"
    },
    {
        "pmid": "40813346",
        "title": "BODIPY-based fluorescent probes distinguish the heterogeneity of lipid droplets in carotid and femoral atherosclerotic plaques.",
        "abstract": "Atherosclerosis AS complex longterm disease major contributor cardiovascular complication leading cause death across globe Lipid droplet LDs closely involved initiation development plaques Therefore visualization quantification complexity LDs may assist understanding biology atherosclerotic plaque assessing lesion stability study report lipophilic fluorescent sensor based BODIPY scaffold iPi1  iPi2 probe exhibited fluorescence responsiveness oilwater system lipid droplet mimic LDMs detection limit low 50 μg mLsup1sup cellular milieu probe effectively tracked LD accumulation induced oxidized lowdensity lipoprotein oxLDL well lipid suppression caused treatment rosiglitazone iEx vivoi imaging atherosclerotic plaque ApoEsupsup mouse human tissue demonstrated probe could distinguish pathological characteristic across various vascular regions Collectively result highlight first application LD sensor sensing distinct lipidic lesion biopsied atherosclerotic plaque patients suggesting organspecific pathogenesis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813346/"
    },
    {
        "pmid": "40813122",
        "title": "Medications for adults with type 2 diabetes: a living systematic review and network meta-analysis.",
        "abstract": "provide uptodate evidence key benefits harms uncertainty regarding medication adult type 2 diabetes Living systematic review network metaanalysis NMA using frequentist random effect GRADE grading recommendations assessment development evaluation approaches Updates planned least two time year Medline Embase searched 31 July 2024 current iteration Randomised controlled trial least 24 week comparing one medication standard treatment placebo other systematic review NMA includes 493 168 participant 869 trial adding 53 trial since October 2022 reporting data 13 drug class 63 drugs 26 outcome interest Regarding benefits moderate high certainty evidence confirms well established cardiovascular kidney benefit sodiumglucose cotransporter2 SGLT2 inhibitors glucagonlike peptide1 receptor agonist GLP1RAs finerenone the last patient established chronic kidney disease effective drug reducing body weight tirzepatide mean difference MD 863 kg 95 confidence interval 934 793 moderate certainty orforglipron MD 787 kg 1024 550 low certainty followed eight GLP1RAs high moderate certainty Absolute benefit medication vary substantially depending baseline risk cardiovascular kidney outcomes riskstratified absolute effect medication summarised using interactive multiple comparison tool httpsmatchitmagicevidenceorg250709distdiabetes Regarding medicationspecific harms SGLT2 inhibitor increase genital infection odds ratio OR 329 95 CI 288 377 high certainty ketoacidosis due diabetes OR 208 145 299 high certainty probably increase amputation OR 127 101 161 moderate certainty tirzepatide GLP1RAs probably increase severe gastrointestinal event most increased risk tirzepatide OR 421 187 949 moderate certainty finerenone increase severe hyperkalaemia OR 592 302 1162 high certainty thiazolidinediones increase major osteoporotic fracture probably increase hospitalisation heart failure Sulfonylureas insulin dipeptidyl peptidase4 inhibitor probably increase risk severe hypoglycaemia low low certainty evidence effect diabetesrelated complications including neuropathy visual impairment Despite interest issue uncertainty whether GLP1RAs may reduce dementia OR 092 083 102 low certainty living systematic review provides comprehensive summary cardiovascular kidney weight loss benefits well medicationspecific harm medication adult type 2 diabetes including effect SGLT2 inhibitors GLP1RAs finerenone tirzepatide PROSPERO number CRD42022325948 detailed protocol available httpsdataaliveevidenceorgrecordsq02rvkm486 article first version living systematic review linked living iBMJi Rapid Recommendation living clinical practice guidelines presenting risk stratified recommendation patient type 2 diabetes lower moderate higher risk cardiovascular kidney complications latest evidence made available via iBMJi Rapid Recommendation via interactive GRADE evidence summary MATCHIT httpsmatchitmagicevidenceorg250709distdiabetes Major update published iThe BMJi",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813122/"
    },
    {
        "pmid": "40813103",
        "title": "Process for mainstreaming genetic cascade testing into primary and tertiary health systems in familial hypercholesterolaemia (FH), an autosomal dominant, fully penetrant disorder.",
        "abstract": "Advances clinical genomics raised importance integrating genomic medicine across healthcare systems including primary care Primary care present ideal environment offer equitable efficient access genetic services Familial hypercholesterolaemia FH preventable treatable cause premature heart disease represents health condition successfully diagnosed managed primary care study describes process tailoring primarytertiary shared care model FH optimise health professional patient engagement Data collected semistructured interview n10 stakeholder New South Wales Australia Interviews gathered feedback tailor shared care model FH tertiary primary care services Reflexive thematic analysis used analyse interview transcripts Analysis generated three main themes 1 current process genetic testing management 2 challenge genetic testing FH primary care 3 component needed enable tertiaryinitiated shared care model Participants considered model care acceptable could successfully implemented provided key support place assist general practitioners Based results process model integrating genetic testing condition primary care setting developed using FH exemplar process model tailoring primarytertiary model care FH applied across range primary care service treatable genetic conditions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813103/"
    },
    {
        "pmid": "40812783",
        "title": "Common Predictors of Return To Work across Cardiovascular Diseases.",
        "abstract": "Return work RTW cardiovascular disease CVDs crucial mitigating societal economic burden productivity losses review review explores common diseasespecific predictor RTW within framework International Classification Functioning Disability Health ICF systematic review systematic review conducted identify common diseasespecific predictor RTW individual cardiovascular disease CVDs including acute coronary syndrome ACS chronic coronary artery disease CCAD heart failure HF stroke Predictors analysed across contextual domain personal environmental factors functional domain body structure body function activities participation methodological quality included review evaluated using AMSTAR2 tool total 28 review included Key common predictor included functional capacity psychological wellbeing work characteristic social support diseasespecific predictor involved severity disease treatment characteristics Modifiable factors workplace accommodation psychological challenges identified critical target intervention Early identification atrisk individual integration personalized rehabilitation strategy critical improving RTW outcome healthrelated quality life review enhances understanding RTW predictors contributing optimized rehabilitation process reduced economic burden associated CVDs Future research investigate clinical applicability finding explore broader application common RTW predictor across chronic conditions inform vocational reintegration strategies Word count 238",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812783/"
    },
    {
        "pmid": "40812673",
        "title": "Lysine β-Hydroxybutyrylation in Metabolic Plasticity and Disease Pathogenesis.",
        "abstract": "Lysine βhydroxybutyrylation Kbhb represents novel posttranslational modification PTM mediated ketone body metabolites particularly βhydroxybutyric acid BHB modification exhibit dynamic elevation ketogenic condition including diabetic ketoacidosis neonatal metabolic disorders fasting sustained physical exertion circulating BHB concentration exceed physiological thresholds Emerging evidence position Kbhb critical epigeneticmetabolic interface demonstrated regulatory role spanning oncology immunomodulation cardiovascular homeostasis neuropsychiatric disorders circadian biology developmental processes Mechanistically Kbhb affect metabolic plasticity modulating structural modification key metabolic enzyme well metabolic flux addition Kbhb exerts pleiotropic effect via competitive interplay canonical PTMs acetylation methylation critical lysine residues Kbhbinduced epigenomic reorganization enhancerpromoter domain enrichment facilitates transcriptional activation functional gene mediates transcriptional network progression multiple diseases review systematically examines discovery timeline enzymatic machinery governing Kbhb dynamic writerserasersreaders molecular mechanism underlying pathophysiological functions therapeutic implication across disease states elucidation Kbhbinduced metabolic signaling paradigm molecular interface catalyzes development innovative therapeutic strategy across multiple diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812673/"
    },
    {
        "pmid": "40812670",
        "title": "Telomere-targeted medicine: Bridging molecular mechanisms and clinical applications in age-related diseases.",
        "abstract": "Telomeres nucleoprotein structure end chromosomes emerged critical regulator cellular aging key contributor pathogenesis agerelated diseases comprehensive review examines evolution telomere biology fundamental research therapeutic applications analyzing molecular mechanism telomere dysfunction across diverse disease categories including autoimmune disorders cardiovascular diseases neurodegeneration respiratory diseases metabolic disorders chronic kidney disease cancer premature aging syndromes explore current therapeutic strategy ranging telomerase modulation senolytic approaches highlighting emerging technology drug discovery including CRISPRbased interventions nanomedicine mRNAbased therapies partial cellular reprogramming artificial intelligence applications convergence mechanistic understanding innovative therapeutic approach position telomere biology promising frontier addressing multiple agerelated condition simultaneously potentially shifting medicine reactive disease treatment toward proactive agingfocused prevention However significant challenge remain including safety considerations biomarker development establishing regulatory framework agingtargeted therapeutics success telomeretargeted intervention could herald paradigm shift toward gerosciencebased medicine extending lifespan health span targeting fundamental biological aging processes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812670/"
    },
    {
        "pmid": "40811499",
        "title": "Insomnia Phenotypes, Cardiovascular Risk and Their Link to Brain Health.",
        "abstract": "30 40 general population experience insomnia symptom difficulty initiating maintaining sleep another 10 15 general population experience chronic insomnia disorder prevalence insomnia disproportionately higher people cardiometabolic risk factors cardiovascular diseases cerebrovascular diseases neurocognitive disorders including vascular cognitive impairment fact recent metaanalytic evidence epidemiological study demonstrated insomnia especially accompanied objective short sleep duration risk factor incident hypertension type 2 diabetes heart failure stroke cognitive impairment Alzheimer disease allcause mortality Insomnia should thus part prevention management adverse health outcomes However randomized clinical trial demonstrated whether treatment cognitivebehavioral therapy insomnia firstline guidelinerecommended treatment hypnoticssedatives improves heart brainrelated outcomes Studies also failed consider insomnia heterogeneous disorder consisting distinct phenotype result relative contribution biological versus cognitivebehavioral perpetuating factors Objective short sleep duration emerged marker physiological hyperarousal insomnia ie dysregulation hypothalamicpituitary axis increased sympathetic nervous system activation increased inflammation predictor insomniarelated adverse heart brain health outcome and potentially poor response cognitivebehavioral therapy insomnia review summarizes metaanalytic evidence association insomnia cardiometabolic risk factors cardiovascular diseases cerebrovascular diseases neurocognitive disorders including current knowledge heterogeneity disorder review also summarizes potential pathophysiologic mechanism lead heart brain morbidity vary across insomnia phenotype based objective sleep duration review suggests basic clinical science need unveil molecular cellular behavioral mechanism play across insomnia phenotypes public health clinical implication association adverse heart brain health demanding immediate attention",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811499/"
    },
    {
        "pmid": "40811451",
        "title": "Omnipresent intercorrelations of metabolic syndrome markers in the general population.",
        "abstract": "Besides usual characterization metabolic syndrome cluster marker arbitrarily defined thresholds unclear extent marker continuous trait correlated general population present study aimed explore correlation across wide array biological social behavioral characteristics crosssectional analysis performed large populationbased French cohort CONSTANCES 159476 adult blood glucose lowdensity lipoprotein LDL highdensity lipoprotein HDL triglycerides body mass index waist hip circumferences systolic diastolic blood pressure measured time recruitment 2012 2021 Correlations pair continuous marker distribution assessed calculating raw partial correlation coefficient r pattern partial correlation observed little variation group sex age individual parental history cardiovascular disease diagnosis metabolic syndrome social position work environment lifetime unemployment exposure smoking nonmoderate alcohol consumption leisuretime physical inactivity diet quality pattern composed strong expected intercorrelations systolic diastolic blood pressure r ranging 062 074 body mass index waist r 050 063 hip r 058 070 circumference waist hip circumference r 007 019 also includes intercorrelations systolic blood pressure waist r 010 021 hip r 007 012 circumference blood glucose r 009 015 triglyceride blood glucose r 007 016 LDL r 024 033 HDL r 020 029 waist circumference r 007 015 finally waist hip circumference blood glucose r 009 017 008 013 HDL r 012 024 008 018 result show metabolic syndrome marker correlated whatever biological social behavioral characteristic individuals suggest make sense systematically consider marker together rather separately term etiology prevention treatment metabolic disease cardiovascular risk general population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811451/"
    },
    {
        "pmid": "40810971",
        "title": "WINFOCUS worldwide survey on central venous catheter insertion and position confirmation practices (CVC-ICON study).",
        "abstract": "Central venous catheter CVC essential medicine monitoring drug fluid administration renal replacement therapy Complications arrhythmias endothelial damage thrombosis hemothorax might arise incorrect positioning Despite evidence showing reduction using ultrasound guide insertion correct tip positioning greater accuracy tip position assessment vs chestXray CXR ultrasound adoption greatly varies worldwide study conducted World Interactive Network Focused Critical Ultrasound WINFOCUS aimed assess global practice CVC insertion tip position confirmation webbased survey conducted AprilSeptember 2023 among WINFOCUS membersaffiliates across five continents assessed clinical backgrounds CVC insertion tip position check methods reason using ultrasound Developed WINFOCUS Research subcommittee survey emailed two reminders Data analyzed using SPSS 270 total 1227 respondent 51 response rate participated mainly Europe 335 Asia 283 Americas 309 954 physicians half 513 six year experience placed 200 CVC mostly using ultrasound guidance 70 cases internal jugular vein IJV preferred insertion site 74 Ultrasound used preinsertion assessment 55 vessel puncture 57 less guidewire confirmation 44 CXR remained primary method tip position assessment 52 12 relied solely bedside ultrasound Barriers exclusive ultrasound use included institutional guideline 339 medicolegal concern 138 Despite evidence favoring ultrasound CVC insertion tip position confirmation use remains inconsistent CXR still widely used survey underscore need standardized protocol training enhance US adoption improve patient safety reduce CXR reliance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810971/"
    },
    {
        "pmid": "40810653",
        "title": "Type 2 Diabetes-Associated Phenylacetylglutamine Induces Deleterious Inflammation Cycle in Myeloid Cells through β<sub>2</sub> Adrenergic Receptors and Impedes Wound Healing.",
        "abstract": "Despite advance glucoselowering therapies many diabetic patient still suffer inflammationrelated complication chronic nonhealing wounds microbiotaderived metabolite phenylacetylglutamine PAGln identified causal driver wound via transmissible βsub2subadrenergic receptormediated trainedimmunity loop Metabolomics reveals PAGln elevated type 2 diabetes tightly associated poor healing diabetic nondiabetic human patients Pharmacokinetic comparison show mouse PAGln exposure closely match concentration kinetics seen humans validated PAGln delay wound closure impairs collagen restoration reduces neovascularization wildtype T1DM T2DM micedefects rescued βblocker treatment Mechanistically PAGln epigenetically train myeloid cell via βsub2subadrenergic receptors promoting hyperresponsiveness heightening systemic inflammation epigenetic reprogramming extends HSCs expanding hyperresponsive myeloid cell sustaining myeloidbiased inflammatory loop PAGlninduced hyperinflammatory woundhealing deficit transmissible via bone marrow transplantation irradiated naïve recipients confirming PAGlntrained hematopoietic cell propagate deleterious phenotypes βblockers cotreatment revers PAGlninduced cytokine elevation woundhealing deficits finding link dietderived microbial metabolite PAGln chronic wound inflammation T2DM PAArelated clinical condition highlight βblockade readily translatable therapy disrupt PAGlndriven deleterious inflammation cycle",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810653/"
    },
    {
        "pmid": "40810352",
        "title": "From sex hormone decrease to hormonal treatment: impacts on cardiovascular risk with ageing.",
        "abstract": "Ageing play critical role deterioration artery function structure clearly represents first cardiovascular CV risk factor men also women Coronary cerebral artery particularly prone atheroma tissue perfuse particularly vulnerable ischaemia sexes agerelated decrease sex hormone menopause andropause deleterious effect CV health extent hormonal supplementation limit CV risk increased ageing remains controversial Women Health Initiative study main clinical intervention designed evaluate benefitrisk ratio hormone treatment menopause revealed 2002 unexpected increase CV event aged woman 70 years given estrogen plus peculiar synthetic progestin medroxyprogesterone acetate whereas estrogen alone harmful even protective younger woman 60 years pointed double problem progestin now natural progesterone preferred age clinical situation yet clear testosterone CV disease men Related questions analyse summarize i importance dos concentration estrogen testosterone human experimental models allowing define relevantphysiological pharmacological action sex hormone respect medical modulation practice ii main clinical study conducted estrogen androgens term CV protection impact age effects iii mechanism underlying actions iv genderaffirming hormone therapy sex hormone cornerstone gender transition care management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810352/"
    },
    {
        "pmid": "40810307",
        "title": "Artificial Intelligence based fractional flow reserve.",
        "abstract": "Fractional flow reserve FFR  physiological indicator coronary stenosis significance  become widely used parameter also guidance percutaneous coronary intervention PCI Several study shown superiority FFR compared visual assessment contributing reduction clinical endpoints However current approach FFR assessment requires coronary instrumentation dedicated pressure wire thus increasing invasiveness cost duration procedure Alternative noninvasive method FFR assessment based computational fluid dynamic widely tested approach generally fully automated may sometimes require substantial computational power Nowadays one rapidly expanding field medicine use artificial intelligence AI therapy optimization diagnosis treatment risk stratification AI usage contributes development sophisticated method imaging analysis allows derivation clinically important parameter faster accurate way recent years AI utility deriving FFR noninvasive manner increasingly reported review critically summarize current knowledge field AIderived FFR based data computed tomography angiography invasive angiography optical coherence tomography intravascular ultrasound Available solutions possible future direction optimizing cathlab performance including use mixed reality well current limitation standing behind wide adoption techniques overviewed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810307/"
    },
    {
        "pmid": "40810163",
        "title": "Cardioprotective Potential of ApoE-Derived Peptide (ApoEFrag) in Myocardial Infarction in Rats: A Mechanistic Study.",
        "abstract": "Cardiovascular disease CVDs leading cause death among noncommunicable disease globally Myocardial infarction MI one significant CVDs resulting acute chronic myocardial ischemia lead irreversible damage Despite substantial burden posed conditions specific treatment remain limited symptomatic management ApoEFrag shown protective CNS However cardioprotective potential ApoEmimetic investigated Thus study investigates cardioprotective potential ApoEFrag novel ApoEmimetic peptide acute MI model rats MI induced rat two dos isoproterenol 100 mgkg via subcutaneous injection administered 24 h apart ApoEFrag given dos 05 1 mgkg ISOtreated rats Following treatment measured electrocardiogram ECG change arterial ventricular pressure function using PVloop system Plasma heart sample collected biochemical assessments including plasma injury markers hypertrophic index parameters inflammatory markers geneprotein expression analysis histopathological studies ISOinduced MI resulted alteration ECG patterns ventricular dysfunction increased fibrosis elevated hypertrophic index parameters Additionally ISO administration led increased inflammatory marker oxidative stress levels reversed ApoEFrag treatment Furthermore ApoEFrag significantly ameliorated cardiac injury inflammation hypertrophic index parameters ECG alterations ventricular dysfunction cardiac fibrosis ISOinduced MI models Notably ApoEFrag also improved mitochondrial health study suggests ApoEFrag significant cardioprotective potential acute myocardial infarction model",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810163/"
    },
    {
        "pmid": "40810152",
        "title": "Exploring Phosphatase and Tensin Homologue Deleted on Chromosome Ten (PTEN) as a Potential Therapeutic Target for Cardiac Hypertrophy.",
        "abstract": "cardiovascular disease continue foremost cause death worldwide heart failure constitutes major segment responsible mortalities Heart failure result exhausted cardiac myocytes lose ability pump blood effectively Cardiac hypertrophy condition heart wherein thickening cardiomyocytes lead abnormal enlargement myocardium PI3KAKTmTOR signaling pathway play pivotal role development cardiac hypertrophy regulating cell growth proliferation metabolism survival cardiac myocytes phosphatase tensin homologue deleted chromosome ten PTEN membranebound lipid phosphatase facilitates dephosphorylation PIP3 PIP2 thus preventing hyperactivation PI3KAKTmTOR signaling pathway Augmentation PTEN expression activity hinder cardiac hypertrophy mitigate risk heart failure present review discusses role PTEN controlling unchecked cardiomyocyte proliferation provides account novel finding current research noncoding RNAs protein interacting PTEN review discusses pharmacological agent restore PTEN expression function may emerge effective therapeutic treatment cardiac hypertrophy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810152/"
    },
    {
        "pmid": "40810106",
        "title": "Attributable burden of steatotic liver disease on cardiovascular outcomes in Asia.",
        "abstract": "association metabolic dysfunctionassociated steatotic liver disease MASLD specific cardiovascular events well attributable burdens remain inconsistent underexplored within single population largescale prospective cohort evaluated association MASLD various cardiovascular outcomes Two additional steatotic liver disease SLD subtypes  MASLD increased alcohol consumption MetALD alcoholrelated liver disease ALD  also evaluated included 303589 adult aged ≥30 year Taiwan underwent health examination 1997 2013 MASLD defined ultrasounddetected steatosis limited alcohol intake ≥1 cardiometabolic risk factor MetALD ALD defined based alcohol intake threshold cardiometabolic profiles Participants followed 2020 outcome mortality ascertained via linkage national registries Cox proportional hazard model used estimate adjusted relative risk RRs population attributable fraction PAFs calculated total population 91877 303 MASLD 7490 25 MetALD 5576 18 ALD 198646 654 SLD median followup 104 years 162959 cardiovascular event occurred adjusted RR cardiovascular disease 129 95 CI 138131 MASLD 138 95 CI 134142 MetALD 148 95 CI 143153 ALD Among SLD subtypes MASLD showed highest RR myocardial infarction RR 146 95 CI 136156 Findings remained consistent accounting liverrelated deaths PAF MASLD 807 95 CI 781858 Despite higher risks MetALD ALD lower PAFs due lower prevalence major SLD subtypes  MASLD MetALD ALD  associated increased longterm cardiovascular risk underscoring need early detection cardiometabolic risk management across SLD spectrum largescale study 303589 individual demonstrates metabolic dysfunctionassociated steatotic liver disease MASLD increase risk cardiovascular disease least 29 Cardiovascular risk escalates across SLD subtypes higher level alcohol consumption Notably MASLD associated highest risk myocardial infarction among SLD subtypes quantifying population burden found 807 cardiovascular event may preventable effective MASLD prevention strategies highlighting critical role cardiometabolic risk management finding emphasize need integrate MASLD identification prevention broader cardiometabolic care public health frameworks applicable",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810106/"
    },
    {
        "pmid": "40809958",
        "title": "Emerging roles of tsRNAs in programmed cell death and disease therapeutics: challenges, opportunities, and future directions.",
        "abstract": "Programmed cell death PCD includes various form apoptosis autophagy necroptosis pyroptosis ferroptosis play pivotal role disease pathogenesis progression tRNAderived small RNAs tsRNAs emerged crucial regulator processes influencing cellular fate disease outcomes Research revealed diverse expression profile tsRNAs across various diseases emphasizing role modulating PCD pathway potential value diagnosis treatment Specific tsRNAs either promote inhibit apoptosis example tsRNA3043a promotes ovarian granulosa cell apoptosis premature ovarian insufficiency whereas tsRNA04002 prevents apoptosis nucleus pulposus cell delay intervertebral disc degeneration Furthermore tsRNAs serve potential biomarkers early disease detection emerging detection technology enhancing clinical utility Therapeutically tsRNAtargeted strategies RNA interference exosomebased drug delivery offer new avenue modulating PCD disease cancer cardiovascular disorders neurodegenerative diseases Despite challenge understanding tsRNA biogenesis functional diversity role regulating PCD highlight strong potential advancing disease diagnostics treatment strategies personalized medicine",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809958/"
    },
    {
        "pmid": "40809950",
        "title": "Concurrent Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patient Treated With Daratumumab and Tafamidis: A Case Report.",
        "abstract": "Immunoglobulin light chain AL wildtype transthyretin ATTRwt amyloidosis sharing similar clinical presentations require distinct treatments report rare case 75yearold man heart failure diagnosed concurrent AL ATTRwt cardiac amyloidosis Immunohistochemistry liquid chromatographytandem mass spectrometry confirmed AL ATTR amyloid deposit heart patient safely effectively treated daratumumabbased chemotherapy followed tafamidis case underscore necessity precise amyloid typing tailored therapy suggesting sequential daratumumab tafamidis viable strategy complex overlap bTrial Registrationb author confirmed clinical trial registration needed submission",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809950/"
    },
    {
        "pmid": "40809732",
        "title": "Clinical Significance of Serum Total Testosterone Concentration in Japanese Elderly Women With Pre-Heart Failure With Preserved Ejection Fraction.",
        "abstract": "Currently limited information available regarding testosterone woman heart failure preserved ejection fraction HFpEF crosssectional study aimed elucidate clinical significance serum total testosterone concentration TT Japanese elderly woman preHFpEF condition develops onset HF total 232 elderly woman outpatient preHFpEF mean age ± standard deviation 75 ± 7 years enrolled Relationships TT clinical parameter investigated definition preHFpEF study patient left ventricular ejection fraction 50 Ee ratio marker left ventricular function greater 9 echocardiography HF symptom history HF hospitalization significantly negative correlation TT Ee ratio r  024 P  0001 low TT significantly related coronary artery disease significant correlation observed TT biomarkers blood brain natriuretic peptide concentration r  031 P  0001 serum highsensitivity cardiac troponin concentration r  033 P  0001 derivativesreactive oxygen metabolite test oxidative stress marker r  046 P  0001 Furthermore multiple regression analysis identified factor described selected independent variable TT dependent variable crosssectional study indicated low TT level reflect unfavorable pathophysiological condition Japanese elderly woman preHFpEF clarify relevance TT predictive indicator onset cardiovascular diseases including HF incidence elderly woman preHFpEF future prospective studies including interventional treatments conducted",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809732/"
    },
    {
        "pmid": "40809699",
        "title": "A Common Genetic Background for Psoriasis and Cardiovascular Diseases: A Narrative Review.",
        "abstract": "Psoriasis immunemediated disease affecting primarily skin joints also systemic implications assumption common genetic background psoriasis cardiovascular diseases narrative review aim provide overview existing data regarding IL23 rs2066808 IL23R rs2201841 IL17RA rs4819554 IL17A rs2275913 polymorphism link psoriasis cardiovascular diseases PubMed Web Science Scopus SNPedia search conducted identify relevant study 2007 2025 investigated association psoriasis cardiovascular diseases IL23 rs2066808 IL23R rs2201841 IL17RA rs4819554 IL17A rs2275913 polymorphisms existing data conflicting polymorphism could implicated psoriasis onset disease susceptibility treatment response also linked coronary artery disease Contradictory data could result heterogeneity population included study laboratory technique used polymorphism determination interplay IL17 IL23 genetic polymorphism illustrates complex landscape psoriasis associated comorbidities standardized casecontrol study needed confirm hypothesis Moreover extensive study diverse population would important clarify relationship potential implication treatment management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809699/"
    },
    {
        "pmid": "40809444",
        "title": "Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry.",
        "abstract": "detect factor capable predicting development macular edema ME throughout disease course patient affected noninfectious uveitis NIU Predictive factor leading development analyzed regression analysis functional impact best corrected visual acuity BCVA also examined total 1160 NIU patient 1857 eyes analyzed observed 148 1276 affecting 211 eyes significantly frequent patient nonanterior NIU ipi  00001 RR  401 retinal vasculitis ipi  00001 structural complication ipi  00005 Gender HLAB27 andor HLAB51 positivity ethnicity show significant impact prevalence ipi  0635 ipi  0372 ipi  0193 respectively Four variable associated development NIU course nonanterior anatomical pattern ipi  00001  401 presence retinal vasculitis ipi  0028  168 complication ipi  0044  151 immunosuppressive treatment ipi  0010 169 diagnosis Behçet diseaserelated uveitis less likely associated development ipi  024 0545 Mean ± SD BCVA significantly lower eye 082 ± 030 compared eye without 071 ± 033 develop across NIU types likely case involving posterior segment retinal vasculitis Regular focused monitoring recommended highrisk patients study also highlight limited predictive value demographic HLArelated factors helping refine clinical risk stratification predictive modeling NIU",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809444/"
    },
    {
        "pmid": "40809152",
        "title": "Prevalence and Pathogenetic Mechanisms of Chronic Kidney Disease in Autoimmune-Mediated Systemic Diseases.",
        "abstract": "Chronic kidney disease CKD affect estimated 15 adult Central Europe affected high risk cardiovascular disease death Inflammatory rheumatic systemic disease manifest extraarticularly varying frequency article summarized prevalence pathogenetic mechanism CKD rheumatic systemic diseases following database searched references PubMed Web Science Cochrane Library Scopus search period spanned 1975 2025 Kidney involvement almost always present systemic lupus erythematosus certain type systemic vasculitis context rheumatic diseases additional mechanism contribute enhancing functional structural integrity kidneys mechanism include inflammation increase cardiovascular risk prevalence CKD disproportionately high certain entity rheumatic form Given disproportionately high prevalence CKD relevant entity inflammatory rheumatic group associated increase risk cardiovascular disease death CKD screening integral part care affected patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809152/"
    },
    {
        "pmid": "40808951",
        "title": "Transcriptional responses in different mouse models of septic liver injury differ from those in patients with septic liver injury.",
        "abstract": "Sepsis particularly sepsisinduced liver injury SLI exhibit acute onset high mortality up 80 murine model widely used mechanistic study due limited human sample availability accuracy replicating human SLI pathophysiology remains debated Human SLI transcriptomes characterized identify core gene immune signature using Venn analysis immune infiltration profiling Transcriptomic feature two murine SLI modelscecal ligation puncture CLP lipopolysaccharide LPS challengewere benchmarked human SLI evaluate pathophysiological relevance model utilized validate core gene expression SLI biomarker identification Human SLI transcriptomics revealed significant enrichment apoptotic processes NFκB regulation inflammatory responses protein phosphorylation bacterial response Key pathway included IL17 signaling antigen processing estrogen signaling atherosclerosis Immune infiltration confirmed multifactorial immune cell involvement murine model recapitulated inflammatory immune responses LPS model mimicking human SLI via chemotaxis phagocytosis NODlike receptor signaling leukocyte migration CLP model uniquely replicated neutrophil chemotaxis apoptosis ER stress IL17 TNF signaling SOCS3 validated potential SLI biomarker Murine model partially replicate human SLI pathology exhibit distinct mechanistic emphases Careful model selection essential biomarker discovery eg SOCS3 pathogenic mechanism exploration highlighting inherent model limitations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808951/"
    },
    {
        "pmid": "40808542",
        "title": "Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF.",
        "abstract": "Guidelinerecommended medical therapy GRMT improves outcome heart failure HF reduced ejection fraction HFrEF yet implementation remains suboptimal TITRATEHF prospectively evaluated GRMT implementation across different HFrEF stages effect 1year prognosis left ventricular ejection fraction LVEF TITRATEHF observational cohort study across 48 hospital Netherlands June 2022February 2024 total 4288 patient enrolled primary analysis includes 12month followup data HFrEF patient n  3367 stratified de novo chronic worsening HF Longitudinal trend GRMT prescription rate dosage analysed Serial echocardiographic data assessed change LVEF baseline 12 months KaplanMeier analysis assessed composite endpoint allcause death HF hospitalization Median age 71 year interquartile range IQR 6378 29 female 56 nonischaemic cardiomyopathy de novo HFrEF n  1353 quadruple therapy 472 6 weeks 647 3 months 695 6 months 644 12 months chronicworsening HFrEF n  1625 quadruple therapy increased 446 baseline 546 12 months primarily driven greater sodiumglucose cotransporter 2 inhibitor uptake 660 785 Among de novo HFrEF patient serial echocardiogram n  752 median LVEF improved 10 IQR 317 ischaemic versus 15 IQR 924 nonischaemic cardiomyopathy p  0001 Early quadruple GRMT initiation within 6 weeks higher 6month dos associated greater LVEF improvement 12 months composite endpoint occurred 133 133 438 de novo chronic worsening HFrEF patients respectively finding highlight importance early intensive GRMT implementation emphasize need continuous dose titration beyond initial phase improve LVEF clinical outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808542/"
    },
    {
        "pmid": "40807750",
        "title": "Advancements in Sensor Technology for Monitoring and Management of Chronic Coronary Syndrome.",
        "abstract": "Chronic Coronary Syndrome CCS significantly impact quality life increase risk adverse cardiovascular events remaining leading cause mortality worldwide use sensor technology medicine emerging promising approach enhance management monitoring patient across wide range diseases Recent advancement engineering nanotechnology enabled development ultrasmall device capable collecting data critical physiological parameters Several sensor integrated wearable implantable devices instrument exhaled gas analysis smart stent tool capable real time biochemical analysis developed demonstrated effective CCS management application CCS could provide valuable insight disease progression ischemic events patient response therapy Moreover sensor technology support personalization treatment plans enable early detection disease exacerbations facilitate prompt interventions potentially reducing need frequent hospital visit unnecessary invasive diagnostic procedure coronary angiography review explores sensor integration CCS care highlighting technological advances clinical potential implementation challenges",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40807750/"
    },
    {
        "pmid": "40807193",
        "title": "Obstructive Sleep Apnea and Type 2 Diabetes: An Update.",
        "abstract": "Obstructive sleep apnea OSA syndrome severe debilitating pervasive sleep disorder OSA mainly affect people obesity type 2 diabetes mellitus T2DM hypertension dyslipidemia strongly associated cardiovascular complications Based bidirectional relationship T2DM OSA latter represents risk factor former and vice versa people T2DM high risk OSA Mechanical hormonal factors inflammatory mediators dysregulated autonomic nervous system contribute mechanism underlying disease Treatment OSA necessary even available remedy always effective addition traditional treatments including lifestyle adaptation bariatric surgery CPAP equipment ie breathing device ensuring continuous positive pressure keep airway open sleep represents common treatment tool recently pharmacological research paved way newer seemingly effective therapeutic strategy involving particular two hypoglycemic agent classes ie sodiumglucose cotransporter 2 inhibitor SGLT2is glucagonlike peptide1 GLP1 receptor agonist GLP1ras narrative review provides update above",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40807193/"
    },
    {
        "pmid": "40807063",
        "title": "The Role of Obstructive Sleep Apnea in Pulmonary Hypertension Associated with Lung Diseases (Group 3 Pulmonary Hypertension): A Narrative Review.",
        "abstract": "Obstructive sleep apnea OSA could increase pulmonary artery pressure However clinical consequence vary mainly depending comorbidities Patients pulmonary hypertension associated lung disease World Health Organization WHO Group 3 pulmonary hypertension particularly vulnerable increase pulmonary artery pressure Managing pulmonary hypertension specific patient population present considerable challenge positive airway pressure therapy OSA shown promise improving pulmonary hemodynamics patient obesity hypoventilation syndrome chronic obstructive pulmonary disease evidence lacking similar improvement pulmonary disease hypoventilation disorders Furthermore pulmonaryarteryspecific therapy may carry risk clinical worsening group Weight management new pharmacotherapy together emerged crucial intervention demonstrating benefit OSA pulmonary hemodynamics reviewed key study provide insight influence OSA Group 3 pulmonary hypertension clinical management conditions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40807063/"
    },
    {
        "pmid": "40807057",
        "title": "A Critical Appraisal of Off-Label Use and Repurposing of Statins for Non-Cardiovascular Indications: A Systematic Mini-Update and Regulatory Analysis.",
        "abstract": "bBackgroundb Statins exhibit pleiotropic antiinflammatory antioxidant immunomodulatory effects suggesting potential noncardiovascular conditions However evidence supporting repurposing remains limited offlabel prescribing policy vary globally bObjectiveb systematically review evidence statin repurposing oncology infectious diseases assess Hungarian regulatory practice regarding offlabel statin use bMethodsb systematic literature search PubMed Web Science Scopus ScienceDirect 2010May 2025 conducted using term drug repositioning offlabel prescription statin cardiovascular following PRISMA guidelines Hungarian offlabel usage data NNGYK 20082025 also analyzed bResultsb 205 publications 12 met inclusion criteria75 oncologyfocused 25 focused infectious diseases preclinical 58 25 offered strong clinical evidence Applications included hematologic malignancies solid tumors Cryptococcus neoformans SARSCoV2 dengue virus Mechanisms involved mevalonate pathway inhibition modulation host immune responses Hungarian data revealed five approved offlabel statin usesthree dermatologic two pediatric metabolicsupported literature requiring posttreatment reporting bConclusionsb preclinical finding promising clinical validation offlabel statin use remains limited Statins continued cancer patient cardiovascular indications initiation purpose trialbased Future direction include biomarkerbased personalization regulatory harmonization costeffectiveness studies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40807057/"
    },
    {
        "pmid": "40806978",
        "title": "Non-Invasive Positive Pressure Ventilation for Pre-Oxygenation of Critically Ill Patients Before Intubation.",
        "abstract": "Preoxygenation key step prior endotracheal intubation particularly critically ill patient prevent lifethreatening periprocedural hypoxemia narrative review explores emerging interest NonInvasive Positive Pressure Ventilation NIPPV preoxygenation modality intensive care unit ICU context reviewed data randomized controlled trial RCTs observational study published 2000 2024 compare NIPPV conventional oxygen therapy High Flow Nasal Cannula Oxygen HFNCO pathophysiological mechanism successful use NIPPV including alveolar recruitment decrease shunting maintenance functional residual capacity reviewed depth Existing study show NIPPV significantly prolongs apnea time reduces rate periintubation severe hypoxaemia selected patient especially effective patient acute hypoxaemic respiratory failure Nevertheless appropriate patient selection still crucial disease contraindicate even harmful NIPPV discussed practical aspect use ventilatory support the best ventilator settings interface apply it lastly discus unanswered question offer suggestion opportunity future exploration guiding role NIPPV use preoxygenation critically ill patient requiring emergent airway management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806978/"
    },
    {
        "pmid": "40806975",
        "title": "A Comprehensive Review of a Mechanism-Based Ventricular Electrical Storm Management.",
        "abstract": "electrical ventricular storm VES defined multiple sustained ventricular arrhythmia arising short time often refractory standard antiarrhythmic treatment three pillar physiopathogenesis VES autonomic dysfunction triggers altered ventricular substrate Incessant highly recurrent ventricular arrhythmia impact hemodynamic status worsening heart failure increasing mortality stepwise teambased tailored therapeutic approach required stop ventricular arrhythmia regain hemodynamic electric stability patient author focused describing currently available therapeutic approach VES intending establish best VES therapeutic approaches process involves considering patients specific condition response previous treatments potential risk benefit approach option range adjusting antiarrhythmic therapy reprogramming ICD sedation epidural anaesthesia stellate ganglion anaesthetic block use ECMO left ventricular assist device radiofrequency catheter ablation Particular attention paid detailed management genetic primary arrhythmia syndrome like longQT syndrome catecholaminergic polymorphic ventricular tachycardia Brugada syndrome WolffParkinsonWhite syndrome early repolarisation syndrome right ventricular arrhythmogenic dysplasia idiopathic ventricular fibrillation overcoming acute event VES obtaining hemodynamic stability treatment shift toward optimal balance heart failure therapy controlling substrate revascularisation procedure resolving pathologygenerating ventricular arrhythmias article provides comprehensive overview ESVs current management option using efficient strategy known date",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806975/"
    },
    {
        "pmid": "40806960",
        "title": "Topical Chlormethine Gel in the Treatment of Lymphomatoid Papulosis: A Case Report and Literature Review.",
        "abstract": "bBackgroundb Lymphomatoid papulosis LyP primary cutaneous CD30positive Tcell lymphoproliferative disorder presenting selfhealing erythematous papulonodular lesion may ulcerate scar Treatment varies lesion extent location severity bCase Reportb describe 57yearold man acral LyP successfully treated chlormethine gel CG patient experienced impaired second finger mobility 3 month due ulcerated nodular mass 3 month CG treatment complete remission symptom resolution full joint recovery achieved Six month posttreatment patient remained remission bConclusionsb case underscore effectiveness CG achieving sustained remission acral LyP suggesting potential treatment option rare condition",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806960/"
    },
    {
        "pmid": "40806809",
        "title": "Fentanyl Research: Key to Fighting the Opioid Crisis.",
        "abstract": "bBackgroundObjectiveb Fentanyl play pivotal role opioid epidemic defined four wave overdose deaths analyse fentanyl research trends examining link mental health pharmaceutical development healthcare diseases pathophysiology within broader social health context time bMethodsb understand evolution scientific publication fentanyl relationship opioid crisis search using Web Science Core Collection PubMed conducted total 53670 document retrieved related opioid scientific production among 1423 article 3 focused specifically fentanyl 21546 MeSH term identified document analysed publication year specific fields Psychiatry Psychology Chemicals Drugs Healthcare Diseases Phenomena Processes RstatisticalFactoMineR library used correspondence analysis bResultsb first overdose death wave research focused improving therapy reducing side effects second wave emphasised detoxification method naltrexone methadone behavioural therapies third wave addressed psychological treatment HIVsyringesharing prevention fourth wave prioritised less addictive analogue understanding consumer profile combat epidemic bConclusionsb Fentanyl research evolved alongside realworld challenges reinforcing connection patients needs healthcare professionals roles illicit users policymakers research communitys contribution addressing therapeutic use broader societal impact finding highlight necessity interdisciplinary approach scientific research integrating prevention treatment education legal reform social support emphasising need public health policy collaborative research mitigate impact",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806809/"
    },
    {
        "pmid": "40806717",
        "title": "Revitalizing Colchicine: Novel Delivery Platforms and Derivatives to Expand Its Therapeutic Potential.",
        "abstract": "Colchicine potent alkaloid wellestablished antiinflammatory properties show significant promise treating classic immunemediated inflammatory diseases well associated cardiovascular diseases including atherosclerosis However clinical use limited narrow therapeutic window doselimiting systemic toxicity variable bioavailability clinically significant drugdrug interactions partly mediated modulation Pglycoprotein cytochrome P450 3A4 metabolism review explores advanced delivery strategy designed overcome limitations critically evaluate lipidbased systems solid lipid nanoparticles liposomes transferosomes ethosomes cubosomes polymerbased nanoparticles microneedles implants including drugeluting stents system ensure targeted delivery improve pharmacokinetics reduce toxicity Additionally discus chemical derivatization approaches prodrugs codrugs strategic ring modification A B Crings aimed optimizing efficacy safety profile colchicine Combinatorial nanoformulations enable codelivery colchicine synergistic agents glucocorticoid statins well theranostic platform integrate therapeutic diagnostic functions also considered innovative delivery system derivative potential transform colchicine therapy broadening clinical application minimizing adverse effects Future challenge include scalable manufacturing longterm safety validation translation research clinical practice",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806717/"
    },
    {
        "pmid": "40806606",
        "title": "Role of Dyadic Proteins in Proper Heart Function and Disease.",
        "abstract": "Cardiovascular disease encompasses wide group condition affect heart blood vessels diseases cardiomyopathy arrhythmia specifically wellstudied relationship cardiac dyads nanoscopic structure connect electrical signal muscle contraction proper development positioning dyad essential excitationcontraction EC coupling and thus beating heart Three proteins namely CMYA5 JPH2 BIN1 responsible maintaining dyadic cleft Ttubule junctional sarcoplasmic reticulum jSR Various dyadic protein play integral role primary function dyadtranslating propagating action potential AP myocardial contraction Casup2sup secondary messenger process act allosteric activator sarcomere cytoplasmic concentration regulated dyad Lossoffunction mutation shown result cardiomyopathy arrhythmias Adenoassociated virus AAV gene therapy dyad component rescue dyadic dysfunction result cardiomyopathy arrhythmias Overall dyad component serve essential mediator calcium homeostasis excitationcontraction coupling mammalian heart and dysfunctional result significant cardiac dysfunction arrhythmias morbidity mortality",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806606/"
    },
    {
        "pmid": "40806443",
        "title": "The Role of Advanced Glycation End-Products in the Pathophysiology and Pharmacotherapy of Cardiovascular Disease.",
        "abstract": "Advanced glycation endproducts AGEs formed nonenzymatic glycation proteins lipids nucleic acid due consumption highcarbohydrate diets production also promoted sedentary lifestyle well cigarette smoking Elevated level AGEs circulatory system internal organ body commonly observed number cardiovascular disease hypertension diabetes atherosclerosis coronary artery disease aortic aneurysm atrial fibrillation myocardial infarction heart failure associated development oxidative stress myocardial inflammation adverse effect AGEs cardiovascular system elicited nonreceptor mechanism involving crosslinking extracellular intracellular proteins receptormediated mechanism involving binding AGEs advanced glycation endproduct receptor RAGEs cell membrane AGERAGE interaction along crosslinking protein promote generation oxidative stress production inflammation occurrence intracellular Casup2supoverload alteration extracellular matrix leading development cardiovascular dysfunction AGEs also bind two protein receptor circulatory system soluble RAGEs sRAGEs released upon proteolysis RAGEs due activation matrix metalloproteinase endogenous secretory RAGEs esRAGEs secreted spliced variant endogenous RAGEs AGERAGE signal transduction axis serf pathogenic mechanism sRAGEs esRAGEs serve cytoprotective interventions serum level sRAGEs decreased ischemic heart disease vascular disease heart failure well cardiovascular diseases increased chronic diabetes renal disease Several intervention reduce formation AGEs block AGERAGE axis increase level circulating sRAGEs shown exert beneficial effect diverse cardiovascular diseases observation support view AGERAGE axis play critical role pathogenesis also excellent target treatment cardiovascular disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806443/"
    },
    {
        "pmid": "40806350",
        "title": "Cardioprotective Role of Captopril: From Basic to Applied Investigations.",
        "abstract": "Captopril wellestablished angiotensinconverting enzyme ACE inhibitor garnered attention cardioprotective effect preventing heart remodeling maintaining cardiac function significantly improving life quality However recent study revealed addition known hemodynamic alterations captopril exhibit significant antioxidant antiinflammatory immunomodulatory effect may underlie protective mechanisms Although appeared overlooked clinical practice recent years additional effort made uncover mechanism drug effects recent research study predict wide spectrum disease beyond recommended indications review thoroughly examines mechanism captopril mediates protective effects bridging basic biochemical observation applied clinical investigation especially ischemic reperfusion IR injury hypertension heart failure HF Evidence point captopril promising agent modulating oxidative inflammatory pathway crucial cardiovascular medicine Directions future research defined determine molecular target captopril optimize clinical utility management cardiovascular possibly diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806350/"
    },
    {
        "pmid": "40806149",
        "title": "Long-Term Outcomes of the Dietary Approaches to Stop Hypertension (DASH) Intervention in Nonobstructive Coronary Artery Disease: Follow-Up of the DISCO-CT Study.",
        "abstract": "original randomised Dietary Intervention Stop Coronary Atherosclerosis DISCOCT trial 12month Dietary Approaches Stop Hypertension DASH project led dietitian improved cardiovascular metabolic risk factor reduced platelet chemokine level patient coronary artery disease CAD unclear whether benefit sustained determine whether metabolic inflammatory clinical benefit achieved DISCOCT trial sustained six year structured intervention ended Ninetyseven adult nonobstructive CAD confirmed coronary computed tomography angiography randomly assigned receive optimal medical therapy control group ini  41 therapy combined intensive DASH counselling DASH group ini  43 301 ± 22 weeks 84 individual 87 given consent underwent reassessment body composition meal frequency assessment biochemical testing lipids hsCRP CXCL4 RANTES homocysteine Major adverse cardiovascular event MACE assessed intervention DASH group lost average 36 ± 42 kg reduced total body fat average 42 ± 48 kg compared average loss 11 ± 29 kg reduction total body fat 03 ± 41 kg control group both ipi  001 Six year later lost body weight fat tissue regained sharp increase visceral fat area group ipi  00001 CXCL4 decreased 43 ± 30 ngmL intervention remained lower baseline values contrast control group initially increased decreased ipi  0001 groups LDL cholesterol hsCRP level returned baseline group remained baseline DASH group one case MACE DASH group compared four case including one fatal myocardial infarction control group ipi  0575 Overall adherence DASH project increased 26 point counselling decreased four points remaining higher control group oneyear DASH project supported physician dietitian resulted longterm suppression proatherogenic chemokine CXCL4 fewer MACE six years despite decline adherence loss anthropometric lipid benefits appears sustained systemic reinforcement behaviour necessary maintain benefit lifestyle intervention CAD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806149/"
    },
    {
        "pmid": "40806137",
        "title": "Myokine Circulating Levels in Postmenopausal Women with Overweight or Obesity: Effects of Resistance Training and/or DHA-Rich <i>n</i>-3 PUFA Supplementation.",
        "abstract": "Menopause increase risk cardiovascular disease CVD accompanied decline muscle function Myokines released skeletal muscle could play significant role cardiovascular health study aimed investigate change induced 16week resistance training RT program andor docosahexaenoic acid DHArich ini3 PUFA supplementation myokine cytokine circulating level study association parameter body composition muscle function glucose lipid serum marker postmenopausal woman overweightobesity baseline interleukin6 IL6 level positively correlated body fat tumor necrosis factoralpha TNFα level negatively associated meterorinlike METRNL levels Moreover METRNL inversely associated insulin level HOMAIR intervention muscle quality improved either treatment notably response RT iNi3 supplementation caused significant improvement cardiometabolic health markers TNFα decreased experimental groups Myostatin level decreased RT ini3 groups IL6 increased ini3RT group Lastly interaction treatment observed postmenopausal woman overweight obesity RT could help improve skeletal muscle function DHArich ini3 supplementation might decrease CVD risk might potentially improve muscle function modulation myokine level could underlying effect DHA RT however research necessary",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806137/"
    },
    {
        "pmid": "40806117",
        "title": "Influence of Matcha and Tea Catechins on the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-A Review of Patient Trials and Animal Studies.",
        "abstract": "Metabolic dysfunctionassociated fatty liver disease MASLD chronic noncommunicable spectrum disease characterized lipid accumulation often asymptomatic prevalence varies region age gender economic status estimated 25 worlds population currently suffer MAFLD 20 million patient die MAFLDrelated diseases last 20 years tea antiobesity research indicated regularly consuming tea decrease risk cardiovascular disease stroke obesity diabetes metabolic syndrome MeS review aimed present study concerning influence matcha extract epigallocatechin3 gallate EGCG supplement metabolic function context MAFLD human animal studies published data show promise human animal studies beneficial effect body weight cholesterol levels liver metabolism function noted even shortperiod experiments safety level EGCG green tea extract consumption marked experiment needed confirm result observed animal study show mechanism green tea exerts effects preliminary data research concerning microbiota epigenetic change observed polyphenols green tea consumption need expanded improve efficiency availability green tea supplement consumption treatment MAFLD patients research larger group longer study duration needed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806117/"
    },
    {
        "pmid": "40806086",
        "title": "Gut-Microbiota-Derived Metabolites and Probiotic Strategies in Colorectal Cancer: Implications for Disease Modulation and Precision Therapy.",
        "abstract": "human gut microbiota significantly influence host health metabolic product interaction immune neural metabolic systems Among these shortchain fatty acid SCFAs especially butyrate play key role maintaining gut barrier integrity modulating inflammation supporting metabolic regulation Dysbiosis increasingly linked diverse condition gastrointestinal metabolic neuropsychiatric disorders cardiovascular diseases colorectal cancer CRC Probiotics offer therapeutic potential restoring microbial balance enhancing epithelial defenses modulating immune responses review highlight physiological function gut microbiota SCFAs particular focus butyrates antiinflammatory anticancer effect CRC also examines emerging microbial therapy like probiotics synbiotics postbiotics engineered microbes Emphasis placed need precision microbiome medicine tailored individual hostmicrobiome interaction metabolomic profiles insight underscore promising role gut microbiota modulation advancing preventive personalized healthcare",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806086/"
    },
    {
        "pmid": "40805894",
        "title": "Neurocognitive and Psychosocial Interactions in Atrial Fibrillation: Toward a Holistic Model of Care.",
        "abstract": "bBackgroundObjectivesb Psychosocial PS factor cognitive dysfunction CD patient atrial fibrillation AF may negatively impact treatment compliance PS profile cover multiple psychological socioeconomic factors although research mostly limited depression anxiety work stress study assessed prevalence broad range PS factor patient AF relationship cognitive decline bMethodsb retrospectively analyzed data patient referred cardiovascular rehabilitation clinic March 2017 April 2023 underwent standardized assessment PS factors cognition quality life bResultsb 798 included patients 230 288 AF mean age 6807 year SD 960 years Six nine PS factor present half overall sample Compared nonAF patients AF showed significantly higher level social isolation depression hostility whereas low socioeconomic status family workrelated stress mental disorder frequent nonAF group CD present 674 total cohort prevalent AF patient higher PS burden Patients permanent AF reported poorest health status bConclusionsb Integrating assessment PS factor cognition cardiac rehabilitation feasible support comprehensive patientcentred model care AF",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40805894/"
    },
    {
        "pmid": "40805864",
        "title": "Effectiveness of Acceptance and Commitment Therapy (ACT) in Patient with Cardiovascular Disease: A Systematic Review.",
        "abstract": "bBackgroundObjectivesb Cardiovascular disease CVDs encompass wide range heart vascular condition remain leading cause death worldwide Acceptance Commitment Therapy ACT psychotherapeutic approach integrates acceptance mindfulness commitment valuebased actions systematic review aim explore current evidence potential role ACT intervention supporting psychological wellbeing among individual CVDs bMethodsb systematic review conducted accordance PRISMA guidelines search literature conducted Scopus PubMed Web Science Cochrane PsycINFO databases Six study met inclusion criteria bResultsb reviewed study suggest ACT may promote psychological flexibility emotion regulation selfcare behavior patient CVDs Reported outcome include improved mindfulness reduced distress enhanced quality life However evidence base limited size methodological rigor included study varying design population bConclusionsb preliminary finding indicate ACT show promise addressing psychological aspect CVDs current evidence remains insufficient draw definitive conclusions highquality largescale study needed evaluate effectiveness clinical applicability ACT cardiovascular populations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40805864/"
    },
    {
        "pmid": "40805859",
        "title": "Evaluation of Pre-Treatment Assessment of Semaglutide Users: Balancing the Benefits of Weight Loss vs. Potential Health Consequences.",
        "abstract": "bBackgroundb Although semaglutide Ozempicsup®sup prescribed offlabel individual obesity concern arisen regarding use particularly regarding risk thyroid pancreatic disorders Therefore crucial screen patients medical family disease histories well certain clinical parameters initiating treatment obesity weight management However limited research investigating whether pretreatment assessment adopted clinical practice bMethodb singlecenter retrospective study involving adult prescribed semaglutide obesity weight management Demographic data comorbid conditions semaglutiderelated lab work disease history assessments including pancreatitis thyroid abnormalities oculopathy neuropathy family history thyroid cancer evaluated documented prior treatment initiation bResultsb total 715 patient included study average age 402 ± 120 years 495 participant male average weight BMI prior using semaglutide 998 ± 181 kg 363 ± 83 kgmsup2sup respectively predominantly overweight obese individual collectively 913 Approximately 69 patient 35 complications high prevalence cardiovascular metabolic disease using semaglutide Although HbA1c serum creatinine TSH T3 T4 triglycerides HDL LDL total cholesterol total bilirubin monitored prior semaglutide use none patients pancreatic lipase amylase calcitonin level measured Although important investigate personal family disease histories including thyroid abnormalities thyroid cancer pancreatitis retinopathy eye problems neuropathy prior semaglutide initiation check conducted 18 patients despite 986 least one disease assessed pretreatment bConclusionsb current pretreatment assessment approach patient prescribed semaglutide weight reduction underdeveloped particularly regard assessing influence disease history semaglutide use predisposes patient risk severe clinical outcomes including thyroid cancer pancreatitis retinopathy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40805859/"
    },
    {
        "pmid": "40804726",
        "title": "Fabry disease in females: organ involvement and clinical outcomes compared with the general population (103/150 characters).",
        "abstract": "Fabry disease FD rare Xlinked progressive multisystem disorder glycosphingolipid metabolism cause cellular organ damage multiple body systems FD studied extensively female male due greater heterogeneity presentation variability disease course females Furthermore despite published evidence contrary female still often referred carrier FD symptom assumed mild Findings recent study patient registry show twothirds female FD experience sign symptom different body systems third experiencing severe clinical manifestations Symptoms include wide variety cardiovascular neurologic kidney gastrointestinal psychiatricpsychologic effects significantly impair healthrelated quality life shorten life expectancy affected females Accurate timely diagnosis hindered overlap sign symptom which may nonspecific conditions well lack physician awareness Females FD often compared affected male counterpart opposed unaffected female general population may result less rigorous management female may appropriate contrasted males clinically appropriate consider onset severity symptom female FD comparison unaffected counterpart general population is therefore need greater representation female clinical study designed powered specifically detect endpoint group evaluate endpoint seen female general population without FD Improvements understanding disease phenotypes biomarkers presentation course outcome pediatric adult female needed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40804726/"
    },
    {
        "pmid": "40804626",
        "title": "Crosstalk between perivascular adipose tissue and adipocyte-derived peptide in the pathogenesis of diabetic cardiomyopathy.",
        "abstract": "Diabetic cardiomyopathy DCM prevalent complication diabetic patients pathogenic mechanism involves multiple endocrine metabolic factors dyslipidemia playing pivotal role pathogenesis disease Recent study highlighted importance peptide energy metabolism potential effect onset development DCM affecting function perivascular adipose tissue PVAT present review aim examine effect peptide perivascular adipose tissue myocardial metabolism pathogenesis DCM focusing role peptide distributed perivascular adipose tissue cardioprotection underlying mechanism action addition explore future research direction potential clinical application peptide treatment DCM",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40804626/"
    },
    {
        "pmid": "40803921",
        "title": "A person-centred clinical approach to the multimorbid patient with COPD.",
        "abstract": "patient chronic disease multimorbid particularly important patient chronic obstructive pulmonary disease COPD average five identified comorbidities independently impact health increase mortality risk Using modified Delphi method selected 20 important disease associated COPD clustered five domains mental respiratory cardiovascular metabolic multiple organ loss tissue developed systematic approach characterise impact clinical presentation individual disease within cluster define priority timing measurement potential marker disease presence severity Given absence integrated guideline treat multimorbid patients reviewed selected individual disease guideline recommendation accessed specific information related management disease addition built multimorbidity Health Dashboard that completed patient health practitioner help identify presence severity comorbid diseases using practical comprehensive approach possible identify characterise important comorbid disease patient COPD implement management tool help improve outcome expert consensus commentary summarises patientcentred recommendation manage comorbidities COPD patients aiming improve qualityoflife reduce disease burden holistic approach Prospective pragmatic trial comparing approach usual care multimorbid patient COPD including longterm followup urgently needed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803921/"
    }
]